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Why this thesis? 
Pharmaceutical compounds often have the tendency to 
crystallize in various polymorphs, solvates or hydrates as a 
function of the crystallization medium, temperature and 
humidity. This can cause many practical problems, including 
changes in stability, dissolution rates, bioavailability, 
morphology, vapor pressure, and packaging; the key factors 
for the development of appropriate dosage forms. The 
possibility to understand polymorphism and solvate or 
hydrate formation at the molecular level is very appealing. It 
critically depends, however, on the availability of powerful 
structure elucidation methods and other methods for solid-
state analysis. 
The first part of this thesis deals with application of different 
solid-state techniques in combination with crystal structure 
determination for the study of solvate and hydrate formation 
of pharmaceutical compounds and excipients. The second 
part presents a new strategy for crystal structure 
determination from powder diffraction data that circumvents 
the difficulties associated with separate indexing, nowadays 
one of the major bottlenecks in structure determination from 
powder diffraction data. 
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1.1 PHARMACEUTICAL SOLIDS 
Pharmaceutical solids have the tendency to crystallize in multiple crystal 
forms and the significance of this phenomenon, polymorphism, has been 
demonstrated through the years (Vippagunta et al., 2001). This can cause many 
practical problems, including changes in stability, dissolution rates, 
bioavailability, morphology and packaging. The physico-chemical properties of 
active pharmaceutical ingredients are key factors to the development of 
appropriate dosage forms. 
Like polymorphs (solid crystalline phases of a compound, which have at least 
two different arrangements of the molecules in solid state), solvates (crystalline 
solids with solvent molecules as part of the structure) or hydrates (crystalline 
solids with water molecules as part of the structure) of an active pharmaceutical 
ingredient or of an excipient may differ in key properties such as solubility, 
dissolution rate, stability, and particle habit. Unlike polymorphs, 
solvates/hydrates represent different chemical entities as defined by the 
stoichiometry of solvent/water with respect to the active compound. Depending 
upon the nature of the solvate/hydrate, the solvent/water content may change 
over time with ambient humidity, temperature, or other processing conditions.  
Pharmaceutical formulations contain the active ingredient(s) as well as 
excipients that serve a variety of purposes: fillers, stabilizers, coatings, drying 
agents, etc. As solid materials excipients exhibit varying degrees of 
crystallinity, from highly crystalline to nearly amorphous. 
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Another issue regarding pharmaceutical solids is the difficulty that is often 
encountered in the process of scaling up from laboratory quantities and 
procedures, through the pilot plant and into full production. Equipment 
changes, differences between the quality of laboratory scale and bulk 
chemicals, variation in heating/cooling rates, stirring procedures, seeding, can 
all influence the result of a crystallization procedure and the polymorph 
obtained (Morris et al,. 2001). 
As a result, the need to identify and evaluate the solid-state interconversions 
that may take place at the molecular level for an active pharmaceutical 
ingredient or an excipient is as great as the need to assess polymorphism. 
Figure 1.1 depicts the central role that solid-state research plays in 
pharmaceutical industry. 
 
Figure 1.1. The role of solid-state technology in pharmaceutical industry 
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1.2 SOLID-STATE ANALYSIS 
Several solid-state techniques are currently used for the study of 
polymorphism and solvate/hydrate formation such as: microscopy (scanning 
electron microscopy, hot stage optical microscopy), thermal methods 
(differential scanning calorimetry, thermogravimetric analysis), dynamic 
vapour sorption, Karl Fisher titrimetry, FT-IR spectroscopy, Raman 
spectroscopy, Solid-state NMR and X-ray diffraction (single-crystal diffraction, 
powder X-ray diffraction, hot-humidity stage X-ray powder diffraction). 
The potential application of chemical and physical techniques for the study 
of polymorphs is virtually limitless. The combination of solid-state techniques 
into a single apparatus in order to extract the maximum information from an 
experiment and a sample is particularly applicable to polymorphic systems. The 
drawback in combining techniques is that the capabilities and versatility of each 
individual technique may be compromised. Nevertheless, the versatility of the 
new technologies combining together different solid-state methods allows for 
the use of the same sample providing valuable and more reliable information. 
Nowadays, there are several examples combining visual methods with 
spectroscopic and calorimetric measurements, mass spectroscopy or FT-IR with 
thermal analysis, Raman and FT-IR (Timken et al. 1990; Williams et al. 1994; 
Webster et al. 1998). The combination of X-ray powder diffraction and climate 
chambers with controlled temperature and humidity is very promising in 
research of hydrated forms of active ingredients (Loisel et al. 1998; Guguta et 
al. 2008). Structure determination from combined data obtained with solid-state 
NMR and X-ray powder diffraction is one of the new trends in solid-state drug 
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industry (Levitt et al. 2005; Reutzel-Edens 2007; Clawson et al. 2008; Brouwer 
2008). 
Structure analysis at the molecular level is an essential step in the 
understanding of chemical and physical properties and in the evaluation of 
polymorphism and solvate/hydrate formation. Combining the information 
obtained from different solid-state techniques with structural data, a detailed 
insight into the polymorphic or hydration/dehydration behaviour of 
pharmaceutical compounds can be obtained, even at the molecular level. 
Therefore, crystal structure determination is a key technique for understanding 
solid-state properties. 
1.3 Crystalline materials 
Crystalline material exists of structural units, unit cells, which are repeated 
regularly and indefinitely in three dimensions, thereby forming a so-called 
crystal lattice (see Fig. 1.2). In case of amorphous material such a long-range 
order is not present.  
 c
b
a 
β 

 
 
 
  
 
 
Figure 1.2. Regularly repeated unit cells in crystals 
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The dimensions of a unit cell are characterized by six quantities; three axial 
lengths (a, b, c) and three interaxial angles (α, β, γ). Therefore, the unit cell has 
a definite volume, V, that contains the atoms and molecules necessary for 
generating the crystal. Each unit cell contains at least one molecule and can be 
classified by one of the seven crystal systems: triclinic, monoclinic, 
orthorhombic, hexagonal, rhombohedral, tetragonal and cubic (see Table 1.1). 
Table 1.1.  The seven crystal systems 
Cubic a = b = c; α = β = γ = 90° 
Tetragonal a = b ≠ c; α = β = γ = 90° 
Orthorhombic a ≠ b ≠ c; α = β = γ = 90° 
Hexagonal a = b ≠ c; α = β = 90°; γ = 120° 
Trigonal a = b = c; α = β = γ ≠ 90° 
Monoclinic a ≠ b ≠ c; α = γ = 90°; β ≠ 90° 
Triclinic a ≠ b ≠ c; α ≠ β ≠ γ ≠ 90° 
 
Bravais discovered that there are 14 crystal lattices, consisting of seven 
primitive and seven non-primitive ones that conform to the seven crystal 
systems (Fig. 1.3). 
Each of the crystal systems can have, in addition, one or more symmetry 
elements that describe the internal symmetry of the unit cell. The different finite 
symmetry elements are rotation, inversion, reflection and roto-inversion 
(simultaneous rotation and inversion) operations. There are 32 possible unique 
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combinations of the 10 possible finite crystallographic symmetry elements, 
each defined by a point group. The combination of 32 crystallographic point 
groups with the 14 Bravais lattices leads to 230 unique arrangements of 
"points" in space, termed space groups (Brittain et al. 1999). 
 
Figure 1.3. The 14 Bravais lattices 
Certain space groups occur more frequently than others. About 79% of all 
organic and organometallic compounds crystallize in 5 space groups: P21/c, 
P-1, P212121, C2/c and P21 (Allen, 2002). The molecules in an organic crystal 
may be chiral or achiral. Chiral molecules (non-superimposable on their mirror 
images) crystallize in chiral space groups. A chiral space group is one without 
an inversion centre, mirror or glide plane. This limits the number of space 
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groups in which chiral molecules can crystallize to a total of 65. For crystal 
structure determination from X-ray powder diffraction data, the chirality of a 
compound is an important factor to take into account since it reduces the 
possible space groups thereby reducing computing time.  
1.4 POLYMORPHS AND SOLVATES 
The best known definition of a polymorphic form is still the one formulated 
by McCrone (1965), who defined a polymorph as ‘a solid crystalline phase of a 
given compound resulting from the possibility of at least two different 
arrangements of the molecules of that compound in the solid state’. A 
schematic representation of different solid forms of a (pharmaceutical) 
compound are shown in Fig. 1.4. In Figure 1.4 polymorph 1 and 2 differ in 
molecular packing while polymorph 1 and 3 differ in molecular conformation 
(conformational polymorphism).  
Solvates are crystalline forms with solvent molecules as an integral part of 
the structure. When the solvent is water, the crystalline forms are called 
hydrates. The term of pseudopolymorphism is also used in connection with 
solvate and hydrate formation. Although the term was and is debated within the 
scientific world due to its ambiguous meaning, it is still used in pharmaceutical 
industry. The desolvation of a solvate can lead to a low-density structure, an 
isomorphic desolvate, which maintains the initial solvate crystal symmetry, or 
forms a desolvate/anhydrate (when the solvent is water) with a totally different 
crystal structure (see Fig. 1.4).  
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The formation of crystalline organic hydrates is a phenomenon that is 
frequently encountered during the isolation of active materials in the 
pharmaceutical and chemical industries. Because of its small size and 
multidirectional hydrogen bonding capability, a water molecule can often be 
easily incorporated into a crystal structure. 
 
Polymorph 1 Polymorph 2 Polymorph 3 
Desolvate/Anhydrate Isomorphic 
desolvate 
Solvate 
Amorphous 
 
 
 
 
 
 
 
Figure 1.4. Different solid forms of a (pharmaceutical) compound 
A search in the November 2007 release of the Cambridge Structural 
Database (~423 752 entries) yields 226 hits for the qualifier ‘form’, 2 757 hits 
for the qualifier ‘phase’, 14 076 hits for the qualifier ‘polymorph’, 137 hits for 
the qualifier ‘modification’, 66 689 hits for the qualifier ‘solvate’, 45 853 hits 
for the qualifier ‘hydrate’ and 2 hits for the qualifier ‘anhydrate’.  The qualifiers 
‘form’, ‘phase’ and ‘modification’ are denominating either a crystalline form of 
a solid compound, which might be a polymorphic form, or a solvate/hydrate 
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form. The frequency of polymorphs/solvates/hydrates, however, is obviously 
underestimated, since many crystal structures of polymorphic/solvate/hydrate 
systems are reported without making note of that fact. 
An amorphous solid material is random in molecular conformation and/or 
molecular packing. Amorphous materials generally have a higher energy than 
crystalline materials and therefore tend to have higher solubilities and rates of 
dissolution. 
1.5 CRYSTAL STRUCTURE DETERMINATION FROM 
POWDER DIFFRACTION DATA 
Nowadays, single-crystal X-ray diffraction is the most common method for 
the determination of molecular structures and for the elucidation of intra and 
intermolecular interactions in various materials. Often, however, suitable 
crystals for single-crystal X-ray diffraction cannot be obtained. Compounds that 
show polymorphism or solvate/hydrate formation frequently cause difficulties 
in the crystallization of one of the modifications. In addition, recrystallization 
of unstable compounds that are initially obtained as microcrystalline powders is 
often not feasible. A possible route for the structure analysis of these 
"problematic" compounds is to make optimal use of powder diffraction data. 
Powder diffraction data contains less information than single-crystal diffraction 
data, but an optimal use of the data can lead to successful results. Every year 
the number of crystal structures determined from X-ray powder diffraction data 
is increasing. 
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 The complexity of crystal structures determined from powder diffraction 
data has steadily increased through further development of "traditional" 
methods for structure determination in reciprocal space and application of 
global optimization algorithms in direct space (Harris et al., 2001; David et al., 
2002; Altomare et al., 2004; Tremayne, 2004). The currently available powder 
methods rely on high quality powder data. High quality data can only be 
obtained when the intrinsic properties of the powder and the underlying crystal 
structure are rather favorable, when frontline instrumentation (preferably 
synchrotron facilities) is used and only by careful sample preparation. 
Figure 1.5 summarizes the possible routes to determine a structure from 
diffraction data. It shows that structure determination fails when no suitable 
single crystals can be grown, when only low or moderate quality powder 
patterns can be obtained and when crystal structure prediction methods cannot 
be applied. 
 
Figure 1.5. The possible routes to determine a structure form diffraction data 
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The usual process for structure determination from powder diffraction data 
consists of the following interdependent steps: 
1. indexing of the powder pattern (determination of unit cell parameters 
a, b, c, ) 
2. space group determination  
3. structure solution (determination of an initial model) 
4. structure refinement (leading to a final, accurate model) 
Nowadays, steps (2) and (4) can be performed reasonably successful: the 
rules for space group determination are known, while for refinement the 
Rietveld method is used, which is available via many computer programs 
(McCusker et al., 1999; Young, 2002). Recent developments with respect to 
step (3) are rather spectacular through the further development of direct-method 
techniques (Favre-Nicolin et al., 2002; David and Shankland, 2008; Altomare 
et al., 2004) and search methods that use prior information on molecular 
geometry, the so-called direct space methods (Harris, 2004; Shankland et al., 
2004; David , 2004; Padgett et al., 2007). The lack of success in step (1) has 
now become one of the major bottlenecks.  
1.6 SCOPE OF THE THESIS 
The first part of this thesis deals with application of different solid-state 
techniques in combination with structure determination for the study of solvate 
and hydrate formation of a number of pharmaceutical compounds and 
excipients. The second part presents a new strategy for structure determination 
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from powder diffraction data that circumvents the difficulties associated with 
separate indexing. 
Part one consists of five chapters that describe aspartame, a sweetener and 
excipient in drug formulation, ethinyl estradiol, a well-known steroid used in 
most of the anticonceptive pills, and three opioids, agonist and antagonist ones 
used for pain relief and treatment of drug and/or alcohol addiction. Chapter 2 
and Chapter 3 provide the unknown crystal structure of aspartame anhydrate 
and a complete insight into the hydration and dehydration behavior of 
aspartame. Chapter 4 presents the crystal structures of four new ethinyl 
estradiol solvates together with a structural study of H-bond formation and 
isostructurality. In Chapter 5 the crystal structures of the naloxone monohydrate 
and four new anhydrate forms of morphine, naloxone, and their hydrochloride 
salts, determined from X-ray powder diffraction data, are presented. The role of 
water and the effect of the chloride counter-ion on structural properties of 
morphine and naloxone in the solid-state is revealed. Chapter 6 is showing how 
the different substituents in naltrexone and naloxone are influencing the 
hydration and dehydration behavior of these antagonists, also on the molecular 
scale. 
The second part of this thesis consists of Chapter 7, where a new 
methodology, called FIDDLE, for structure determination from non-indexable 
powder patterns is proposed. Structure determination from powder diffraction 
data can be seen as a process of global optimization of all model parameters, 
including the unit cell parameters. This strategy is applied in the FIDDLE 
program. For the simultaneous optimization of the parameters that describe a 
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crystal structure a genetic algorithm together with a pattern matching technique 
based on auto and cross correlation functions is used. This "one-pot" strategy 
for indexing and structure determination was successfully used for determining 
the unknown crystal structures of ethinyl estradiol anhydrate, naloxone 
monohydrate and creatine anhydrate, cases for which indexing was 
problematic. 
Introduction |      17
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Aspartame has three pseudo-polymorphic forms, two hydrates 
and a hemi-hydrate, for which crystal structures were 
determined from single-crystal diffraction data. This paper 
presents the crystal structure of the anhydrate, which was 
obtained by dehydrating the hemi-hydrate. The crystal 
structure of aspartame anhydrate, L-aspartyl-L-phenylalanine 
methyl ester, was determined from X-ray powder diffraction 
data. Aspartame anhydrate crystallizes in the monoclinic 
system with space group P21 and cell parameters: 
a=19.4078(10) Å, b=4.9605(2) Å, c=15.6547(9) Å, 
β=94.876(2)°, V=1501.65(14) Å3. Final Rietveld refinement 
ended up with Rwp=2.26 and a GOF of 2.30. Comparison with 
the hydrates of aspartame and using molecular modeling 
provides a complete and clear picture of the dehydration 
behavior of aspartame at the molecular level. 
 
2.1  INTRODUCTION  
The tendency of many pharmaceutical solids and their excipients to 
crystallize in multiple crystal forms and the significance of this phenomenon, 
polymorphism, has been demonstrated through the years. The systematic 
analysis of the polymorphic, solvate or anhydrous forms of a drug or of its 
Aspartame anhydrate |      21
excipients is nowadays an essential step in drug development as polymorphism 
can affect the final chemical, biological and pharmaceutical properties.  
Aspartame, L-aspartyl-L-phenylalanine methyl ester, is a dipeptide sweetener 
increasingly used in pharmaceuticals, food and beverages. It is known to have 
different pseudo-polymorphic forms, each one containing a different amount of 
water (Leung et al., 1998). The molecular structure of aspartame is presented in 
Fig. 2.1. 
NH
O
CH3
O
O
NH3+
-OOC
 
Figure 2.1. The molecular structure of aspartame 
Most papers report the existence of four crystal forms of aspartame, hence 
forth called IA, IB, IIA and IIB, and just three of them are described in 
literature and available from the CSD database: IA (refcode EFIFOO01), IB 
(refcode ODOBAK) and IIA (refcode DAWGOX). The anhydrate form was 
described by S.S. Leung et al. in 1998, but without any details related to the 
crystal structure. The crystal structure of the water richest form IA was 
described recently in 2005 (H. M. Cuppen et al., 2005). It crystallizes in the 
monoclinic system with space group P21 and cell parameters: a=25.450(2) Å, 
b=4.8795(9) Å, c=23.749(2) Å, =116.468(8)°, V=2640.12 Å3. The second 
hydrate of aspartame, form IB, was determined in 2000 (T. Meguro et al., 
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2000). IB also crystallizes in the monoclinic system with space group P21 and 
cell parameters: a=22.96(2) Å, b=4.964(5) Å, c=23.50(2) Å, =123.2(1)°, 
V=2241.17 Å3 and the structure shows remarkable similarities with the structure 
of IA. Aspartame hemi-hydrate (IIA) crystallizes in the tetragonal system with 
space group P41 and cell parameters: a=17.685(5) Å, b=17.685(5) Å, 
c=4.919(2) Å, ===90°, V=1538.46 Å3 (M. Hatada et al., 1985). The three 
known structures of aspartame were determined from single-crystal diffraction 
data and are presented in Fig. 2.2. The recently solved structure of the IA form 
shed light on the dehydration process between aspartames pseudo-polymorphs 
IA and IB. It appears that during dehydration of the water richest form (14% 
hydration water), IA, the principal packing does not change, but instead, the 
hydrate channels become smaller. The hydrate form IB contains a much smaller 
amount of hydration water (3.9%) and accordingly the ratio V/Z (cell 
volume/number of molecules in the cell) is significantly smaller for the IB form 
(373.528 Å3) than for the IA form (440.02 Å3). 
In this paper the structure of aspartame anhydrate (from now on called IIB) is 
described and compared to the other known forms. The structure was 
determined from powder diffraction data using the DASH software (David et 
al., 2004) and final Rietveld refinement was performed using the Topas 
software (Bruker AXS, 2003). It was a challenge to determine the crystal 
structure of this anhydrate form for several reasons. Aspartame anhydrate is 
extremely hygroscopic, crystallizes in tiny, thin needles, and due to these, no 
successful single-crystal X-ray diffraction experiment could be performed.  
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a) 
 
b) 
 
c) 
Figure 2.2. Projections along the short axis of the unit cell for (water 
molecules are indicated in gray): a) hydrate form IA (EFIFOO01); b) hydrate 
form IB (ODOBAK); c) hemi-hydrate form IIA (DAWGOX) 
Other problems are related to experimental factors like preferred orientation 
and the quality of the microcrystalline powder that is usually obtained for the 
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anhydrate. Solution of the crystal structure of the anhydrate form using the 
DASH software, was hampered by the large amount of torsion angles present in 
the molecule in combination with the number of molecules in the asymmetric 
unit, Z' = 2. As it would complete the dehydration picture on the molecular 
level for all known pseudo-polymorphic forms of aspartame, determination of 
the structure of the anhydrate was very appealing. 
2.2  EXPERIMENTAL 
2.2.1 Preparation of the anhydrate form 
Aspartame anhydrate was obtained by dehydrating hemi-hydrate form IIA. 
Hemi-hydrate form IIA was prepared at room temperature from a saturated 
solution of commercially available aspartame in water, mixed in equal volume 
with a solution made of 20% acetone, 20% ethanol, 10% dimethyl sulfoxide, 
50% water (Hatada et al., 1985). The mixture was kept at room temperature for 
four days after which a layer of needle shaped crystals was formed. To 
determine the dehydration temperature, a hemi-hydrate sample was placed in a 
Setaram calorimeter C80 II and heated from 20ºC to 300ºC at a rate of 
0.01ºC/minute. The scan indicated the formation of the anhydrate at 90ºC. 
Therefore, aspartame anhydrate was finally prepared in the calorimeter at 90ºC 
in air for 24 hours starting from pure hemi-hydrate. Before and after the 
experiment, argon gas was flushed into the calorimeter to avoid hydration. The 
sample was stored in a glove box under nitrogen atmosphere. Attempts to grow 
crystals suitable for single-crystal diffraction failed. 
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2.2.2 Solid-state NMR spectroscopy 
100.6 MHz solid-state 13C cross-polarization/magic angle spinning 
(CP/MAS) spectra were obtained using a Bruker AXS 400MHz spectrometer. 
The samples were packed into a 4 mm rotor and spun with a rate of 12 kHz. 
The 13C spectra were collected using decay with 90 excitation pulse, 6.5 ms 
relaxation delay and 2.5ms cross polarization time. 
2.2.3 X-ray powder diffraction 
X-ray powder diffraction measurements were performed on the anhydrate 
sample using a Bruker D8 AXS Advance X-ray Diffractometer. The D8 was 
equipped with a Johansson type monochromator with a focusing curved Ge 111 
crystal. A VÅNTEC-1 detector was used with an effective angular region of 2. 
The data was collected in transmission capillary geometry using 
monochromatic Cu K1 radiation. The most important instrumental and data 
collection parameters are presented in Table 2.1. 
The anhydrate sample was lightly ground, using an agate mortar with pestle 
and mounted in a 0.5 mm glass capillary tube in order to reduce preferred 
orientation effects (Howard et al., 2000). The capillary tube was filled with the 
material and sealed in a glove box under nitrogen atmosphere. The capillary 
tube was spun at 15 rpm during data collection to minimize instrumental and 
sample packing aberrations (Dollase et al., 1986). 
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Table 2.1. Instrumental and data collection parameters 
Typical instrument settings 
System  Bruker D8 AXS Advance /2 
Generator  40 kV, 40 mA 
Measuring circle (mm)  435 
Radiation (Å)  Cu K1, =1.54056Å 
Monochromator  Primary, focusing curved Ge 111 
Geometry  Transmission capillary configuration 
Sample holder  0.5 mm glass capillary tube 
Detector  VÅNTEC-1 
Typical measuring conditions 
 
Range ( 2)  4-50 
Step size ( 2)  0.0084696 
Step time (s)  50 
Total data collection time (h)  ca 74 
Spinning (rpm)  15 
 
2.2.4 Data analysis 
The diffraction pattern was indexed using DICVOL91 (Boultif & Louër, 
1991) to obtain lattice parameters that were subsequently refined in a Pawley fit 
(Pawley, 1981). Z-matrices describing the molecular topology of the fragments 
in the compound were generated automatically by DASH (David et al., 2004) 
from the structural data of hydrate form IB. Twenty runs with 107 SA 
(simulated annealing) moves per run were performed for structure solution. A 
final Rietveld refinement was performed using Topas (Cheary et al., 1992).  
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For molecular mechanics modeling, Cerius2 (Accelrys Inc., 2002) with the 
Dreiding force field was used. The electrostatic and van der Waals interactions 
were calculated using Ewald summation and Gasteiger point charges. 
2.3  RESULTS AND DISCUSSION 
2.3.1 Dehydration of aspartame hemi-hydrate 
The calorimeter scan performed on the hemi-hydrate sample in a temperature 
range from 20ºC to 300ºC indicated an endothermic peak around 90ºC, the 
decomposition of aspartame in diketopiperazine and release of methanol at 
152ºC and finally the melting point of diketopiperazine at 216ºC, in accordance 
with the data reported by Leung et al. in 1997 (Fig. 2.3). The first endothermic 
peak was interpreted as resulting from the loss of the water in the hemi-hydrate 
form IIA. This was confirmed by the absence of water in the final crystal 
structure of the samples, which were dehydrated at 90ºC.  
 
Figure 2.3. The calorimeter scan performed on the hemi-hydrate form IIA 
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2.3.2 Indexing, Pawley refinement and simulated annealing 
The X-ray powder diffraction data collected in transmission capillary 
geometry for the anhydrate had a spatial resolution of 1.8230 Å in a range from 
4-50 2. 
Twenty reflections with low and high intensity were introduced into 
DICVOL91 and a monoclinic cell with a volume of 1488.21 Å3 was found. 
Space group determination in DASH resulted in P21. The volume and space 
group P21 correspond to Z' = 2 (molecules per asymmetric unit). 13C solid-state 
NMR confirmed the number of molecules per asymmetric unit to be equal to 
two ( Fig. 2.4).  
 
Figure 2.4. Solid-state 100.6 MHz 13C CP/MAS NMR spectra of anhydrate 
form IIB 
The lattice parameters obtained after indexing were subsequently refined 
along with background, zero point, peak shape parameters and reflection 
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intensities in a Pawley fit. The characteristic parameters of the monoclinic cell 
obtained after the Pawley fit are presented in Table 2.2. 
Table 2.2. Lattice parameters and Pawley fit results 
Lattice parameters  
System Monoclinic 
Space group P21 
a (Å) 19.404 
b (Å) 4.960 
c (Å) 15.654 
 () 90 
 () 94.87 
 () 90 
V (Å3) 1501.24 
Zero point correction 0.046 
Pawley fit results 
Number of reflections 327 
Data points 5408 
Rwp 9.45 
Rexp 5.28 
Pawley 2 3.20 
 
The peak shape is implemented in DASH as a convolution of Gaussian, 
Lorentzian and axial divergence terms (asymmetry). Actually, the X-ray line 
shape is a full Voigt function, which uses two parameters 1 and 2 to describe 
the angle-dependent Gaussian component: 
 2222212 tansec   
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and two parameters 1 and 2 to describe the angle-dependent Lorentzian 
component: 
 tansec 21   
The two other asymmetry parameters are fully defined by the peak fitting 
procedure and cannot be refined by Pawley fitting. The sample gave sharp 
diffraction lines with a mean FWHM = 0.110º and a minimum value FWHM = 
0.104º for the first nine fitted peaks.  
The profile Pawley 2 is described in DASH as: 
       CPNcalcyobsyw iiiNi  /22 , 
where yi(obs) is the observed intensity at the ith step in the powder diffraction 
pattern; yi(calc) is the associated calculated intensity; , where 2/1 iiw  i  is 
the standard deviation of the observed intensity at that point. The summation is 
performed over all N data points, where N is the number of data points, P the 
number of parameters and C the number of parameter constraints. The profile 
2 for the Pawley fit had a final value of 3.20. 
Two molecular conformations of the Z-matrices describing the molecular 
geometry are shown in Fig. 2.5.  
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 Figure 2.5. The two molecular conformations used for the Z-matrices 
By superimposing the molecular conformations of the three known pseudo-
polymorphs, a high degree of similarity between the molecular conformations 
of the IA, IB and IIA forms can be noticed (see Fig. 2.6).  
 
Figure 2.6. Molecular conformations of the three pseudo-polymorphs of 
aspartame 
It is known that the two hydrates, IA and IB, have each three molecules in 
the asymmetric unit and the hemi-hydrate, IIA, has just one molecule in the 
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asymmetric unit. So, the total number of independent molecular conformations 
is seven. Measuring the values of the nine flexible torsion angles in the seven 
molecular conformations, all torsion angles, except one, exist in a narrow range 
of values. Therefore, two different simulated annealing processes were carried 
out. For one of the processes most, in principle optimisable, torsion angles in 
the anhydrate form were fixed. Only two torsion angles corresponding to each 
molecule used for the Z-matrices were optimized: O2:C4:C3:C1 and 
C4:C3:C1:C2, respectively O7:C18:C17:C15 and C18:C17:C15:C16. For the 
other simulated annealing process, all nine torsion angles had 60 of freedom. 
Both simulated annealing processes ended up with the same crystal structure 
for the solutions, having low profile 2 values. A superposition of the two 
molecular conformations resulting from the two simulated annealing processes 
is presented in Fig. 2.7a.  
 
a)     b) 
Figure 2.7. Superposition of the two molecular conformations resulting 
from: a) the two simulated annealing runs (black: fixed torsion angles; gray: 
60 freedom in torsion angles); b) simulated annealing with 60 freedom in 
torsion angles (black) and the one after Rietveld refinement (gray) 
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The structure of the best solution had a profile 2 of 8.16. The fit of the 
observed and calculated diffraction data for this solution is shown in Fig. 2.8. 
 
Figure 2.8. The fit to the diffraction data returned by the SA process 
2.3.3 Rietveld refinement 
A final Rietveld refinement (Young, 1996) of the best solution returned by 
the SA process gave a final profile Rwp=2.26, Rp=1.71 and a GOOF of 2.30. 
The fit of the final calculated diffraction data to the observed data is shown in 
Fig. 2.9. 
A comparison between the rough structure initially determined by simulated 
annealing (SA) and the one after Rietveld refinement is presented in Fig. 2.7b. 
All coordinates of the non-hydrogen atoms were freely refined, but soft 
restraints on bond lengths and angles were introduced in order to reduce the 
number of free parameters. The final crystal structure of aspartame anhydrate is 
presented in Fig. 2.10. 
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 Figure 2.9. The fit after Rietveld refinement 
 
  
  a)      b) 
Figure 2.10. Crystal structure of aspartame anhydrate: a) b-projection of four 
unit cells, b) c-projection of four unit cells  
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2.3.4 Comparison between the four pseudo-polymorphs of 
aspartame 
A comparison between the crystal structure of hemi-hydrate form IIA and the 
anhydrate form is presented in Fig. 2.11a. 
 
a) 
 
b) 
Figure 2.11. The crystal structures of: a) hemi-hydrate form IIA (black) and 
anhydrate IIB (gray) and b) hydrate form IA (black) and hydrate form IB (gray) 
A high degree of similarity between the structural models can be observed. 
Apparently, by dehydrating the hemi-hydrate (tetragonal system), the water 
disappears from the channels, the structure collapses slightly and the tetragonal 
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symmetry breaks to give a monoclinic one. The resulting volume of the unit cell 
of the anhydrate form is obviously smaller. H. M. Cuppen et al. discussed in 
2004 whether the water molecules do or do not play an important role in 
stabilizing the crystal structure of hemi-hydrate form IIA. 
Now, after determining the crystal structure of the anhydrate form, it is clear 
that the water molecules do play a role in stabilizing the tetragonal structure of 
the hemi-hydrate since dehydration leads to a loss of the tetragonal symmetry 
and the disappearance of the channels initially occupied by water. To shed more 
light on the role of the water molecules in form IIA and to possibly mimic the 
conversion of form IIA to IIB by dehydration, a number of energy minimization 
experiments were carried out in analogy with the experiments performed earlier 
by Cuppen et al., this time however with a different approach and final goal. 
For that, the same software and force field settings were used. The most 
obvious strategy to mimic dehydration of IIA is the removal of all water 
molecules from the channels and the minimization of the resulting structure. 
Cuppen already showed that such a minimization in P41 hardly changes the 
structure and it is clear that such a minimization cannot lead to the experimental 
anhydrate structure in P21. Redoing this minimization after removing all water 
molecules and reducing the space group symmetry of the structure to P1, which 
opens the possibility for symmetry breaking, yields a result that is very similar 
to the one obtained by Cuppen for P41. Clearly, only removing the water 
molecules is not sufficient to simulate the conversion from IIA to IIB. It is 
important to realize that the P41 structure IIA contains disordered water 
channels and that the presence of merely two molecules per four molecules of 
aspartame on the average leads to the conclusion that locally the water 
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molecules must be arranged according to a P21 symmetry. By converting the 
DAWGOX structure of IIA, that contains one water molecule per aspartame 
molecule, to P1 and by removing half of the water molecules per channel, an 
ordered hemi-hydrate structure can be built which has an ideal P21 symmetry 
and which shows no disordered channels. Minimizing this structure in P1 
imposes no specific symmetry on the system and might result, in principle, in a 
structure with other or lower symmetry than P21. Remarkably, minimizing this 
structure leads to a hemi-hydrate structure that is virtually identical to the 
anhydrate structure with respect to the packing of aspartame molecules (see 
Fig. 2.12).  
 
Figure 2.12. Comparison between the crystal structures of anhydrate form 
IIB (black) and ordered hemi-hydrate minimized after removing half of water 
molecules per channel (gray) 
Subsequent removal of the remaining water molecules from this minimized 
hemi-hydrate structure, which shows almost ideal P21 symmetry, results in a 
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structure that shows a slightly better match with the anhydrate structure but this 
last step is clearly less important than the ordering step (see Fig. 2.13).  
These results suggest that during dehydration of IIA, which takes place at 
elevated temperatures, the essential first step for conversion of the P41 structure 
to the P21 structure is an ordering of the water molecules inside the channels, 
prior to the final removal of the water molecules. The effect of a temperature 
raise might be a widening of the channels in IIA just enough to allow the water 
molecules, which are locked at lower temperatures as a result of the narrow 
channels, and stabilize the tetragonal structure by being disordered, to become 
ordered according to the P21 symmetry. This also suggests that there might be 
another polymorph of the hemi-hydrate, which is an ordered form of IIA, 
having P21 symmetry and having a structure very similar to the anhydrate IIB. 
The existence of this new polymorph is the subject of subsequent research. 
Minimization experiments suggest that the crystal structure after removing once 
all water molecules is a more stable structure with energy difference 
0.92 kcal/mol lower in comparison with the structure for which the water 
molecules were removed in subsequent steps. However, this energy difference 
is on the edges of the accuracy of the force field calculations. 
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 Figure 2.13. Comparison between the crystal structures of anhydrate form 
IIB (black) and ordered hemi-hydrate minimized after removing also the 
remaining water molecules (gray) 
Minimization experiments can also be performed on the IIA structure 
described in P1 in which the ratio aspartame to water is 4:1 instead of 2:1, 
followed by a minimization of the resulting structure in which all water 
molecules are removed. This would mimic partly dehydration of the IIA 
structure and could show an alternative pathway for the dehydration process. In 
this case, however, such minimizations never lead to a structure with a 
symmetry and packing close to the experimental anhydrate structure, but rather 
closer to the tetragonal packing. 
A different relation was noticed between the crystal packing of the water 
richest hydrate form IA and hydrate form IB. During dehydration of IA, the 
principal packing also does not change and the hydrate channels only shrink 
(see Fig. 2.11b). However, the monoclinic symmetry is maintained during the 
transition. In Table 2.3 the crystallographic data for all pseudo-polymorphic 
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forms of aspartame is presented to illustrate the structural differences and 
similarities between the aspartame forms. 
Table 2.3. Crystallographic data of the aspartame pseudo-polymorphs 
Unit cell IA (EFIFOO01) 
IB 
(ODOBAK) 
IIA 
(DAWGOX) 
IIB 
(Anhydrate) 
System Monoclinic-b Monoclinic-b Tetragonal-c Monoclinic-b 
Space group P21 P21 P41 P21 
a (Å) 25.450(2) 22.96(2) 17.685(2) 19.4078(10) 
b (Å) 4.8795(9) 4.964(5) 17.685(5) 4.9605(2) 
c (Å) 23.749(2) 23.50(2) 4.919(5) 15.6547(9) 
 () 90 90 90 90 
 () 116.468(8) 123.2(1) 90 94.876(2) 
 () 90 90 90 90 
V/Z (Å3) 440.02 373.528 384.615 375.412 
% H2O 14 3.9 3 0 
 
Moreover, in the case of hydrate form IA, the hydrophilic channel is made up 
of both water and aspartame molecules. Inside the channels, the remaining 
water molecules are disordered as they are much more loosely bound to the 
skeleton (H. M. Cuppen et al, 2005). Hydrate form IB has the hydrophilic 
channels made up only of aspartame molecules and the water molecules can be 
found only inside these channel. As for the case of the hemi-hydrate and 
anhydrate forms, the crystal packing of the two hydrates IA and IB are still very 
comparable. The hydrogen-bonding scheme formed by the polar amino and 
carboxyl groups of the aspartame molecules is similar. The hydrophobic sides 
of aspartame, the phenyl rings, are grouped in triples for the hydrate forms IA 
and IB, and for the hemi-hydrate and anhydrate forms in quadruples. 
Obviously, there is a relation between the crystal structures of IA, IB, IIA and 
IIB, and the possible conversions that take place between the four forms. A 
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detailed study of the possible transitions between the four forms of aspartame is 
described in Chapter 3. 
2.4  CONCLUSIONS 
The crystal structure of aspartame anhydrate was determined successfully by 
collecting X-ray powder diffraction data in transmission capillary geometry and 
using the DASH software for structure determination.  
Comparison of the structures of the hydrates and the anhydrate reveals a 
remarkable similarity between the structures of IA and IB on the one hand and 
between IIA and IIB on the other hand. Minimization experiments suggest that 
another hemi-hydrate polymorph exists and that the ordering of the water 
molecules inside the channels is an essential step in the dehydration mechanism 
of the hemi-hydrate. 
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Aspartame, L-aspartyl-L-phenylalanine methyl ester, has two 
hydrates (IA and IB), a hemi-hydrate (IIA) and an anhydrate (IIB). 
The hydration/dehydration behavior of aspartame was investigated 
using hot-humidity stage X-ray powder diffraction (XRPD) and 
molecular mechanics modeling in combination with differential 
scanning calorimetry (DSC) and thermogravimetric analysis (TGA). 
The results of this study are compared to earlier studies on 
aspartame as described in literature. It is shown that earlier transition 
studies were hampered by incomplete conversions and wrong 
assignment of the forms. The combination of the techniques applied 
in this study now shows consistent results for aspartame and yields a 
clear conversion scheme for the hydration/dehydration behavior of 
the four forms. 
 
3.1  INTRODUCTION  
Pharmaceutical solids have the tendency to crystallize in multiple crystal 
forms and the significance of this phenomenon, polymorphism, has been 
demonstrated through the years (Cui, 2007). Like polymorphs, the hydrates of 
an active pharmaceutical ingredient or of an excipient may differ in key 
properties such as solubility, dissolution rate, stability, and particle habit. 
Unlike polymorphs, hydrates represent different chemical entities as defined by 
the stoichiometry of water with respect to the active compound. Depending 
upon the nature of the hydrate, the water content may change over time with 
ambient humidity, temperature, or other processing conditions. A well-known 
example in industry is the "caking" phenomenon attributed to (re)crystallization 
of a form during storage, often induced by humidity. As a result, the need to 
identify and evaluate the hydration states available to an active pharmaceutical 
ingredient or an excipient is as great as the need to assess polymorphism. 
Aspartame, L-aspartyl-L-phenylalanine methyl ester, is a dipeptide sweetener 
increasingly used in pharmaceuticals, food and beverages. The molecular 
structure of aspartame (APM) is presented in Fig. 3.1. 
NH
O
CH3
O
O
NH3+
-OOC
 
Figure 3.1. The molecular structure of aspartame 
In 1983, Chauvet et al. reported on the kinetics of desolvation and 
decomposition of aspartame (Chauvet et al., 1983). Two years later, in 1985, 
the crystal structure of aspartame hemi-hydrate form IIA was described by 
Hatada et al. (Hatada et al., 1985). Aspartame hemi-hydrate (IIA) crystallizes in 
the tetragonal system with space group P41 and cell parameters: a=17.685(5) 
Å, c=4.919(2) Å, V/Z=384.615 Å3. Kishimoto et al. reported in 1988 on the 
morphology and process development of aspartame, demonstrating that the 
large-scale crystallization process is technically and economically possible 
(Kishimoto et al., 1988). Almost nine years later, in 1997, Leung et al. 
presented stability studies of aspartame and aspartylphenylalanine, showing that 
such model dipeptides undergo solid-state intra-molecular aminolysis by the 
elimination of methanol (Leung et al., 1997). In the case of aspartame, this 
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process leads to the cyclic compound diketopiperazine (DKP) as the exclusive 
solid product. 
In 1998, Leung et al. described the existence of two polymorphs of 
aspartame hemi-hydrate, pointing actually to hydrate form IB and hemi-hydrate 
form IIA (Leung et al., 1998). In the same year, the authors described the 
hydration and dehydration process for the hemi-hydrate form IIA and the 
existence of four forms for aspartame (Leung et al., 1998). They also provided 
a conversion scheme for the four (hydrate) forms of aspartame, based on 
differential scanning calorimetry (DSC), hot-stage X-ray powder diffraction 
(XRPD) and humidity experiments. Meguro et al. reported in 2000 on the 
crystal structure of the "low-humidity" form IB determined from single-crystal 
X-ray diffraction data (Meguro et al., 2000). The hydrate form IB crystallizes in 
the monoclinic system with space group P21 and cell parameters: a=22.96(2) 
Å, b=4.964(5) Å, c=23.50(2) Å, =123.2(1)°, V/Z=373.528 Å3. In the same 
year, Rastogi et al. presented a study of the decomposition behavior of the 
hemi-hydrate form IIA using real-time hot-stage XRPD (Rastogi et al., 2001). 
The authors also discussed the decomposition of aspartame, concluding that the 
amount of the reaction product increases with increasing temperature. In 2004, 
Cuppen et al. described the needle-like morphology of aspartame crystals by 
means of Monte Carlo simulations (Cuppen et al., 2004). 
One year later, Cuppen et al. reported on the crystal structure of the hydrate 
form IA and the morphology prediction for this form (Cuppen et al., 2005). The 
water richest hydrate form IA crystallizes in the monoclinic system with space 
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group P21 and cell parameters: a=25.450(2) Å, b=4.8795(9) Å, c=23.749(2) Å, 
=116.468(8)°, V/Z=440.02 Å3. 
The crystal structure of the anhydrate form of aspartame (IIB) was recently 
described by Guguta et al. (Guguta et al., 2006). The anhydrate form IIB 
crystallizes in the monoclinic system with space group P21 and cell parameters: 
a=19.4078(10) Å, b=4.9605(2) Å, c=15.6547(9) Å, =94.876(2)°, V/Z=375.412 
Å3. An overview of the crystal structures of the four forms of aspartame is 
presented in Fig. 3.2 (Spek, 1990). 
  
a)     b) 
  
c)      d) 
Figure 3.2. Projections along the short axis of the unit cell for: a) hydrate 
form IA (CSD refcode EFIFOO01); b) hydrate form IB (CSD refcode 
ODOBAK); c) hemi-hydrate form IIA (CSD refcode DAWGOX); d) anhydrate 
IIB (CSD refcode KETXIR); water molecules are indicated in gray 
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A high degree of similarity between the structures of hydrate form IA and 
form IB can be observed. In the case of form IA, the hydrophilic channel is 
made up of both water and aspartame molecules. Inside the channels, the 
remaining water molecules are disordered as they are loosely bound to the 
skeleton (Cuppen et al., 2005). Hydrate form IB contains hydrophilic channels 
made up of only aspartame molecules and the water molecules can be found 
only inside these channels. The hydrophobic sides of aspartame, the phenyl 
rings, are grouped in triples for the hydrate forms IA and IB. During 
dehydration of the water richest form IA (14% hydration water corresponding 
to 2.6 molecules H2O/molecule aspartame), the principal packing does not 
change, but instead, the hydrate channels become smaller. The hydrate form IB 
contains a smaller amount of hydration water (3.9% hydration water 
corresponding to 0.6 molecule H2O/molecule aspartame) and accordingly the 
ratio V/Z (cell volume/number of aspartame molecules in the cell) is 
significantly smaller for the IB form (373.528 Å3) than for the IA form 
(440.02 Å3).  
For the case of the hemi-hydrate and anhydrate forms, a different relation 
was noticed between the crystal structures (Guguta et al., 2006). Both the 
hydrophobic and hydrophilic sides of aspartame are grouped in quadruples in 
these forms. Hemi-hydrate form IIA has hydrophilic channels made up of only 
aspartame molecules and the water molecules can be found only inside these 
channels. Apparently, by dehydrating the hemi-hydrate (3% hydration water 
corresponding to 0.5 molecule H2O/molecule aspartame), the water disappears 
from the channels, the structure collapses slightly and the tetragonal symmetry 
breaks down to give a monoclinic one. 
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Altogether, aspartame is a well-studied and interesting system with respect to 
its hydration/dehydration behavior. However, combining all the information 
existent in the literature about conditions and possibilities for conversions and 
trying to match the recently available structural information of all forms IA, IB, 
IIA, and IIB with the forms identified and described in the literature, leads to 
confusing and contradictory results. The various assignments of pure forms 
seem to be hampered by incomplete conversions leading to different conditions 
for transitions. 
Therefore, this study is aimed to provide a detailed insight into the hydration 
and dehydration behavior of aspartame, down to the molecular level, using hot-
humidity stage X-ray powder diffraction and molecular mechanics modeling in 
combination with differential scanning calorimetry and thermogravimetric 
analysis. 
 3.2  EXPERIMENTAL 
3.2.1 Preparation of the four forms of aspartame 
Hydrate form IA was prepared from a saturated solution of commercially 
available aspartame in water (1.16g APM : 100mL H2O) at room temperature. 
After a few hours small needle shaped crystals already formed. To avoid the 
dehydration of the sample before the measurements, the adhering water solution 
was not removed. 
Hydrate form IB was obtained from a saturated solution of commercially 
available aspartame in water, heated to 50ºC (2.6g APM : 100mL H2O) and 
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allowed to cool to room temperature. After one week, the solvent solution was 
evaporated completely and a layer of needle shaped crystals was formed. 
Hemi-hydrate form IIA was prepared at room temperature from a saturated 
solution of commercially available aspartame in water, by mixing it with an 
equal volume of a solution made of 20% acetone, 20% ethanol, 10% dimethyl 
sulfoxide and 50% water (Leung et al., 1998). After four days, the solvent 
solution was evaporated completely and a layer of needle shaped crystals was 
formed. 
The anhydrate form IIB can be obtained by dehydrating the hemi-hydrate 
form IIA at 90ºC. Exposure to air of the anhydrate form IIB leads immediately 
to conversion to the hemi-hydrate form IIA and therefore IIB form was stored 
in a glove box under nitrogen atmosphere.  
The purity of all four forms of aspartame was checked using X-ray powder 
diffraction (Fig. 3.3). 
3.2.2 Hot-humidity stage X-ray Powder Diffraction (XRPD) 
X-ray powder diffraction was performed on the investigated samples using a 
Bruker D8 AXS Advance X-ray Diffractometer with hot-humidity stage and 
VÅNTEC-1 detector. The diffractometer was equipped with a Johansson type 
monochromator. The detector was set at an effective angular region of 2°. The 
data were collected in reflection geometry using monochromatic CuK1 
radiation. The most important instrumental and data collection parameters are 
presented in Table 3.1.  
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 Figure 3.3. The experimental X-ray powder diffraction patterns of: hydrate 
form IA; hydrate form IB; hemi-hydrate form IIA; anhydrate form IIB together 
with the simulated patterns of the forms 
Table 3.1. Instrumental and data collection parameters 
Typical measuring conditions 
Range ( 2)  2 – 40 
Step size ( 2)  0.05 
Step time (s)  1 
Relative Humidity (%RH)  0 – 80 
Temperature range (C)  25 – 125 
Heating rate (C/min)  1 
Carrier gas  Nitrogen 
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3.2.3 Differential Scanning Calorimetry (DSC) 
Differential scanning calorimetry curves were obtained using a Mettler 
Toledo 822 DSC with a TSO 801RO Sample Robot. The instrument was 
temperature calibrated using indium standards. The samples were scanned at 
0.5ºC/min or 1ºC/min from 20 to 250ºC under nitrogen purge at 40 mL/min in 
pierced aluminum pans.  
3.2.4 Thermogravimetric Analysis (TGA) 
Thermogravimetric analysis curves were generated using a TA Instruments 
Q500 TGA. The instrument was temperature calibrated using indium, tin and 
zinc standards. A weight calibration was performed using standard weights 
under nitrogen purge. The samples were scanned at 1ºC/min from 20 to 250ºC 
under nitrogen purge at 40 mL/min in pierced aluminum pans. 
3.2.5 Molecular mechanics modeling 
For molecular mechanics modeling, Cerius2 with the Dreiding force field was 
used. The electrostatic and van der Waals interactions were calculated using 
Ewald summation and Gasteiger point charges (Cerius2, 2002). 
3.3  RESULTS AND DISCUSSION 
3.3.1 Hot-humidity stage X-ray powder diffraction (XRPD) 
The complete conversions recorded with hot-humidity stage X-ray powder 
diffraction for the hydrate forms IA and IB and hemi-hydrate form IIA are 
presented in Fig. 3.4. 
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Hot-humidity stage X-ray powder diffraction was first performed on samples 
of the water richest form IA. During the hydration of form IA at 40°C and 80% 
RH for 12 hours, no other forms with a higher amount of hydration water were 
observed. After dehydrating form IA in a temperature range between 45 - 85°C 
at 0%RH, hydrate IB is formed. In order to study the reverse process, i.e. the 
conversion of the hydrate IB to form IA, form IB was hydrated at 40°C and 
80% RH. After 30 min at 40°C and 80% RH a complete conversion to form IA 
was observed (Fig. 3.4a). 
By dehydrating form IB in a temperature interval of 25 - 125°C at 0%RH, a 
complete conversion to the anhydrate form IIB was observed (Fig. 3.4b). No 
intermediate conversion to the hemi-hydrate form IIA was observed. 
To study the dehydration of the hemi-hydrate form IIA, the crystallized form 
IIA was heated in a temperature range between 40 - 85°C at 0%RH. A complete 
conversion to the anhydrate form IIB was already observed at 40°C. Leaving 
the anhydrate form IIB at 40°C and 80% RH for 140 min resulted in the reverse 
formation of form IIA (Fig. 3.4c). Continued exposure of the hemi-hydrate 
form IIA to 80%RH and 40°C, did not lead to any further conversion. 
If we compare our results with the conversion scheme reported by Leung et 
al. in 1997, we find significant differences. The X-ray powder diffraction 
patterns of the converted forms described by Leung et al. do not correspond to 
pure forms but to mixtures, as can be concluded from the crystal structures of 
the four forms now available. Leung et al. state that reversible conversions take 
place between aspartame "di-hemi-hydrate" and "hemi-hydrate form II". The 
dehydration of the "hemi-hydrate form II" leads to the anhydrate form. The 
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aspartame "hemi-hydrate form I" can be hydrated to the "di-hemi-hydrate". 
During the dehydration of the "hemi-hydrate form I", the anhydrate is formed. 
Leung et al. also states that dehydration of the "hemi-hydrate form II" leads to 
the "hemi-hydrate form I". We can now reinterpret the conversion scheme of 
Leung et al.. In terms of forms IA, IB, IIA and IIB, the scheme shows that their 
hemi-hydrate form II is in fact hydrate form IB and their "di-hemi-hydrate" is in 
fact the water richest hydrate form IA which contains considerably more water 
than the presumed monohydrate. Their hemi-hydrate form I corresponds to our 
hemi-hydrate form IIA and their anhydrate to our anhydrate form IIB. The main 
discrepancy between Leung et al. conversion scheme and ours is that we do not 
find a conversion from form IIA to form IA and also do not find a conversion 
from form IB to form IIA. In addition, Leung et al. attempted to investigate the 
susceptibility of aspartame "hemi-hydrate" to polymorphic transitions by ball-
milling at elevated temperatures and compression. Pointing towards a 
"mechanical activation" of the solid fractions as a final result, the decreased 
crystallinity of the obtained forms unfortunately hampered the solid-state 
characterization of the investigated forms. On the other hand, we found that 
milled material when used as such for conversion experiments, often shows 
incomplete conversions. Our study shows that for all conversions pure forms, in 
principal, can be obtained. Therefore, we attribute this discrepancy between our 
results and those of Leung et al. to our use of crystalline material that was not 
ground before experiments and to the extreme hygroscopicity of the anhydrate 
form. 
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a) 
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c) 
Figure 3.4. 3D pictures (left) and top views (right) of the hot-humidity stage 
X-ray powder diffraction experiments: a) the conversion of hydrate form IA to 
form IB and back to hydrate form IA; b) the conversion of hydrate form IB to 
anhydrate form IIB; c) the conversion of hemi-hydrate form IIA to anhydrate 
form IIB and back to hemi-hydrate form IIA  
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3.3.2 Thermal Analysis 
Thermal analysis can provide information on the nature of the hydrate and 
proof of the hydration level. Differential scanning calorimetry and 
thermogravimetric analysis were applied to both hydrates (IA and IB) and 
hemi-hydrate (IIA). As expected, each of the forms yielded unique DSC and 
TGA signatures. 
3.3.3 Differential Scanning Calorimetry (DSC) 
Differential scanning calorimetry curves of hydrates IA, IB and hemi-hydrate 
IIA at different heating rates are shown in Fig. 3.5.  
In order to avoid the dehydration of the sample, the adhering water from the 
IA crystals was not removed before the measurement was carried out. 
Otherwise, the sample would already have partly converted into the hydrate 
form IB. The DSC measurement of hydrate form IA, applying a heating rate of 
0.5ºC/min, exhibits two endothermic events between 20 - 100ºC due to solvent 
loss, corresponding to the formation of the hydrate form IB and respectively to 
the formation of the anhydrate form IIB (also suggested by the results obtained 
with hot-humidity stage X-ray powder diffraction). The first endothermic effect 
is remarkably large due to the removal of adsorbed water molecules and the 
water molecules incorporated in the crystal structure on one hand, and to the 
degradation of aspartame on the other hand (Fig. 3.5a). It is known that in 
aqueous solution, aspartame hydrolyses to form aspartylphenylalanine and 
phenylalanine methyl ester, competing with diketopiperazine formation (Leung 
et al., 1997). Using a higher heating rate (1ºC/min), the presence of the second 
endothermic event becomes uncertain but the hot-humidity stage X-ray powder 
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diffraction experiments at the same heating rate supports the presence of this 
event. 
The DSC measurement of hydrate form IB (Fig. 3.5b) shows an endothermic 
event due to solvent loss at temperatures between 80 - 120ºC confirming once 
again the results obtained with hot-humidity stage X-ray powder diffraction.  
DSC analysis recorded for the sample of hemi-hydrate form IIA exhibits an 
endothermic event at temperatures between 20 - 50ºC indicating the loss of 
solvent and the formation of the anhydrate IIB (Fig. 3.5c). 
Both hydrates and the hemi-hydrate exhibit two endothermic events in the 
region from 160 to 250ºC for a heating rate of 1ºC/min. The endothermic event 
recorded around 160ºC, corresponding to the decomposition of aspartame, is 
significantly smaller when starting with form IA compared to the results when 
starting with form IB or IIA, due to prior decomposition of the sample. 
The endothermic event is attributed to a cyclization reaction, which involves 
an intra-molecular aminolysis with release of methanol to form the cyclic 
compound diketopiperazine (DKP), which is in a good agreement with the 
findings of Leung et al (Leung et al., 1997). The second endothermic event 
observed at 230ºC indicates the melting of the DKP. The DSC measurement 
recorded with 0.5ºC/min for the hemi-hydrate form IIA exhibits an endothermic 
event at 230ºC indicating the decomposition of DKP and another endothermic 
effect at 235ºC, indicating the melting of the decomposition compound. The 
shifts recorded for all the investigated forms with 1ºC/min in comparison with 
the ones observed at 0.5ºC/min are attributed to the higher heating rate. 
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Figure 3.5. DSC curves recorded for: a) hydrate IA; b) hydrate IB; c) hemi-
hydrate IIA (the endothermic events are pointed out with arrows) 
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3.3.4 Thermogravimetric Analysis (TGA) 
TGA curves and their derivatives of the investigated hydrates (IA and IB) 
and hemi-hydrate (IIA) are presented in Fig. 3.6.  
Hydrate IA exhibited a remarkably high weight loss of 82.36% in a 
temperature range from 20 - 120ºC. In order to avoid the dehydration of the 
sample into the hydrate form IB, the adhering water solution from the IA 
crystals was not removed. Taking also into account that aspartame readily 
degrades in an aqueous solution, it is impossible to distinguish between the loss 
of weight caused by the removal of adsorbed water molecules, the loss due to 
the removal of water molecules incorporated in the crystal structure and the one 
corresponding to the degradation process (Fig. 3.6a). It seems that like in 
aqueous solution, the presence of adhered water allows the hydrolysis of 
aspartame to form aspartylphenylalanine and phenylalanine methyl ester, to 
compete with diketopiperazine formation (Leung et al., 1997). Determination of 
an exact temperature range corresponding to the formation of hydrate IB and 
anhydrate IIB from hydrate IA is impossible using TGA alone. 
For hydrate form IB, the TGA curve shows a weight loss of 3.469% (0.59 
molecule H2O/molecule aspartame) in a temperature range from 20  - 130ºC, 
which can be associated with the formation of the anhydrate IIB (Fig. 3.6b). In 
this case, the data obtained from TGA are in accordance with the data obtained 
from hot-humidity stage X-ray powder diffraction and DSC. 
In a temperature range from 20 - 130ºC, the TGA curve of the hemi-hydrate 
IIA exhibits a two-step weight loss corresponding to 0.38 molecule 
H2O/molecule aspartame in total (Fig. 3.6c). This might be an indication that 
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the hemi-hydrate IIA can convert upon heating to another form and finally to 
the anhydrate form. This could, however, not be confirmed by DSC or hot-
humidity stage X-ray powder diffraction. 
 
a) 
 
b) 
 
c) 
Figure 3.6. TGA and derivative curves (1ºC/min) for: a) hydrate form IA; b) 
hydrate form IB; c) hemi-hydrate form IIA 
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All investigated forms of aspartame decomposed at 170°C and the 
decomposition product DKP melted at temperatures between 230 - 250°C. As 
found in the DSC measurements, the weight loss recorded at 170ºC, 
corresponding to the decomposition of aspartame is significantly smaller when 
starting with form IA as compared to the results when starting with form IB or 
IIA, due to prior decomposition of the sample. The decomposition of aspartame 
results in the release of methanol with a theoretical weight loss of 10.55% close 
to the observed weight loss of 10.24% for the hydrate form IB and respectively 
10.49% for the hemi-hydrate form IIA. This shows that almost all aspartame is 
decomposed. 
3.3.5 Molecular mechanics modeling 
To shed more light on the role of the water molecules in form IA and to 
mimic the conversion of form IA to IB by dehydration, a number of energy 
minimization experiments were carried out in analogy with the experiments 
successfully performed earlier for the dehydration of form IIA (Guguta et al., 
2006). The most obvious strategy to mimic dehydration of the IA form is the 
removal of some water molecules from the channels in P21 and the 
minimization of the resulting structure. The inconvenience in this case is that 
the water molecules inside the channels are disordered and loosely bound to the 
skeleton, whereas the water molecules making up the channels are relatively 
strongly bonded to the aspartame architecture. The second problem is that not 
all water molecules inside the channels were well determined by single-crystal 
X-ray diffraction. Nevertheless, partial removal of water molecules, by 
removing two of the water molecules making up the channel and placing the 
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other two water molecules at an arbitrary position inside the channel followed 
by minimization of the energy, leads to a packing similar to the hydrate form IB 
minimized (Fig. 3.7a). Removing all water molecules existent in hydrate form 
IA and minimizing the structure again, also leads to such a structure (Fig. 3.7b). 
In Table 2, the unit cell parameters of the structures of hydrate IB, minimized 
hydrate IB, hydrate IA minimized in P21 after partial removal of the water 
molecules and hydrate IA minimized in P21 after removal of all water 
molecules are presented. 
 
a)      b) 
Figure 3.7. Comparison between the crystal structures of: a) the minimized 
hydrate IB (black) and hydrate IA minimized in P21 after partial removal of two 
water molecules (gray); b) the minimized hydrate IB (black) and hydrate IA 
minimized in P21 after removing all water molecules (gray) 
Repeating the minimization experiments with partial removal of water 
molecules but now reducing the space group symmetry of the structure to P1, 
which opens the possibility for symmetry breaking, yields a result that is almost 
similar to the one obtained before. Minimizing this structure in P1 imposes no 
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specific symmetry on the system and might result, in principle, in a structure 
with other or lower symmetry than P21. Apparently, in the case of aspartame 
forms IA and IB the water molecules do not play an important role in 
maintaining the monoclinic symmetry. This might have been expected for the 
water molecules inside the channels, but surprisingly even holds for the water 
molecules that make up the channels of form IA. 
Table 3.2. Comparison between the hydrate IB and the minimized IA 
structures 
Unit cell 
parameters 
IB (CSD 
refcode 
ODOBAK) 
Minimized IB 
Minimized IA 
after partial 
removal of 
water molecules
Minimized IA 
after removal 
of all water 
molecules 
a (Å) 22.96(2) 23.062 23.03 23.356 
b (Å) 4.964(5) 5.061 4.953 5.293 
c (Å) 23.50(2) 23.784 23.922 23.438 
°) 123.2(1) 118.88 117.06 123.80 
V (Å3) 2241.17 2430.6 2429.22 2408.07 
 
3.4  CONCLUSIONS 
The hydration/dehydration behavior of aspartame was investigated using hot-
humidity stage X-ray powder diffraction (XRPD) and molecular mechanics 
modeling in combination with differential scanning calorimetry (DSC) and 
thermogravimetric analysis (TGA). 
The combination of the applied techniques shows consistent results for 
aspartame and yields a clear conversion scheme for the four forms. It also 
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indicates that application of hot-humidity stage X-ray powder diffraction gives 
more detailed information. 
Hot-humidity stage X-ray powder diffraction showed reversible and 
complete conversions between the two hydrates IA and IB, and between the 
hemi-hydrate IIA and anhydrate IIB. Using the same technique, the irreversible 
conversion upon heating between hydrate form IB and anhydrate IIB was also 
observed. The conversions can be summarized in the following scheme: 
 
Hot-humidity stage X-ray powder diffraction offers a convenient way to 
follow both hydration and dehydration with respect to time, showing in 
particular the completeness of the conversions. 
Comparison of the two hydrates IA and IB revealed a remarkable similarity 
between the crystal structures. Molecular modeling experiments for the 
conversion of form IA to form IB suggest that the water molecules do not play 
an important role in maintaining the overall structure and the monoclinic 
symmetry of form IA. On removal of the water molecules in various ways and 
to various extents the packing of the aspartame molecules around the channels 
attains a similar motif. The major structural change is a shrinkage of the 
channel diameter. 
Comparing our experimental results with the structural information of the 
four forms of aspartame shows that a number of forms described in literature 
IA IB IIB25-85
oC+0%RH 85-125oC+0%RH
40oC+80%RH 
IIA
40-85oC+0%RH 
40oC+80%RH 
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are wrongly assigned or correspond to mixtures. The systematic study on 
aspartame as presented in this paper may be of importance for a further 
understanding of the formation of hydrates and shows that the availability of 
crystal structures together with analytical data provides a detailed insight into 
the hydration/dehydration behavior of compounds. 
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The (pseudo)polymorphism of ethinyl estradiol was 
investigated via extensive crystallization experiments. Four 
new crystal structures of ethinyl estradiol solvates that 
resulted from this study are presented, containing dioxane, 
nitromethane, ethanolate or DMF. The crystal structures of the 
hemihydrate, methanolate and acetonitrile solvates were 
redetermined to obtain accurate hydrogen atom positions. The 
structural details of the different solvates of ethinyl estradiol 
were investigated in order to understand the scope of solvate 
formation of ethinyl estradiol. Ethinyl estradiol forms many 
solvates, mostly with solvents having H-bond accepting or 
both accepting and donating propensity. Despite our rather 
comprehensive study no true polymorph of ethinyl estradiol 
anhydrate was found. 
 
4.1  INTRODUCTION  
Many drugs on the market are available in crystalline form owing to reasons 
of stability and ease of handling during the various stages of drug development. 
Crystalline solids can exist in pure form, as solvates or hydrates and, moreover, 
often show polymorphism. Phase transitions such as polymorph 
interconversion, desolvation, formation of hydrates and conversion of 
crystalline to amorphous forms may occur during various pharmaceutical 
processes, which may alter the dissolution rate and transport characteristics of a 
drug. Hence it is desirable to choose the most suitable and stable form of a drug 
in the initial stages of its development.  
The success rate of discovering new polymorphs by crystallization from 
solution may be increased if solvents with diverse properties are used during 
initial polymorph screening. Over the last years, several solvent classifications 
were made to provide guidelines for the judicious choice of solvents with 
diverse properties for polymorph screening. In 1994 Gu et al. reported a cluster 
analysis of different solvent properties. The authors separated 96 solvents into 
15 solvent groups taking into account eight solvent parameters, including 
hydrogen bond acceptor propensity, hydrogen bond donor propensity, 
polarity/dipolarity, dipole moment, dielectric constant, viscosity, surface 
tension and cohesive energy density which is equal to the square of the 
solubility parameter. Since the current understanding of the influence of solvent 
properties on the occurence of polymorphs is limited, it is difficult to choose 
the set of solvents that represents each group most appropriately. Therefore, Gu 
et al. recommended combining the solvents routinely used for polymorph 
screening, such as methanol and water, with other solvents from the same 
cluster. The authors also suggested that if a polymorph is discovered from a 
particular solvent, the corresponding solvent cluster might assist the choice of 
solvents for process optimization. 
In 1999 Nangia and Desiraju analyzed the relative solvate-forming properties 
of fifty common solvents, and highlighted the need for systematic studies on the 
formation and crystal structure determination of solvates. We have been 
engaged in such a study, focusing on ethinyl estradiol, an estrogen analogue 
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which shows remarkable solvate forming abilities, as was found from a detailed 
investigation of the pseudo-polymorphism of this compound.  
Estrogens are the essential hormones for the development of primary and 
secondary female sex characteristics and have a common steroid ring skeleton. 
Since the molecular conformation of steroids is related to their biological 
activity, several estrogen analogues have been investigated. Ethinyl estradiol is 
the most widely used estrogenic component in low dose oral contraceptives and 
is at least twenty times as potent in oral doses as the natural estradiol hormone. 
The molecular structure of ethinyl estradiol is presented in Fig. 4.1. 
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Figure 4.1. The molecular structure of ethinyl estradiol 
Ethinyl estradiol, (17)-19-norpregna-1,3,5-(10)-trien-20-yne-3,17-diol is 
known to have different pseudo-polymorphic forms. Crystal structures of three 
of them are described in literature and the hemihydrate structure is available 
from the CSD database. In 1987 van Geerestein reported the crystal structure of 
the hemihydrate form (CSD refcode FISWIN). It crystallizes in the monoclinic 
system with space group C2 and cell parameters: a=20.99(1) Å, b=6.647(7) Å, 
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c=12.124(2) Å, =90.51°, V=1691.4(8) Å3. In 1989, Ishida et al. redetermined 
the hemihydrate structure and also determined the structures of the methanolate 
and the acetonitrile solvates. The methanolate crystallizes in the monoclinic 
system with space group P21 and cell parameters: a=6.685(2) Å, b=16.631(6) 
Å, c=8.665(3) Å, =106.27(5)°, V=924.8(6) Å3. The acetonitrile solvate 
crystallizes in the orthorhombic system with space group P212121 and cell 
parameters: a=20.531(9) Å, b=7.283(2) Å, c=23.815(9) Å, V=3561(2) Å3. 
Here we are presenting the crystal structures of four new ethinyl estradiol 
solvates (the dioxane, nitromethane, ethanolate and N,N–dimethylformamide 
solvates), redeterminations of the hemihydrate, the methanol and acetonitrile 
solvates and an attempt to characterize an unstable solvate formed from toluene. 
In order to understand the diversity in solvate formation of ethinyl estradiol, 
structural details like H-bond formation and isostructurality were investigated. 
4.2  EXPERIMENTAL 
4.2.1 Material 
Ethinyl estradiol was obtained from Organon commercial supply. The 
preparation of the individual pseudo-polymorphic forms of ethinyl estradiol is 
described below. 
4.2.2 Preparation of the solvates 
A large number of solvates was used for possible solvate formation, but just a 
few of them gave solvate crystals or the already known hemihydrate form. All 
obtained solvates were prepared from saturated solutions of the commercially 
available ethinyl estradiol in the corresponding solvents (methanol, acetonitrile, 
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dioxane, nitromethane, N,N–dimethylformamide (DMF), ethanol and toluene) 
that were heated to temperatures about 10°C below the boiling points, followed 
by cooling to room temperature. 
4.2.3 Single-crystal X-ray diffraction 
Crystals were mounted on glass needles (Table 4.2). Intensity data were 
collected at -65C on a Nonius Kappa CCD single-crystal diffractometer, using 
Mo-K radiation and applying φ and  scan modes. The intensity data were 
corrected for Lorentz and polarization effects. A semi-empirical multi-scan 
absorption correction was applied (SADABS, Sheldrick, 1996). Direct methods 
(CRUNCH, de Gelder et al., 1993) and Patterson search methods (DIRDIF, 
Beurskens et al., 1999) were applied for structure determination. The structures 
were refined with standard methods (refinement against F2 of all reflections 
with SHELXL97) with anisotropic displacement parameters for the non-
hydrogen atoms (Sheldrick, 1997). When possible, the hydrogen atoms were 
obtained from a difference Fourier map and refined independently. In other 
cases they were placed at calculated positions and refined riding on the parent 
atoms. 
4.2.4 Hot-humidity stage X-ray powder diffraction (XRPD) 
X-ray powder diffraction employed for investigating the 
dehydration/desolvation behavior of the pseudo-polymorphs was performed 
with a Bruker D8 AXS Advance X-ray diffractometer configured with a hot-
humidity stage, controlled by an Ansyco humidity and temperature control unit. 
The samples were scanned at 25 to 150ºC in a 2θ range from 5º to 40º, with 
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0.01º step size and a counting time of 0.1s per step. Several measurements were 
done with the same characteristics using a Panalytical X'Pert Pro 
Diffractometer and an Anton Paar TTK 450 cell. 
4.2.5 Differential Scanning Calorimetry (DSC) 
Differential scanning calorimetry curves were obtained using a Mettler 
Toledo 822 DSC with a TSO 801RO Sample Robot. The temperature axis and 
the cell constant were calibrated using indium. The samples were scanned with 
5ºC/min starting from 20ºC to 245ºC under nitrogen purge at 50 mL/min in 
punched aluminum pans.  
4.3  RESULTS AND DISCUSSION 
4.3.1 (Pseudo)polymorphism screening 
It is an endless task to try every solvent in the hope to find new 
(pseudo)polymorphic forms, therefore a selection of solvents has to be made. 
Every selection contains the risk of overlooking a new form. A solvent 
classification based on cluster analysis looks very promising; however, it is not 
guaranteed that solvents from the same group show comparable behavior. In 
Table 4.1, the solvents used for (pseudo)polymorph screening are presented, 
ordered according to their hydrogen bond accepting and/or donating 
capabilities. 
The choice of solvents depended mainly on their availability. Those with 
both hydrogen bond accepting and donating propensity have either an amine 
group or an alcohol group. The solvents that yielded crystalline material are 
shown in colors, blue meaning known solvate formation, red meaning new 
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solvate formation and green meaning hemihydrate formation although an 
excess of another solvate was used. The crystals from solvents in the first two 
columns could be used for single-crystal X-ray diffraction and appeared to 
include the corresponding solvent. For the solvents with no hydrogen bond 
accepting or donating capability, crystals could only be obtained from benzene, 
chloroform, 1,2-dichloroethane and toluene. Except for toluene those crystals 
appeared to be the hemihydrate, although in the literature a solvate of 
chloroform is described (Ishida et al., 1989). For all other solvents (black) no 
(micro) crystalline material was obtained. Ethinyl estradiol did not show any 
true polymorphism as was concluded from our crystallization experiments. 
Table 4.1. Overview of solvents used 
H-bond accepting and 
donating propensity 
Only H-bond accepting 
propensity 
No H-bond accepting and 
donating propensity 
Water Acetonitrile Toluene 
Methanol N,N-Dimethylformamide Benzene 
Ethanol 1,4-Dioxane Chloroform 
Aniline Nitromethane 1,2-Dichloroethane 
Di-isopropylamine Acetone Benzylchloride 
Dimethylamine Butyl Acetate Chlorobenzene 
Methylamine Diethylether Cyclohexane 
Propanol Dimethylsulfoxide Dichlorobenzene 
 Ethyl Acetate Hexane 
 Ethylsulfide Methylenechloride 
 Nitroethane Pentane 
 Propionitrile Tetrachloromethane 
 Propyl Acetate o-Xylene 
 Pyridine  
 Tetrahydrofuran  
 Triethylamine  
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4.3.2 Structural details of the solvates 
It has been estimated that approximately one-third of the pharmaceutically 
active substances are capable of forming crystalline hydrates (Morris et al., 
1993). The water molecule, because of its small size, can easily fill structural 
voids and because of its multidirectional hydrogen bonding capability, is also 
ideal for linking a majority of drug molecules into stable crystal structures 
(Byrn et al., 1999). Solvates behave in a similar way as hydrates do. Solvent 
molecules have four different functions in crystal lattices: participants in 
hydrogen-bonding networks, space fillers with no strong interactions between 
solvent and solute molecules, bridges between polar and apolar regions and/or 
ligands completing the coordination around a metal ion. The last function will 
not be discussed here, because it is not relevant for ethinyl estradiol.  
The crystal structures of the four new solvates obtained from dioxane, 
nitromethane, ethanol and N,N-dimethylformamide were determined from 
single-crystal X-ray diffraction data. The most important crystal data for the 
new solvates together with three redeterminations are given in Table 4.2. 
In 1989 Ishida et al. reported the existence of four pseudo-polymorphs of 
ethinyl estradiol: the hemihydrate, the methanolate, the acetonitrile and the 
chloroform solvates and the crystal structures of the hemihydrate, methanolate 
and acetonitrile crystal structures could be determined. The hemihydrate form 
was already reported by van Geerestein two years earlier. We redetermined the 
crystal structures of the hemihydrate, the methanolate and the acetonitrile forms 
at -65C, resulting in lower final R factors (0.0509 for the hemihydrate, 0.0412 
for the methanolate and 0.0514 for the acetonitrile vs. the values obtained by 
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Ishida et al.: 0.057, 0.082 and 0.084 respectively). The main reason behind 
these redeterminations was, however, the wish to obtain the positions of the 
hydrogen atoms. 
 
 
 
 
 
 
 
 
 
Structure determinations of the ethinyl estradiol solvates showed a 
remarkable variety of structures with varying propensity of hydrogen bonding 
between the ethinyl estradiol and solvent guest molecules. Ethinyl estradiol 
forms different types of hydrogen bonds, such as: O-H…O, N-H…O, and 
C-H…O. In all investigated solvates (except the toluate) hydrogen bonds 
involving the –OH groups attached to the C(3) and/or C(17) of ethinyl estradiol 
and the corresponding solvent molecules are found. Another type of hydrogen 
bond appears between different ethinyl estradiol molecules, namely between the 
–OH groups attached to the C(3) and those attached to C(17). These hydrogen 
Table 4.2. Crystal data for the investigated pseudo-polymorphs 
Hemihydrate Methanolate Acetonitrile Dioxane Nitromethane Ethanolate DMF  
System Monoclinic Monoclinic Orthorhombic Orthorhombic Monoclinic Monoclinic Monoclinic 
Space
group 
 C2 P21 P212121 P212121 P21 P21 P21 
a (Å) 21.0163(7) 6.6449(7) 7.2604(5) 6.7531(9) 12.2381(5) 7.7250(4) 7.0732(3) 
b (Å) 6.5877(5) 16.5425(14) 20.4231(17) 12.2300(14) 6.7999(7) 14.6810(13) 11.2715(6) 
c (Å) 12.0946(5) 8.6480(4) 23.6356(16) 50.824(7) 21.4221(14) 23.9456(16) 30.645(2) 
 () 91.099(3) 106.090(7) 90 90 94.878(4) 94.327(4) 94.895(6) 
V (Å3) 1674.18(16) 913.38(13) 3504.6(8) 4197.5(8) 1776.2(2) 2708.0(3) 2434.2(8) 
Z’ 1 1 2 2 2 3 2 
Density
(mg/m
 
3) 1.212 1.1942(2) 1.2013(1) 1.2168(3) 1.2225(1) 1.1868(1) 1.2076(1) 
F(000) 660 356 1368 1664 704 1048.6 960 
Final R 0.0509 0.0412 0.0514 0.0565 0.0588 0.0643 0.1306 
Crysta
dimensio
(mm3
l 
ns 
) 
0.55x0.15x0.1 0.2x0.29x0.3 0.45x0.35x0.4 0.16x0.23x0.3 0.55x0.5x0.25 0.3x0.5x0.06 0.3x0.3x0.4 
 
bonds are comparable to those found in the hemihydrate form. The crystal 
structure of the hemihydrate form is presented in Fig. 4.2. 
   
  
a)     
 
                 b) 
Figure 4.2. Projection of the hemihydrate form along: a) b-axis, b) c-axis 
The water molecules in the hemihydrate structure form hydrogen bonds with 
four ethinyl estradiol molecules. For the methanolate form this is obviously 
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impossible. The molecules of ethinyl estradiol in the methanolate form are 
hydrogen bonded in a head-to-tail-to-methanol fashion forming a two-
dimensional network (Fig. 4.3). 
 
a) 
 
b) 
Figure 4.3. Projection of the methanol form along: a) a-axis, b) c-axis 
In the acetonitrile solvate, the molecules of ethinyl estradiol are hydrogen 
bonded in a head-to-head-to-tail fashion forming a two-dimensional network. 
The hydrogen bonds are between the -OH groups attached to C(3) from 
different ethinyl estradiol molecules, as well as between –OH groups attached 
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to C(17) and C(3). The solvent molecule forms a hydrogen bond between its N 
atom and the –OH group attached to C(17) of an ethinyl estradiol molecule 
(Fig. 4.4).  
    
a) 
  
b) 
Figure 4.4. Projection of the acetonitrile form along: a) a-axis, b) b-axis 
The dioxane solvate forms chains of ethinyl estradiol molecules in a head-to-
tail fashion, with another molecule of ethinyl estradiol perpendicularly bonded 
to the chain (Fig. 4.5). The space between neighboring chains of ethinyl 
estradiol molecules that are related by a twofold screw axis are occupied by 
molecules of dioxane. One of those solvent molecules forms hydrogen bonds 
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with the –OH group attached to C(17). The second dioxane solvent molecule 
forms hydrogen bonds with the ethinyl group of the ethinyl estradiol molecules 
(O…H-C(51)). As Nangia and Desiraju concluded in 1999, in most dioxane 
solvates the acceptor O atom of the dioxane molecule is found in the 
neighborhood of a hydrogen donor. 
 
a) 
 
b) 
Figure 4.5. Projection of the dioxane form along: a) a-axis, b) b-axis 
Making a comparison with the dioxane solvate, the nitromethane solvate 
shows similar chains of ethinyl estradiol molecules, and once again other 
molecules of ethinyl estradiol are perpendicularly bonded to the chain 
(Fig. 4.6). However, now only one molecule of nitromethane occupies the space 
between neighboring chains. Nitromethane shows the same type of hydrogen 
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bonding to the –OH group of the ethinyl estradiol as dioxane, but the ethinyl 
group is now involved in a hydrogen bond between two ethinyl estradiol 
molecules, resulting in a two-dimensional hydrogen bonding network.  
    
a)  
 
b) 
Figure 4.6. Projection of the nitrom ane form along: a) a-axis, b) b-axis 
The ethinyl estradiol molecules in the DMF solvate are oriented anti-parallel 
an
eth
d are shifted by half a unit cell edge with respect to each other. Remarkably 
in this solvate no hydrogen bonds are formed between ethinyl estradiol 
molecules (Fig. 4.7). Hydrogen bonding is only present between ethinyl 
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estradiol and solvent molecules. Nangia and Desiraju concluded from their 
search in the Cambridge Structural Database that 13 entries out of 14 for –OH, 
13 out of 16 for –NH and 29 out of 38 for –CH act as donors to DMF.  
   
a) 
     
b) 
Figure 4.7. Projection of the DMF form along: a) a-axis, b) b axis 
Hydrogen bonding for the ethanolate solvate yields an infinite three-
di
presented in Appendix 4.1. 
-
mensional network. The molecules are ordered in a head-to-tail-to-ethanol-to-
tail fashion (Fig. 4.8). The ethinyl groups of the ethinyl estradiol molecules are 
also involved in hydrogen bonding as was the case for the dioxane solvate. 
The hydrogen bond distances and angles for all investigated solvates are 
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a) 
  
b) 
Figure 4.8. Projection of the ethanolate form along: a) a-axis, b) b-axis 
The toluene solvate is a very unstable pseudo-polymorph converting to the 
hemihydrate form
not sufficient in order to collect enough data for a successful structure 
de
 within minutes. Protecting the crystals with paraffin oil was 
termination. Although the unit cell parameters and a P4212 space group 
could be determined, a final refinement of the crystal structure was not 
successful. It seems that the ethinyl estradiol molecules form square type 
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channels with the    -OH groups attached to the C(3) and C(17) atoms pointing 
to each other at the corners. Inside the square type channels, disordered toluene 
molecules are present. 
In summary, a high degree of similarity between the packing of the 
nitromethane and dioxane solvates can be observed (Fig. 4.9). Despite these 
solvates crystallize in different space groups, the two solvates contain 
isostructural layers of ethinyl estradiol molecules. 
 
Figure 4.9. Comparison between the crystal structures of dioxane (black) and 
nitromethane (gray) 
The crystal packing of the acetonitrile (ACN) solvate shows some similarities 
with the dioxane and nitromethane packing model. These solvents all have 
hydrogen bond accepting capabilities. Another solvent with only hydrogen 
bond accepting propensity and yielding a solvate is DMF. However this solvate 
showed a remarkable different packing. 
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Ethinyl estradiol can very easily form hydrogen bonds between the solvent 
molecules and the steroid molecule, and between the ethinyl estradiol 
mo
e both acceptors 
and donors, like ethanol and m
4.3.3 Hot-humidity and DSC studies 
The investigated solvates are converting over time into the hemihydrate 
form. Therefore the hemihydrate form is apparently the most stable form under 
normal conditions. A representative thermal conversion analyzed with X-ray 
lecules themselves. A solvent with either hydrogen bond accepting and 
donating propensity or only hydrogen bond accepting capability is necessary 
for the formation of stable solvates. Solvents with no hydrogen bond accepting 
or donating propensity occur as instable solvates (toluene and chloroform), as a 
hemihydrate or do not yield crystalline material at all. Clearly ethinyl estradiol 
has the flexibility of forming distinctly different hydrogen-bonding patterns and 
therefore it allows for the formation of a rather large and diverse series of 
pseudo-polymorphs. All investigated pseudo-polymorphs of ethinyl estradiol 
form hydrogen bonds between the –OH groups attached to the C(3) and/or 
C(17) and the corresponding solvent molecules, as well as  hydrogen bonds 
between different ethinyl estradiol molecules in most of them. 
Ethinyl estradiol forms solvates with acceptor molecules, like acetonitrile, 
DMF, dioxane and nitromethane, and with solvents, which ar
ethanol. Only with toluene, which does not 
exhibit any acceptor/donor propensity, an unstable solvate is formed. In Table 
4.3 the structural data for all pseudo-polymorphic forms of ethinyl estradiol are 
presented to illustrate the structural differences and similarities between the 
ethinyl estradiol forms.  
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powder diffraction of one of the ethinyl estradiol solvates is presented in Fig. 
4.10. Due to fast scanning time and the climate chamber environment, the X-
ray powder diffraction data showed poor resolution. However, the recorded 
data allowed us to conclude on the desolvation process of the ethinyl estradiol 
solvates. From the thermal measurements performed with hot-stage X-ray 
powder diffractometer, it is shown that during heating in the end at similar 
temperatures (100 - 110°C) all solvates transform into the anhydrate form (Fig. 
4.10).  
 
Figure 4.10. XRPD patterns of acetonitrile solvate conversions at different 
temperatures 
There are some exceptions: the methanolate form changes via an 
intermediate form to the anhydrate form. The dioxane solvate shows a different 
behavior: the solvate melts and recrystallizes from the melt, despite DSC could 
not confirm these events. 
All investigated pseudo-polymorphs of ethinyl estradiol yielded unique 
events in DSC, although some similarities could be noticed. 
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The dioxane solvate exhibits two gradually broad and small endothermic 
effects, prior to the endothermic melt event, which takes place at 100°C. The 
ethanolate solvate shows a dif
. 4.11.  
ferent behavior: the solvate recrystallizes at 
145°C after the two endothermic events (100-110°C, respectively 125-130°C), 
although this could not be confirmed with hot-stage X-ray powder diffraction 
experiments. The endothermic melting effect takes place at 184°C like for the 
other investigated pseudo-polymorphs. The hemihydrate form shows an 
endothermic effect at 130°C due to the loss of water, respectively the anhydrate 
formation. All the other investigated solvates showed a similar endothermic 
event at temperatures between 125-130°C. Despite the fact that in the DSC 
analysis the anhydrate formation takes place at a higher temperature than the 
one recorded with the hot-stage X-ray powder diffraction, this technique 
confirms that ethinyl estradiol solvates melt as the anhydrate form. The 
methanolate, acetonitrile and nitromethane solvates showed a unique 
endothermic effect at temperatures between 100-125°C, which is probably due 
to partial loss of solvent. Unfortunately, this event could not be reproduced by 
the hot-stage X-ray powder diffraction experiments. Despite the fact that DSC 
and hot-stage X-ray powder diffraction experiments show that ethinyl estradiol 
solvates melt as the anhydrate form, the DSC results do not match completely 
with the ones obtained from the hot-stage X-ray powder diffraction 
measurements. 
The DSC data recorded for the investigated pseudo-polymorphs are 
presented in Fig
  
a)     b) 
  
c)    d) 
  
e)    f) 
Figure 4.11. DSC results of ethinyl estradiol pseudo-polymorphs: a) 
hemihydrate, b) methanolate, c) acetonitrile, d) dioxane, e) nitromethane, f) 
ethanolate 
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Table 4.3. Structural data for all pseudo-polymorphic forms of ethinyl estradiol 
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4.4  CONCLUSIONS  
Ethinyl estradiol forms a fairly large number of pseudo-polymorphs but no 
true polymorph was found in this study. The crystal structures of four new 
ethinyl estradiol solvates (dioxane, nitromethane, ethanolate and DMF) were 
determined from single-crystal X-ray diffraction data. The crystal structures of 
the hemihydrate and the methanolate and ACN solvates were also redetermined 
from single-crystal X-ray diffraction data. An attempt to determine the crystal 
structure of the toluene solvate failed, owing to the instability of the crystallized 
material.  
The characteristic H-bonds formed by the ethinyl estradiol pseudo-
polymorphs are between the –OH groups attached to the C(3) and/or C(17) and 
the corresponding solvent molecules, as well as  hydrogen bonds between 
different ethinyl estradiol molecules, namely between the –OH groups attached 
to the C(3) and those attached to C(17). Ethinyl estradiol forms pseudo-
polymorphs mainly with solvents having H-bond accepting or both accepting 
and donating propensity and shows a remarkable flexibility in forming 
distinctly different hydrogen-bonding patterns, resulting in a diverse set of 
solvate structures. A high degree of similarity can be observed between the 
crystal packing of the nitromethane and dioxane solvates, forming isostructural 
sheets of ethinyl estradiol molecules arranged parallel in a head-to-tail fashion. 
DSC and hot-stage X-ray powder diffraction measurements showed that upon 
heating all ethinyl estradiol pseudo-polymorphs convert to the anhydrate form 
before melting.  
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Appendix 4.1. Hydrogen bond distances and angles for all investigated 
solvates 
Donor-H…Acceptor D-H (Å) H…A (Å) D…A (Å) D-H…A () 
Hemihydrate 
H
O H  
O(3) – H(3)…O(§) 0.80(3) 2.01(3) 2.804(3) 170 
O(17) – H(17)…O(3) 0.79(3) 2.09(3) 2.864(3) 172 
O(§) – H(§)…O(17) 0.82(3) 2.01(3) 2.805(3) 166 
Methanol          OH  
O(3) – H(3)…O(§) 0.85(3) 1.80(3) 2.642(2) 171(3) 
O(17) – H(17)…O(3) 0.86(3) 1.88(3) 2.7271(19) 169(2) 
O(§) – H (§)…O(17) 0.82(3) 1.90(3) 2.725(2) 175(3) 
Acetonitrile          N  
O(3) – H(3)…O(17) 0.88(3) 1.90(3) 2.765(2) 167(2) 
O(17) – H(17)…O(33) 0.85(3) 2.05(3) 2.8691(2) 160(3) 
O(33) – H (33)…O(3) 0.84(3) 2.04(3) 2.868(2) 167(2) 
O(47) – H(47)…N(§) 0.82(4) 2.12(4) 2.938(4) 171(3) 
C(§) – H(§)…O(47) 0.97(4) 2.43(3) 3.375(4) 165(2) 
Dioxane          
O O
 
O(3) – H(3)…O(33) 0.79(4) 1.93(4) 2.716(3) 179(5) 
O(17) – H(17)…O(3) 0.93(3) 1.87(3) 2.795(3) 170(3) 
O(33) – H (33)…O(17) 0.77(3) 1.94(3) 2.702(3) 175(3) 
O(47) – H(47)…O(§) 0.83(4) 1.98(4) 2.808(3) 177(3) 
C(48)–H (48)…O(47) 0.88(4) 2.44(3) 2.752(4) 101(3) 
C(51)–H (51)…O(§) 0.87(3) 2.32(3) 3.161(4) 162(2) 
Nitromethane          
N+
O–
O
 
O(3) – H(3)…O(33) 0.85(5) 1.93(5) 2.761(4) 167(4) 
O(17) – H(17)…O(3) 0.86(5) 2.02(4) 2.836(4) 158(4) 
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O(33) – H (33)…O(17) 0.81(5) 1.92(5) 2.712(4) 168(5) 
O(47) – H(47)…O(§) 0.99(6) 2.03(6) 2.998(4) 165(4) 
C(§) – H(§)…O(47) 0.93(5) 2.53(5) 3.362(5) 150(4) 
N,N-Dimethylformamide (DMF)           
O
N  
O(3) – H (3)…O(§) 0.83 2.14 2.720(8) 126 
O(17) – H(17)…O(§) 0.83 1.86 2.673(8) 165 
O(33) – H (33)…O(§) 0.83 1.97 2.718(9) 150 
O(47) – H(47)…O(§) 0.83 1.88 2.702(8) 171 
C(2)–H (2)…O(§) 0.94 2.55 3.218(9) 129 
C(32)–H (32)…O(§) 0.94 2.54 3.231(8) 130 
C(§)–H (§)…O(3) 0.97 2.53 3.347(9) 142 
C(§)–H (§)…O(§) 0.97 2.33 2.737(13) 105 
C(18)–H (18)…O(17) 0.97 2.26 2.812(7) 115 
Ethanol          OH  
O(3) – H(3)…O(§) 0.83 1.84 2.674(4) 177 
O(17) – H (17)…O(§) 0.83 1.81 2.613(9) 163 
O(33) – H (33)…O(17) 0.83 1.94 2.745(6) 164 
O(47) – H(47)…O(3) 0.83 1.91 2.736(3) 174 
O(63) – H (63)…O(47) 0.83 1.87 2.685(3) 165 
O(77) – H (77)…O(§) 0.83 2.47 2.795(8) 105 
O(§) – H(§)…O(63) 0.83 1.99 2.813(4) 174 
C(81)–H (81)…O(33) 0.94 2.32 3.260(7) 179 
C(§)–H (§)…O(33) 0.98 2.31 3.162(10) 144 
C(§)–H (§)…O(77) 0.98 2.58 3.156(12) 118 
§ - from different solvent molecules 
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For the structurally related agonist morphine and the antagonist 
naloxone, hydrates and anhydrates exist for both the free bases and 
the hydrochloride salts. We present five new crystal structures, 
determined from X-ray powder diffraction data, for morphine and 
naloxone: four anhydrates and one hydrate. These new structures, 
together with already known structures from the Cambridge Structural 
Database, enabled us to investigate the influence of the subtle 
molecular differences between these agonist and antagonist, the role 
of water and the effect of the chloride counter-ion on structural 
properties of morphine and naloxone in the solid state. These results 
suggest that the introduction of water or counter-ions like chlorine 
generate structures with higher dimensional hydrogen bonding 
networks than the corresponding anhydrate or free base structures. 
 
5.1  INTRODUCTION  
An agonist is a compound which binds to a specific receptor and triggers a 
response in the cell. An antagonist can compete with an agonist for a receptor 
site and can prevent an agonist from acting (Karle, 1974). Narcotic antagonists 
are 10 to 1000 times more potent enhancing receptor binding than their 
corresponding agonists (Pert et al., 1973). The agonist morphine, (5α,6α)-7,8-
didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol, a prototypical opioid, is a 
highly potent opiate analgesic drug and is one of the main active agents in 
opium. The chemical structure of morphine was established by Gates & 
Tschudi in 1952, who succeeded in synthesizing the complete molecule. In 
1925, Gulland & Robinson had already proposed exactly the same structure but 
were unable to confirm it. The molecular structure of morphine was finally 
determined and verified from two projections of hydroiodide di-hydrate by 
MacKay & Hodgkin in 1955 and therefore the chemical structure was verified. 
In Fig. 1 the molecular structure of morphine is presented. It has been observed 
that when a suitable substituent is introduced on the nitrogen atom of a nor-
morphine derivate, the resulting compounds are not addicting and, are actually 
narcotic antagonists. The antagonist naloxone (NLX), (5)-17-(allyl)-4,5-
epoxy-3,14-dihydroxymorphinan-6-one, is a drug used to counter the effects of 
opioid overdose, for example morphine or heroin. Although differing only 
slightly from narcotics, the antagonist naloxone can completely block the 
analgesic and euphoric effects of agonists, and currently it is used as emergency 
treatment for overdose of narcotics and/or alcohol.  
Naloxone (NLX) is marketed as naloxone hydrochloride due to its solubility 
in water. The molecular structure of the naloxone is presented in Fig. 5.1.  
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Figure 5.1. The molecular structures of morphine and naloxone  
For the structurally related agonist morphine and the antagonist naloxone, 
hydrates and anhydrates exist for both the free bases and the hydrochloride 
salts. The hydrochloride tri-hydrate form of morphine (refcode MORPHC) was 
determined by Gylbert in 1973 and crystallizes in the orthorhombic space group 
P212121 with cell parameters: a=6.941 Å, b=13.019 Å, c=20.750 Å, 
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V=1875.071 Å3. The crystal structure of the hydrochloride anhydrate form is 
not described in literature. The crystal structure of the morphine monohydrate 
(refcode MORPHM01) was determined in 1976 by Bye. It crystallizes in the 
orthorhombic space group P212121 with cell parameters: a=7.438(1) Å, 
b=13.751(3) Å, c=14.901(3) Å, V=1524.073 Å3. The morphine anhydrate 
(refcode MORPIN) was determined for the first time by Duchamp, but 3D 
coordinates are not available in the CSD (Duchamp et al., 1977). The authors 
reported that the morphine anhydrate crystallizes in the orthorhombic space 
group P212121 with cell parameters: a=7.408 Å, b=13.713 Å, c=14.781 Å, 
V=1501.541 Å3. Making a comparison between the unit cell parameters of the 
monohydrate and anhydrate forms of morphine, the values reported for the unit 
cell parameters are doubtful. The unit cell parameters of the morphine 
anhydrate are very close to the cell parameters of the morphine monohydrate. 
Therefore, it is unlikely that the reported unit cell is related to the crystal 
structure of the morphine anhydrate. Crystallographic data of the morphine 
hydroiodide di-hydrate (refcode MORPHI) and the morphine hydrobromide di-
hydrate (refcode ZZZRHC) is also available from the CSD indicating that the 
two forms are isostructuraly related, crystallizing in the orthorhombic system 
with space group P212121 (Mackay et al., 1955). The hydrobromide and 
hydroiodide forms of morphine are not subjected to the present study due to 
their toxic properties and are therefore less important for the pharmaceutical 
industry. 
Naloxone hydrochloride exists in different crystal forms, but just one of them 
is described in literature and available from the CSD database: the di-hydrate 
form (refcode NALOXC02). The cell parameters were described for the first 
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time in 1974 (Karle et al., 1974), but the crystal structure was determined later 
on, in 1975 and redetermined in 1987. It crystallizes in the orthorhombic space 
group P212121 with cell parameters: a=7.769(3) Å, b=13.234(5) Å, 
c=18.492(7) Å, V=1901.254 Å3 (Klein et al., 1987). The monohydrate form of 
the naloxone crystallizes in the orthorhombic system with space group P212121 
and cell parameters: a=13.903(5) Å, b=7.257(7) Å, c=16.641(1) Å, V=1678.99 
Å3 (Guguta et al., 2008). 
Comparing the molecular conformation of the agonist (i.e. morphine) and the 
antagonist (i.e. naloxone) opioids the well-known T-shape is observed. The 
five-ring system forms two planes. The stock of the T-shape is formed by the B, 
C and D rings and the arms of the T by the A and E rings (Fig. 5.2). 
Furthermore, there are no remarkable differences in the bond lengths and 
angles. The B and D rings take an envelope conformation, while the E ring has 
a chair conformation and C is a flat ring. The A ring has a twisted boat 
conformation in the already known morphine forms while, within the known 
naloxone forms, the A ring has a twisted chair conformation. 
   
Figure 5.2. The T-shape five-ring system depicting with gray the molecule 
of morphine and with black the molecule of naloxone (the dashed circle points 
to the different A ring conformation) 
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The overall molecular conformation of the agonist and antagonist opioids 
shows minor differences although chemically they are quite different. The 
effects of the longer substituent on the nitrogen atom or the existence of a 
counter ion is not affecting in a dramatic way the molecular structure of the two 
opioids.  
Comparing the existent structural data in the CSD shows that all morphine 
and naloxone forms crystallize in the orthorhombic space group P212121. From 
a crystallographic point of view it is interesting to determine how substituents, 
water and counter ion are influencing the chemical crystallography of the 
agonist and antagonist under subject. In this study the crystal structures of the 
naloxone monohydrate and four new anhydrate forms of morphine, naloxone 
and their hydrochloride salts are determined from X-ray powder diffraction 
data. Knowledge of the structural crystallographic data enables us to investigate 
the influence of the subtle molecular differences between these agonist and 
antagonist, the role of water and the effect of the chloride counter-ion on 
structural properties of morphine and naloxone in the solid state. 
5.2  EXPERIMENTAL 
5.2.1 Material 
Morphine hydrochloride and morphine were obtained from Campro 
Scientific commercial supply. Naloxone hydrochloride was obtained from 
Diosynth commercial supply. The preparation procedures of the individual 
hydrate/anhydrate forms for morphine hydrochloride, morphine, naloxone 
hydrochloride and naloxone, are described below. 
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5.2.2 Preparation of morphine hydrochloride anhydrate 
Morphine hydrochloride anhydrate was obtained by dehydrating the tri-
hydrate form at 140C, under vacuum (10-2mbar). Before and after the 
experiment, argon gas was flushed into the reaction vessel. The sample was 
stored in a glove box under nitrogen atmosphere. 
5.2.3 Preparation of morphine anhydrate 
Morphine anhydrate was obtained by dehydrating the monohydrate at 150C, 
under vacuum (10-2mbar). Before and after the experiment, argon gas was 
flushed into the reaction vessel. The sample was stored in a glove box under 
nitrogen atmosphere. 
5.2.4 Preparation of naloxone hydrochloride di-hydrate 
The di-hydrate form of naloxone hydrochloride was prepared from a diluted 
aqueous HCl solution of starting material at room temperature (1g NLX : 
100mL H2O). After the complete evaporation of the solvent, needle shaped 
crystals were obtained. 
5.2.5 Preparation of naloxone hydrochloride anhydrate 
Naloxone hydrochloride anhydrate was obtained by dehydrating the di-
hydrate form at 140C, under vacuum (10-2mbar) and in presence of P2O5 
drying agent. Before and after the experiment, argon gas was flushed into the 
reaction vessel. The sample was stored in a glove box under nitrogen 
atmosphere. Attempts to grow crystals suitable for single-crystal diffraction 
failed. 
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5.2.6 Preparation of naloxone monohydrate 
A solution of sodium bicarbonate (0.25g NaHCO3 :100 mL H2O) was added 
to an aqueous solution of naloxone hydrochloride (1g naloxone hydrochloride: 
100 mL H2O). After complete addition, the reaction mixture was stirred for one 
hour at room temperature to stimulate CO2 release. The formed naloxone free 
base was extracted from the NaCl solution with chloroform. After the total 
removal of the chloroform the monohydrate form of naloxone was obtained. 
5.2.7 Preparation of naloxone anhydrate 
The previously obtained white powder of naloxone monohydrate was heated 
at 140C, under vacuum (10-2mbar). Before and after the experiment, argon gas 
was flushed into the reaction vessel. White needle shaped crystals of naloxone 
anhydrate sublimated on the reaction vessel. The sample was stored in a glove 
box under nitrogen atmosphere. 
5.2.8 X-ray Powder Diffraction (XRPD) 
X-ray powder diffraction measurements for crystal structure determination 
were performed using a Bruker AXS D8 Advance X-ray Diffractometer. The 
D8 was equipped with a Johansson type monochromator with a focusing curved 
Ge 111 crystal. A VÅNTEC-1 detector was used with an effective angular 
region of 2. The data was collected in transmission capillary geometry using 
monochromatic Cu K1 radiation. The anhydrate samples were lightly ground, 
using an agate mortar with pestle and mounted in 0.5 mm glass capillary tubes. 
The capillary tubes were filled with the materials and sealed in a glove box 
under nitrogen atmosphere. The capillary tubes were spun at 15 rpm during data 
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collection in order to reduce preferred orientation effects (Howard et al., 2000) 
and to minimize instrumental and sample packing aberrations (Dollase et al., 
1986). 
The most important instrumental and data collection parameters are 
presented in Table 5.1. 
Table 5.1. Instrumental and data collection parameters 
Typical instrument settings 
System  Bruker AXS D8 Advance /2 
Generator  40 kV, 40 mA 
Measuring circle (mm)  435 
Radiation (Å)  Cu K1, =1.54056Å 
Monochromator  Primary, focusing curved Ge 111 
Geometry  Transmission capillary configuration 
Sample holder  0.5 mm glass capillary tube 
Detector  VÅNTEC-1 
Typical measuring conditions 
Range ( 2)  5-50 (60) 
Step size ( 2)  0.0084696 
Step time (s)  50 
Total data collection time (h)  ca 75 (92) 
Spinning (rpm)  15 
5.2.9 Data analysis for crystal structure determination 
All diffraction patterns (except the one for naloxone monohydrate) were 
indexed using DICVOL91 (Boultif & Louër, 1991) to obtain lattice parameters 
that were subsequently refined in a Pawley fit (Pawley, 1981). Z-matrices 
describing the molecular topology of the fragments in the compound were 
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generated automatically by DASH (David et al., 2004) from the structural data 
of the investigated compounds available in the CSD and twenty runs with 107 
SA (simulated annealing) moves per run were performed for structure solution. 
To the best solution obtain after SA process, a final full Rietveld refinement 
was performed using Topas software (Cheary et al., 1992). 
The crystal structure of naloxone monohydrate was determined using the 
FIDDLE program (2008).  A final full Rietveld refinement was performed on 
the naloxone monohydrate structure using the Topas software. 
5.2.10 Solid-State NMR Spectroscopy (SSNMR) 
100.6 MHz solid-state 13C cross-polarization/magic angle spinning 
(CP/MAS) spectra were obtained using a Bruker AXS 400MHz spectrometer. 
The samples were packed into a 4 mm rotor and spun with a rate of 12 kHz. 
The 13C spectra were collected using decay with 90 excitation pulse, 6.5 ms 
relaxation delay and 2.5ms cross polarization time.  
5.3  RESULTS 
5.3.1 Crystal structure determination of the four anhydrate forms 
Indexing, Pawley refinement and simulated annealing process 
The 2 ranges used for indexing, Pawley refinement and simulated annealing 
were from 5-45 for the anhydrate forms of morphine hydrochloride and 
naloxone hydrochloride with a spatial resolution of 2.0129 Å, and from 5-60 
for the anhydrate forms of morphine and naloxone, with a spatial resolution of 
1.5406 Å.  
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Twenty reflections with low and high intensity were introduced into 
DICVOL91 and an orthorhombic cell was found for the anhydrates of morphine 
hydrochloride, morphine and naloxone hydrochloride. Naloxone anhydrate 
crystallizes in the monoclinic system. Space group determination in DASH 
resulted in P212121 for morphine hydrochloride, morphine and naloxone 
hydrochloride, and P21 for the naloxone anhydrate. The volume and space 
group P212121 respectively P21 correspond to Z' = 1 (molecules per 
asymmetric unit). 13C solid-state NMR confirmed the number of molecules per 
asymmetric unit to be equal to one.  
The lattice parameters obtained after indexing were subsequently refined 
along with background, zero point, peak shape parameters and reflection 
intensities using Pawley refinement. The characteristic parameters of the 
orthorhombic cells and the monoclinic one obtained after Pawley refinements 
are presented in Table 5.2.  
The peak shape is implemented in DASH as a convolution of Gaussian, 
Lorentzian and axial divergence terms (asymmetry). Actually, the X-ray line 
shape is a full Voigt function, which uses two parameters 1 and 2 to describe 
the angle-dependent Gaussian component: 
 2222212 tansec   
and two parameters 1 and 2 to describe the angle-dependent Lorentzian 
component: 
 tansec 21   
 
Table 5.2. Lattice parameters and Pawley refinement results 
Lattice parameters 
Morphine 
hydrochloride 
anhydrate 
Morphine 
anhydrate 
Naloxone 
hydrochloride 
anhydrate 
Naloxone 
anhydrate 
System Orthorhombic Orthorhombic Orthorhombic Monoclinic 
Space group P212121 P212121 P212121 P21 
a (Å) 16.179 13.861 17.453 8.540 
b (Å) 12.816 12.770 14.684 12.679 
c (Å) 7.430 7.690 7.978 7.652 
 () - - - 97.081 
V (Å3) 1540.882 1362.059 2044.816 822.330 
Zero point correction 0.084 0.032 0.057 0.030 
Pawley refinement results 
Number of reflections 134 249 173 254 
Data points 4738 6862 4612 6515 
Pawley 2 9.306 7.056 22.460 4.880 
 
The two other asymmetry parameters are fully defined by the peak fitting 
procedure and cannot be refined by Pawley fitting. The investigated samples 
gave sharp diffraction lines, for the first eight fitted peaks, with a mean FWHM 
= 0.178º for morphine hydrochloride anhydrate, 0.085º for morphine anhydrate, 
0.092º for naloxone hydrochloride anhydrate and 0.076º for naloxone 
anhydrate, and a minimum value FWHM = 0.131º for morphine hydrochloride 
anhydrate, 0.072º for morphine anhydrate, 0.078º for naloxone hydrochloride 
anhydrate and 0.0704º for naloxone anhydrate.  
The profile Pawley 2 is described in DASH as: 
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       CPNcalcyobsyw iiiNi  /22 , 
where yi(obs) is the observed intensity at the ith step in the powder diffraction 
pattern; yi(calc) is the associated calculated intensity; , where 2/1 iiw  i  is 
the standard deviation of the observed intensity at that point. The summation is 
performed over all N data points, where N is the number of data points, P the 
number of parameters and C the number of parameter constraints. 
The molecular conformations of the Z-matrices describing the molecular 
geometry of the investigated forms are shown in Fig. 5.3.  
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Figure 5.3. The molecular conformations used for the Z-matrices of: a) 
morphine; b) naloxone  
Morphine does not have free rotable torsion angles. The 20 solutions 
obtained after the simulated annealing processes showed 2 profile values of 
18.66 for morphine hydrochloride anhydrate and 19.17 for morphine anhydrate. 
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Naloxone has two rotable torsion angles: C18:C17:N1:C9 and 
C19:C18:C17:N1, optimized during the simulated annealing (SA) process. The 
simulated annealing process ended up with 20 solutions having a 2 profile 
values of 40.87 for naloxone hydrochloride anhydrate and 28.62 for naloxone 
anhydrate. 
The fit of the observed and calculated diffraction data for the best solutions 
found after simulated annealing are shown in Fig. 5.4 for all four investigated 
forms. 
5.3.2 Rietveld refinement 
After structure solution, full Rietveld refinements were applied to the best 
solutions returned by the SA processes (Young, 1996). To the crystal structure 
of naloxone monohydrate determined with the FIDDLE software, a full 
Rietveld refinement was also applied. Almost all coordinates of the non-
hydrogen atoms were freely refined, but soft restraints on bond lengths and 
angles were introduced in order to reduce the number of free parameters. The 
full Rietveld refinements proceeded smoothly to reach a minimum 
characterized by an excellent fit to the diffraction profiles presented in Fig. 5.5 
for all five investigated forms. The crystallographic data of the refined crystal 
structures is presented in Table 5.3. 
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a) 
 
b) 
 
c) 
 
d) 
Figure 5.4. The fit to the diffraction data returned by the SA processes for 
the anhydrate forms of: a) morphine hydrochloride anhydrate; b) morphine 
anhydrate; c) naloxone hydrochloride anhydrate; d) naloxone anhydrate 
     | Chapter 5  110
Table 5.3. Crystallographic data of the refined forms after full Rietveld 
refinement 
Cell 
parameters 
Morphine 
hydrochloride 
anhydrate 
Morphine 
anhydrate 
Naloxone 
hydrochloride 
anhydrate 
Naloxone 
monohydrate  
Naloxone 
anhydrate 
System Orthorhombic Orthorhombic Orthorhombic Orthorhombic Monoclinic 
Space group P212121 P212121 P212121 P212121 P21 
a (Å) 16.079(4) 13.861(7) 17.452(4) 13.903(5) 8.539(2) 
b (Å) 12.874(6) 12.777(1) 14.681 (4) 7.257(7) 12.678 (4) 
c (Å) 7.494(6) 7.690(4) 7.978 (2) 16.641(1) 7.652(2) 
 () - - - - 97.078 
V (Å3) 1551.50 1362.06 2044.10 1678.99 822.16 
Final profiles 
Rwp 4.161 4.157 2.650 2.901 5.212 
Rp 3.034 3.016 1.850 2.211 3.492 
GOF 2.373 3.643 2.600 1.527 3.344 
 
5.4  DISCUSSION 
Many pharmaceutical compounds are available on the market in crystalline 
form mainly due to reasons of stability during the time between the 
manufacture of the active ingredient and used by the patient. Most of the 
crystalline drugs are able to form solvates or hydrates. Hydrates are solid 
adducts containing the parent compound (e.g., the anhydrate of a drug) and 
water. Due to its small molecular volume, high ability to form H-bonds and 
non-toxic properties, water is an ideal solvent for linking drug molecules into 
stable crystalline forms. The environment of the water molecules may exhibit 
various defined packing patterns, which will reflect in the drug behavior.  
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a) 
 
b) 
 
c) 
 
d) 
 
e)  
Figure 5.5. The fit after the final Rietveld refinement for: a) morphine 
hydrochloride anhydrate; b) morphine anhydrate; c) naloxone hydrochloride 
anhydrate; d) naloxone monohydrate; e) naloxone anhydrate 
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The presence of water molecules influences the intermolecular interactions 
(affecting the internal energy and enthalpy) and the crystalline disorder 
(entropy), hence influences the free energy, the thermodynamic activity, 
solubility, dissolution rate, stability, and bioavailability (Khankari et al., 1995). 
Therefore we will further discuss various structural features and in particular 
typical H-bonds formed by morphine, naloxone and their hydrochloride forms 
in order to evaluate the influence of the subtle molecular differences between 
these two agonist and antagonist opioids, the role of water and the effect of the 
chloride counter-ion on structural properties of morphine and naloxone in the 
solid state. 
In morphine hydrochloride tri-hydrate, the morphine molecules are packed in 
a zigzag head-to-tail fashion. H-bonds are formed between the –OH group 
attached to C(6) and the N atom from another morphine molecule. With the aid 
of the water molecules, the zigzag layers in morphine hydrochloride tri-hydrate 
are assembled in a three-dimensional network. The three-dimensional network 
is formed by H-bonds between the –OH groups attached to C(3), respectively 
C(6) and water molecules. The Cl- is involved in H-bonding with the water 
molecules as well. H-bonds are also observed between different water 
molecules. The anhydrate form of morphine hydrochloride has the zigzag 
packing pattern like in the tri-hydrate, but this time the morphine molecules are 
bonded in a head-to-Cl--to-tail fashion forming a one-dimensional network 
between the N atom, the Cl- and –OH groups attached to C(3) and C(6). The 
packing of the morphine molecules in morphine hydrochloride tri-hydrate and 
hydrochloride anhydrate is presented in Fig. 5.6. 
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a)      b) 
Figure 5.6. The packing of the morphine: a) hydrochloride tri-hydrate, 
b) hydrochloride anhydrate (characteristic H-bonds are depicted in gray) 
The molecules of morphine in morphine monohydrate are H-bonded in a 
head-to-tail fashion forming layers assembled together by the water molecules 
in to a three-dimensional network. The H-bonds are formed between the –OH 
group attached to C(3) and the N atom. The water molecules are also involved 
in H-bonding on one hand with the –OH groups attached to C(3) and C(6) and 
on the other hand with other water molecules. In the absence of water 
molecules the morphine molecules are packed in a head-to-head fashion, 
forming a one-dimensional network. The –OH group attached to C(3) of a 
morphine molecule is then involved in H-bonding with the –OH group attached 
to C(6) of another morphine molecule. The packing of the morphine molecules 
in morphine monohydrate and anhydrate is presented in Fig. 5.7. 
     | Chapter 5  114
                 
a)     b) 
Figure 5.7. The packing of the morphine: a) monohydrate, b) anhydrate 
(characteristic H-bonds are depicted in gray) 
The naloxone molecules in naloxone hydrochloride di-hydrate are also 
packed in a three-dimensional network with the aid of water molecules. H-
bonds are formed between the –OH group attached to C(3), respectively C(14) 
and water molecules. The carboxyl group and the Cl- are also involved in H-
bonding with the water molecules. As expected, H-bonds between different 
water molecules are also observed. Obviously, the water molecules play a 
stabilizing role in the network formation of naloxone hydrochloride di-hydrate. 
The naloxone molecules in naloxone hydrochloride anhydrate are also 
assembled in a three-dimensional network, but this time with the aid of the Cl- 
anion. Cl- forms H-bonds with the N atom and with the (-OH) groups attached 
to C(3), and C(14). The packing of the naloxone molecules in naloxone 
hydrochloride di-hydrate and hydrochloride anhydrate is presented in Fig. 5.8. 
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a ) 
Figure 5.8. a) hydrochloride di-hydrate, 
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tail. The packing of the naloxone molecules in naloxone monohydrate and 
anhydrate is presented in Fig. 5.9. 
 
                     
a)      b) 
Figure 5.9. The packing of the naloxone: a) monohydrate, b) anhydrate 
(characteristic H-bonds are depicted in gray) 
The presence of water molecules leads to the formation of three-dimensional 
networks in the hydrated forms of the agonists’ morphine, morphine 
hydrochloride and the antagonist naloxone hydrochloride. On the other hand, 
the anhydrate forms of morphine, morphine hydrochloride and naloxone are 
able to form only one-dimensional networks due to the absence of water 
molecules and their involvement in H-bonding.  
Dehydration of the hydrate forms of both the salt and the free base of 
morphine, induces a change in the H-bond network dimensionality from 3D to 
1D. For naloxone, the dehydration takes place without any change in the H-
bond network dimensionality.  
The salt forms of naloxone show a higher dimensionality than the free base 
forms due to the involvement of Cl- in additional H-bonding. Naloxone 
hydrochloride anhydrate forms a three-dimensional network due to the 
favorable position of the Cl- in the crystal structure. Morphine hydrochloride 
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anhydrate is only able to form a one-dimensional network due to a different 
position of the Cl- in the crystal structure.  
All the hydrate forms of the investigated opioids form 3D H-bond networks, 
except naloxone monohydrate that forms a 1D H-bond network. Naloxone 
monohydrate dehydrates to form the anhydrate with breaking of the 
orthorhombic symmetry, ending up in a monoclinic one with space group P21. 
Apparently, in this case, the water molecules play a role in stabilizing the 
orthorhombic symmetry. By dehydrating the monohydrate water molecules 
disappear from the net, however, without disturbing the one-dimensional 
network of naloxone.  
In the anhydrate forms of the investigated opioids, the counter ion Cl- usually 
takes over the role of the water molecules. Cl- can form H-bonds with the N 
atom as well, but when water molecules are present in the crystal structure, Cl- 
prefers the water molecules instead of the N atom. When Cl- and water 
molecules are not present (morphine anhydrate and naloxone anhydrate), 
intermolecular H-bonds are formed between the –OH groups, taking over the 
role of the counter ion and/or water molecules. While in the monohydrate form 
of naloxone the allylic group is involved in H-bonding, in the anhydrate form 
the allylic group is no longer involved. 
The characteristic structural features of the hydrate and anhydrate forms of 
naloxone, naloxone hydrochloride, morphine, and morphine hydrochloride are 
presented in Table 5.4. 
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 Table 5.4. Characteristic structural data of the eight investigated forms 
Opioids H-bond network 
Packing pattern 
of the molecules Characteristic of H-bond 
Morphine hydrochloride 
tri-hydrate 3D head-to-tail 
C(6)-OH...N 
C(3)-OH...O(water) 
C(6)-OH...O(water) 
OH(water)...Cl- 
OH(water)...O(water) 
Morphine hydrochloride 
anhydrate 1D 
head-to-Cl--to-
tail 
N-H... Cl- 
C(3)-OH...Cl- 
C(6)-OH...Cl- 
Morphine 
monohydrate 3D head-to-tail 
C(3)-OH...N 
C(3)-OH...O(water) 
C(6)-OH...O(water) 
Morphine anhydrate 1D head-to-head C(3)-OH...O-C(6) 
Naloxone hydrochloride 
di-hydrate 3D head-to-tail 
C(3)-OH...O(water) 
C(14)-OH...O(water) 
OH(water)...Cl- 
OH(water)... O-C(6) 
N-H... Cl- Naloxone hydrochloride 
anhydrate C(3)-OH...Cl
-
 3D head-to-tail 
C(14)-OH...Cl- 
C(3)-OH...O(water) 
OH(water)... O-C(14) 1D Naloxone monohydrate head-to-allyl OH(water)...O(2) 
C(19)-H...O-C(14) 
1D Naloxone anhydrate head-to-tail C(3)-OH...O-C(14) 
 
Besides having a different substituent on the N atom, the OH group attached 
to C(6) in morphine is substituted with a carboxyl group in naloxone. But on 
the other hand, in naloxone another OH group is attached to C(14). In the 
general H-bonding scheme of morphine, the two OH groups attached to C(3) 
and respectively to C(6) are always involved in H-bonding. For naloxone this 
also holds for the two OH groups attached to C(3) and C(14). The carboxyl 
group attached to C(6) is only involved in H-bonding with water molecules in 
naloxone hydrochloride di-hydrate. Although the OH groups are differently 
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positioned in morphine and naloxone, they are equally involved in the general 
H-bonding scheme. 
Incorporation of water into the crystal lattice produces a new unit cell 
different from that of the anhydrate and, consequently, the physical properties 
and the behavior of the solvate may differ from those of the anhydrate (Evans et 
al., 2004). In all cases, the dehydration processes of morphine hydrochloride tri-
hydrate, morphine monohydrate, naloxone hydrochloride di-hydrate and 
naloxone monohydrate to form the anhydrates induce only an anisotropic 
shrinkage of the unit cells. 
5.5  CONCLUSIONS 
The crystal structures of the anhydrate forms of morphine hydrochloride, 
morphine, naloxone hydrochloride and naloxone were successfully determined 
from X-ray powder diffraction data collected in transmission capillary 
geometry. The DASH software was used for structure determination and the 
Topas software for Rietveld refinement. The crystal structure of naloxone 
monohydrate was determined by the FIDDLE software and successfully refined 
by Topas software as well. 
Comparison of the crystal structures of the hydrated and the anhydrate forms 
of morphine hydrochloride, morphine, naloxone hydrochloride and naloxone 
reveals similarities. The hydrate and anhydrate forms of morphine 
hydrochloride, morphine, naloxone hydrochloride and naloxone crystallize all, 
except one, in the orthorhombic space group P2 2 21 1 1. The dehydration 
processes of morphine hydrochloride tri-hydrate, morphine monohydrate, 
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naloxone hydrochloride di-hydrate and naloxone monohydrate induces only an 
anisotropic shrinkage of the unit cells of the hydrated forms.  
The dehydration process of the hydrate forms of the investigated opioids 
takes place without any change in symmetry except for naloxone monohydrate 
which shows a lowering of the orthorhombic symmetry to the monoclinic one 
during dehydration. The H-bond dimensionality reduces to lower values for the 
anhydrate forms of the agonist opioid, while for the antagonist there is no 
change in dimensionality.  
-The counter ion Cl  takes over the role of the water molecules in the 
anhydrates forming H-bonds with the N atom as well. When water molecules 
are present, Cl- prefers the water molecules instead of the N atom. If water 
molecules and the counter ion are not present, intermolecular H-bonds are 
formed between different -OH groups. The allylic group of the naloxone 
molecule takes over the role of the counter ion Cl- only in its absence. For the 
rest, the N atom can act as a donor as well as an acceptor. 
For morphine and naloxone, the introduction of water or counter-ions like 
chlorine generates structures with higher dimensional hydrogen bonding 
networks than the corresponding anhydrate or free base structures. 
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For the chemically and structurally related antagonists naltrexone and 
naloxone, hydrate and anhydrate forms exist for the hydrochloride salts, the 
generic forms that are on the market. The hydration/dehydration behavior of 
these salts was studied by applying hot-humidity stage X-ray powder 
diffraction, microscopy, differential scanning calorimetry, thermogravimetric 
analysis and solid-state NMR. The combination of these techniques shows 
consistent results and yields a detailed conversion scheme. A new crystal 
structure, determined from X-ray powder diffraction data, for naltrexone 
hydrochloride anhydrate is presented. The structure was solved by the DASH 
program and was refined with TOPAS. This new structure, together with the 
already known structures of naltrexone and naloxone hydrochloride, enabled 
us to investigate the influence of the subtle molecular differences between the 
two antagonists and the role of water on structural properties in the solid state. 
All known hydrate and anhydrate forms of naltrexone and naloxone 
hydrochloride crystallize in the orthorhombic space group P212121, although 
the crystal packings show clear differences. Dehydration causes in both cases 
no breaking of the symmetry but the change in unit cell is for naltrexone 
profoundly different from naloxone. Dehydration of naltrexone hydrochloride 
tetra-hydrate takes place with shrinkage of the volume of the unit cell, while 
dehydration of naloxone hydrochloride di-hydrate results in an expansion of 
the unit cell. The H-bonding patterns corresponding to the two opioids seem to 
be footprints for the crystal structures and also for the hydration/dehydration 
behavior of the two antagonists. Despite naltrexone and naloxone 
hydrochloride are chemically and structurally related and show similarities in 
their biological behavior, the overall hydration and dehydration process is 
fundamentally different. 
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6.1  INTRODUCTION  
An agonist is a compound which binds to a specific receptor and triggers a 
response in the cell. An antagonist can compete with an agonist for a receptor 
site and can prevent an agonist from acting (Karle, 1974). Narcotic antagonists 
are 10 to 1000 times more potent in enhancing receptor binding than their 
corresponding agonists (Pert et al., 1973). The molecular structures of two 
antagonist opioids, naloxone and naltrexone, that are the subject of the present 
study, are presented in Fig. 6.1. 
Naltrexone is an opioid receptor antagonist used primarily in the 
management of alcohol and/or opioid dependence. Synthesized in 1965 and 
tested during the 1970s and early 80s, naltrexone represents actually the 
pharmacotherapy for helping eliminate drug cravings and opiate-seeking 
behaviors, thus preventing opiate relapse (Ginzburg and Glass, 1984). 
Naltrexone is marketed in the generic form as its hydrochloride salt. The 
naltrexone hydrochloride tetra-hydrate form (CSD refcode PABCEA) 
crystallizes in the orthorhombic system with space group P212121 and cell 
parameters: a=7.768(11) Å, b=15.926(6) Å, c=18.099(5) Å, V=2239.085 Å3 (Le 
Dain et al., 1992). The malonate form (CSD refcode JEXRAF) crystallizes also 
in the orthorhombic system with space group P212121 and has cell parameters: 
a=8.434(3) Å, b=15.469(4) Å, c=16.047(4) Å, V=2093.581 Å3 (Amato et al., 
1990).  
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Figure 6.1. The molecular structure of the agonists: morphine, codeine and 
antagonist opioids: naloxone and naltrexone 
Naloxone is a drug used to counter the effects of opioid overdose. Although 
differing only slightly from narcotics, the antagonist naloxone can completely 
block the analgesic and euphoric effects of agonists. The naloxone 
hydrochloride di-hydrate (CSD refcode NALOXC01) is the generic marketed 
form and crystallizes in the orthorhombic system with space group P212121 and 
cell parameters: a=7.833(3) Å, b=13.185(5) Å, c=18.569(5) Å, V=1917.77 Å3 
(Sime et al., 1975), and was determined for the first time by Karle in 1974. The 
naloxone hydrochloride anhydrate crystallizes also in the orthorhombic system 
with space group P212121 and cell parameters: a=17.452(4) Å, b=14.681(4) Å, 
c=7.978(2) Å, V=2044.10 Å3 (Guguta et al., 2008). The monohydrate form of 
naloxone free base crystallizes in the orthorhombic system with space group 
P212121 and cell parameters: a=13.903(5) Å, b=7.257(7) Å, c=16.641(1) Å, 
V=1678.99 Å3 (Guguta et al., 2008). However, the anhydrate form of naloxone 
free base crystallizes in the monoclinic system with space group P21 and cell 
parameters: a=8.539(2) Å, b=12.678(4) Å, c=7.652(2) Å, β=97.078°, 
V=822.16 Å3 (Guguta et al., 2008). 
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The well-known T-shape of opioid compounds is also observed for 
naltrexone and naloxone (Fig. 6.2). The five-ring system forms two planes. The 
stock of the T-shape is formed by the B, C and D rings and the arms of the T by 
the A and E rings. There are no significant differences in bond lengths and 
angles. The B and D rings take an envelope conformation, while the E ring has 
a chair conformation and the C ring is flat. The A ring has a twisted chair 
conformation in the known forms of naloxone and naltrexone. The different 
substituent on the nitrogen atom or the existence of a counter ion is hardly 
affecting the molecular structure of the opioids. 
 
Figure 6.2. The T-shape five-ring system, depicting with gray the molecule 
of naltrexone and with black for the molecule of naloxone (the dashed circle 
points to the different A ring conformation) 
In a previous paper a comparison of the crystal structures of the hydrate and 
anhydrate forms of the agonist morphine and antagonist naloxone 
hydrochloride,  and naloxone hydrochloride revealed similarities. Although 
they act completely different in the human body, the two agonist and antagonist 
opioids showed to be crystallographically related (Guguta et al., 2008).  
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It is interesting to determine how the different substituents in naltrexone and 
naloxone are influencing the hydration and dehydration behavior of these 
antagonists, also on the molecular scale. The hydration/dehydration behavior of 
these salts was therefore studied by applying hot-humidity stage X-ray powder 
diffraction, microscopy, differential scanning calorimetry, thermogravimetric 
analysis and solid-state NMR. The crystal structure of naltrexone hydrochloride 
anhydrate was determined from X-ray powder diffraction data in order to be 
able to study the changes in the crystal structures during dehydration. 
6.2  EXPERIMENTAL 
6.2.1 Materials 
Naltrexone and naloxone hydrochloride were obtained from Diosynth 
commercial supply. The preparation procedures for the hydrate/anhydrate forms 
are described below. 
6.2.2 Preparation of naltrexone hydrochloride tetra-hydrate 
The tetra-hydrate form was prepared at room temperature from a diluted 
aqueous HCl solution of starting material (1.5g naltrexone hydrochloride : 
30mL H2O). After complete evaporation of the solvent, needle shaped crystals 
were obtained. 
6.2.3 Preparation of naltrexone hydrochloride anhydrate 
Naltrexone hydrochloride anhydrate was obtained by dehydrating the tetra-
hydrate form at 110C, under vacuum (10-2mbar) and in presence of P2O5 
drying agent. Before and after the experiment, argon gas was flushed into the 
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reaction vessel. The sample was stored in a glove box under nitrogen 
atmosphere. Several attempts to grow crystals suitable for single-crystal 
diffraction failed. 
6.2.4 Preparation of naloxone hydrochloride di-hydrate 
The di-hydrate form of naloxone hydrochloride was prepared at room 
temperature from a diluted aqueous HCl solution of starting material (1g 
naloxone hydrochloride : 100mL H2O). After complete evaporation of the 
solvent, needle shaped crystals were obtained. 
6.2.5 Preparation of naloxone hydrochloride anhydrate 
Naloxone hydrochloride anhydrate was obtained by dehydrating the di-
hydrate form at 140C, under vacuum (10-2mbar) and in presence of P2O5 
drying agent. Before and after the experiment, argon gas was flushed into the 
reaction vessel. The sample was stored in a glove box under nitrogen 
atmosphere.  
6.2.6 Analytical Methodology 
X-ray Powder Diffraction (XRPD) 
X-ray powder diffraction measurements for crystal structure determination of 
naltrexone hydrochloride anhydrate were performed using a Bruker D8 AXS 
Advance X-ray Diffractometer. The D8 was equipped with a Johansson type 
monochromator with a focusing curved Ge 111 crystal. A VÅNTEC-1 detector 
was used with an effective angular region of 2. The data was collected in 
transmission capillary geometry using monochromatic Cu K1 radiation. The 
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anhydrate sample was lightly ground, using an agate mortar and pestle and 
mounted in order to reduce preferred orientation effects (Howard et al., 2000). 
A 0.5 mm glass capillary tube was filled with the material and sealed in a glove 
box under nitrogen atmosphere. The capillary tube was spun at 15 rpm during 
data collection to minimize instrumental and sample packing aberrations 
(Dollase et al., 1986). 
X-ray powder diffraction employed for investigating the hydration and 
dehydration behavior of the naltrexone and naloxone hydrochloride forms was 
done using a hot-humidity stage attached to the above-mentioned diffractometer 
and controlled by an Ansyco humidity and temperature control unit. The most 
important instrumental and data collection parameters are presented in 
Table 6.1. 
Data analysis for crystal structure determination 
The diffraction pattern was indexed using DICVOL91 (Boultif & Louër, 
1991) to obtain lattice parameters that were subsequently refined in a Pawley fit 
(Pawley, 1981). Z-matrices describing the molecular topology of the fragments 
in the compound were generated automatically by DASH (David et al., 2004) 
from the structural data of the tetra-hydrate form. Twenty runs with 107 SA 
(simulated annealing) moves per run were performed for structure solution. To 
the best solution obtained after the SA process, a final full Rietveld refinement 
was performed using the Topas software (Cheary et al., 1992). 
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Table 6.1. Instrumental and data collection parameters 
Typical instrument settings 
System  Bruker AXS D8 Advance /2 
Generator  40 kV, 40 mA 
Measuring circle (mm)  435 
Radiation (Å)  Cu K1, =1.54056Å 
Monochromator  Primary, focusing curved Ge 111 
Geometry  Transmission capillary configuration 
Sample holder  0.5 mm glass capillary tube 
Detector  VÅNTEC-1 
Measuring conditions for structure determination 
Range ( 2)  5-60 
Spatial resolution (Å) 1.5407 Å 
Step size ( 2)  0.0084696 
Step time (s)  50 
Total data collection time (h)  ca 92 
Spinning (rpm)  15 
Typical measuring conditions for hot-humidity measurements 
Range ( 2)  2 - 40 
Step size ( 2)  0.05 
Step time (s)  1 
Humidity range (%RH)  0 – 80 
Temperature range (C)  25 - 125 
Heating rate (C/min)  1 
Carrier gas  Nitrogen 
 
Microscopy 
Scanning electron microscopy photographs were taken with a JEOL JSM 
6330F, operating at 3 kV, 12μA and equipped with a secondary electron 
detector. In order to induce good conductivity of the samples, prior to SEM 
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analysis, the crystals were coated with gold at 10-5 Torr using a Cressington 
208HR Sputter Coater. 
The polarized light microphotographs were taken with a Leica DM-RX 
microscope. 
Differential Scanning Calorimetry (DSC) 
Differential scanning calorimetry curves were obtained using a Mettler 
Toledo 822 DSC with a TSO 801RO Sample Robot. The instrument was 
calibrated using indium standards. The samples were scanned at 1ºC/min or 
5ºC/min from 25 to 280ºC under nitrogen purge at 40 mL/min in punched 
aluminum pans.  
Thermogravimetry Analysis (TGA) 
Thermogravimetry analysis curves were generated using a TA Instruments 
Q500 TGA. The instrument was temperature calibrated using indium, tin and 
zinc standards. A weight calibration was performed using standard weights 
under nitrogen purge. The samples were scanned at 1ºC/min from 25 to 300ºC 
under nitrogen purge at 40 mL/min in punched aluminum pans. 
Solid-State NMR Spectroscopy (SSNMR) 
100.6 MHz solid-state 13C cross-polarization/magic angle spinning 
(CP/MAS) spectra for the naltrexone hydrochloride samples were obtained 
using a Bruker AXS 400MHz spectrometer. The samples were packed into a 4 
mm rotor and spun with a rate of 12 kHz. The contact time for CP was 2.5ms. A 
signal was acquired with proton decoupling. 
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The 13C NMR spectra for the naloxone hydrochloride were obtained on a 
CMX-300 spectrometer (300.15 MHz for 1H, 75.46 MHz for 13C) using a 
Bruker 4mm double resonance MAS probe spinning at 4 kHz. The CP/MAS 
spectra were recorded employing a variable amplitude CP (1 ms contact time, 
an rf field of 64 kHz on 1H with a ±1 kHz ramp and a 60 kHz rf field on 13C). 
Protons were decoupled using the CM sequence with an rf field strength of 84 
kHz (Gerbaud et al., 2003). A 5-pulse TOSS sequence was used to suppress 
spinning sidebands for the amorphous and anhydrous sample (Song et al., 
1993). 
6.3  RESULTS AND DISCUSSION 
6.3.1 Crystal structure determination of naltrexone hydrochloride 
anhydrate 
Indexing, Pawley refinement and simulated annealing process 
Twenty-three reflections with low and high intensity were introduced into 
DICVOL91 and an orthorhombic cell with a volume of 1820.73 Å3 was found. 
Space group determination in DASH resulted in P212121. The volume and space 
group P212121 correspond to Z' = 1 (molecules per asymmetric unit). The lattice 
parameters obtained after indexing were subsequently refined along with 
background, zero point, peak shape parameters and reflection intensities in a 
Pawley fit. The characteristic parameters of the orthorhombic cell obtained after 
the Pawley fit are presented in Table 6.2.  
The peak shape is implemented in DASH as a convolution of Gaussian, 
Lorentzian and axial divergence terms (asymmetry). Actually, the X-ray line 
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shape is a full Voigt function, which uses two parameters 1 and 2 to describe 
the angle-dependent Gaussian component: 
 2222212 tansec   
and two parameters 1 and 2 to describe the angle-dependent Lorentzian 
component: 
 tansec 21   
The two other asymmetry parameters are fully defined by the peak fitting 
procedure and cannot be refined by Pawley fitting. The sample gave sharp 
diffraction lines with a mean FWHM = 0.092º and a minimum value FWHM = 
0.078º for the first twelve fitted peaks.  
The profile Pawley 2 is described in DASH as: 
       CPNcalcyobsyw iiiNi  /22 , 
where yi(obs) is the observed intensity at the ith step in the powder diffraction 
pattern; yi(calc) is the associated calculated intensity; 2/1 iiw  , where i  is 
the standard deviation of the observed intensity at that point. The summation is 
performed over all N data points, where N is the number of data points, P the 
number of parameters and C the number of parameter constraints. The profile 
2 for the Pawley fit had a final value of 3.36. 
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Table 6.2. Lattice parameters and Pawley fit results 
Lattice parameters  
System Orthorhombic 
Space group P212121 
a (Å) 15.529 
b (Å) 14.991 
c (Å) 7.840 
V (Å3) 1825.44 
Zero point correction 0.0201 
Pawley fit results 
Number of reflections 328 
Data points 6309 
Pawley 2 3.36 
The molecular conformations of the Z-matrices describing the molecular 
geometry are shown in Fig. 6.3.  
 
Figure 6.3. The molecular conformations used for the Z-matrices 
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Naltrexone hydrochloride has two torsion angles: C18:C17:N1:C9 and 
C19:C18:C17:N1, optimized during the simulated annealing (SA) process. The 
simulated annealing process ended up with 13 solutions having low 2 profile 
values out of 20. The structure of the best solution had a profile 2 of 15.32. 
The fit of the observed and calculated diffraction data for this solution is shown 
in Fig. 6.4. 
 
Figure 6.4. The fit to the diffraction data returned by the SA process 
 
Rietveld refinement 
A full Rietveld refinement (Young, 1996) of the best solution returned by the 
SA process gave a final profile Rwp=3.65, Rp=2.64 and a GOF of 2.54. The fit 
of the final calculated diffraction data to the observed data is shown in Fig. 6.5. 
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 All coordinates of the non-hydrogen atoms were freely refined, but soft 
restraints on bond lengths and angles were introduced in order to reduce the 
number of free parameters. The final crystal structure of naltrexone 
hydrochloride anhydrate is presented in Fig. 6.6. The crystallographic data of 
the refined crystal structure is presented in Table 6.3. 
 
 
Figure 6.5. The fit after the final Rietveld refinement  (high 2 theta angle is 
enlarged) 
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a) 
 
b) 
Figure 6.6. Crystal structure of naltrexone hydrochloride anhydrate: a) c-
projection, b) a-projection  
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Table 6.3. Crystallographic data of the refined naltrexone hydrochloride 
anhydrate structure after full Rietveld refinement 
Cell 
parameters 
Naltrexone 
hydrochloride 
anhydrate 
Final profiles 
System Orthorhombic 
Space group P212121 
a (Å) 15.5338(4) 
b (Å) 14.9942(4) 
c (Å) 7.8420(2) 
V (Å3) 1826.53(8) 
Rwp = 3.65 
Rp = 2.64 
GOF = 2.54 
 
 
6.3.2 Hot-humidity stage X-ray powder diffraction (XRPD) 
The conversions recorded with hot-humidity stage X-ray powder diffraction 
for naltrexone hydrochloride tetra-hydrate are presented in Fig. 6.7.  
To study the dehydration of naltrexone hydrochloride tetra-hydrate, the 
compound was heated in a temperature range between 25 - 75°C at 0%RH and 
kept at 75°C for 1hr. A complete conversion to the anhydrate form was already 
observed at 30°C. 
In order to study the reverse process, i.e. the conversion of the anhydrate to 
the tetra-hydrate, naltrexone hydrochloride anhydrate was subjected to 40°C 
and 80% RH. After 40 min this resulted in the formation of an unknown 
hydrate form Y. Continued exposure of form Y to 80%RH and 40°C lead to 
further conversion to the tetra-hydrate form. Leaving the tetra-hydrate form at 
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40°C and 80% RH for 12 hours did not lead to other forms with a higher 
amount of hydration water. 
 
a) 
   
b) 
Figure 6.7. Top view (a) and 3D pictures (b) of the hot-humidity stage X-ray 
powder diffraction experiments recorded for the conversion of naltrexone 
hydrochloride tetra-hydrate (bottom) to the anhydrate, further on to an unknown 
hydrate form Y and back to the tetra-hydrate (top) 
The conversions recorded with hot-humidity stage X-ray powder diffraction 
for naloxone hydrochloride di-hydrate are presented in Fig. 6.8. To study the 
dehydration of the di-hydrate form, the samples were heated in a temperature 
range between 25 - 145°C at 0%RH and kept at 145°C for 1hr. A complete 
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conversion to the anhydrate form was observed at 75°C. No intermediate forms 
were observed. In order to study the reverse process, i.e. the conversion of the 
anhydrate to the tetra-hydrate form, the anhydrate was subjected to 40°C and 
80% RH. After 1hour and 20 min this resulted in the formation of an 
amorphous form.  
 
a) 
 
b) 
Figure 6.8. Top view (a) and 3D pictures  (b) of the hot-humidity stage X-
ray powder diffraction experiments recorded for the conversion of naloxone 
hydrochloride di-hydrate (bottom) to the anhydrate form, further on to the 
amorphous form and back to the di-hydrate form (top) (enlarged picture of the 
conversion anhydrate - amorphous - di-hydrate). 
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Continued exposure of the amorphous form to 80%RH and 40°C lead to the 
formation of the di-hydrate form of naloxone hydrochloride. Leaving the di-
hydrate form at 40°C and 80% RH for 12 hours did not lead to other forms with 
a higher amount of hydration water. 
6.3.3 Microscopy 
The scanning electron microphotographs of naltrexone hydrochloride 
samples are presented in Fig. 6.9. Three different magnifications were used in 
order to emphasize the small differences between the morphology of the two 
morphs. 
The naltrexone hydrochloride tetra-hydrate consists of acicular crystal found 
in stacked ordered aggregates with chord thickness of 2 to 18m (Fig. 6.9a). 
The anhydrate form of naltrexone hydrochloride exhibits in general the same 
characteristics as the tetra-hydrate form, although the anhydrate seems to 
consist of more defected and thinner needle crystals. The chord thickness for 
the anhydrate form varies from 1 to 12m (Fig. 6.9b). 
Naloxone hydrochloride di-hydrate crystallizes in rather large pyramidal 
crystals (Fig. 6.10a). Therefore an examination using an optical microscope was 
possible. During a close investigation, droplets of water coming out on the 
surface of the crystals could be detected. It seems that the crystals of the 
naloxone hydrochloride di-hydrate are not stable and loose at least part of the 
hydration water already at room temperature. Applying vacuum (10-2mbar) the 
di-hydrate pyramidal crystals brake apart in order to form the anhydrate form 
within a few minutes. The morphology of the naloxone hydrochloride 
anhydrate crystals was investigated using scanning electron microscopy. The 
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naloxone hydrochloride anhydrate shows needle shaped crystals stacked in 
ordered aggregates with chord thickness of 2 to 15m (Fig. 6.10b).  
    
 
    
 
 
    
 
 
a)      b) 
 
Figure 6.9. Scanning electron microphotographs of naltrexone hydrochloride 
forms at different magnifications (x200; x1000; x4500) of: a) tetra-hydrate ; b) 
anhydrate 
Tetra-hydrate 
Tetra-hydrate 
Tetra-hydrate 
Anhydrate
Anhydrate
Anhydrate
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a)       b) 
Figure 6.10. Microphotographs of naloxone hydrochloride: a) di-hydrate 
form with enlarged zoom on the water droplets (down) and the pyramidal 
shaped crystal (up); b) anhydrate form at x370 magnification 
6.3.4 Differential Scanning Calorimetry (DSC) 
Differential scanning calorimetry curves of naltrexone hydrochloride tetra-
hydrate at different heating rates are shown in Figure 6.11. The DSC 
measurements of the tetra-hydrate form shows an endothermic effect due to 
solvent loss and anhydrate formation at temperatures from 25 - 110C, 
confirming the results obtained with hot-humidity stage X-ray powder 
diffraction. The endothermic event observed at 220C indicates the 
decomposition of naltrexone hydrochloride. 
The anhydrate form yielded no thermal events measurable by DSC until 
220C, where the onset of decomposition appears. The shifts recorded with 
1C/min in comparison with the ones observed at 5C/min are attributed to the 
higher heating rates. 
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DSC Results for Tetra-hydrate form
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Figure 6.11. DSC curves with 1ºC/min and 5ºC/min for naltrexone 
hydrochloride tetra-hydrate 
Differential scanning calorimetry curves of naloxone hydrochloride di-
hydrate at different heating rates are shown in Figure 6.12. The DSC 
measurements of the naloxone hydrochloride di-hydrate show a two-step 
endothermic effect due to solvent loss and the final anhydrate formation at 
temperatures between 75 - 150C. Taking into account that the hot-humidity 
stage XRPD data did not show the formation of another form besides the 
anhydrate during dehydration, this suggests that part of the water molecules can 
be removed from the hydrate without a structural change.  
The obtained anhydrate form yielded an endothermic event measurable by 
DSC at 175C. Due to the total solvent loss and anhydrate formation at 150C, 
the recorded endothermic event at 175C must be due to partial decomposition 
of the sample. The onset of further decomposition of naloxone hydrochloride is 
observed at 250C. The shifts recorded for all the investigated forms with 
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1C/min in comparison with the ones observed at 5C/min are attributed to the 
higher heating rates. 
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Figure 6.12. DSC curves with 1ºC/min. and 5ºC/min. for naloxone 
hydrochloride di-hydrate 
6.3.5 Thermal Gravimetric Analysis (TGA) 
The thermal profile of the naltrexone hydrochloride tetra-hydrate is shown in 
Fig. 6.13. The TGA curve is denoted by a normal font line on a percentage of 
initial weight scale.  
Dehydration of the naltrexone hydrochloride tetra-hydrate was observed 
gradually as a mass loss of 15.57% in a temperature range from 25 - 75C. The 
dehydration of the tetra-hydrate form results in the release of water with a 
theoretical weight loss of 16.01% close to the observed weight loss of 15.57% 
(3.89 molecules H2O/molecule NTX). The investigated sample of naltrexone 
hydrochloride tetra-hydrate decomposed in a temperature range of 220 to 
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280ºC. The TGA data confirms the results obtained with hot-humidity stage X-
ray powder diffraction and DSC. 
 
Figure 6.13. TGA curves with 1ºC/min heating rate for naltrexone 
hydrochloride tetra-hydrate 
The thermal profile of the naloxone hydrochloride di-hydrate is shown in 
Fig. 6.14. Dehydration of the naloxone hydrochloride di-hydrate was observed 
gradually as a mass loss of 8.81% in a temperature range from 25 - 75C. The 
dehydration of the di-hydrate form results in the release of water with a 
theoretical weight loss of 9% close to the observed weight loss of 8.81% (1.95 
molecules H2O/molecule NLX). The investigated sample of naloxone 
hydrochloride di-hydrate decomposed partially in a temperature range from 175 
- 250C continued by the final decomposition process in a temperature range of 
250 to 300ºC. The TGA data confirm the results obtained with hot-humidity 
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stage X-ray powder diffraction and DSC, however, the separate steps in 
dehydration as seen in DSC are not visible here. 
 
Figure 6.14. TGA curves with 1ºC/min heating rate for naloxone 
hydrochloride di-hydrate 
6.3.6 Solid-State NMR Spectroscopy (SSNMR) 
The 13C CPMAS spectra of the naltrexone hydrochloride samples are 
displayed in Fig.6.15. Compared to the tetra-hydrate form of naltrexone 
hydrochloride, the undetermined hydrate Y and the anhydrate forms show 
significant differences. The tetra-hydrate and the anhydrate forms both have 
single resonances per carbon atom, a clear indication of one molecule per 
asymmetric unit cell. However, for the undetermined hydrate Y there seem to 
be 3 resonances per carbon atom, of more or less equal intensity within each 
carbon species. Some groups of 3 carbon resonances have shifts that neither 
occur in the anhydrate, nor in the tetra-hydrate. This excludes the existence of a 
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mixture of the anhydrate and the tetra-hydrate and together with another 
unknown form. Although a mixture of 3 unknown compounds is still a 
possibility, Z’=3 is much more likely for this unknown form.   
 
 
 
Figure 6.15. Solid-state 13C CP/MAS NMR spectra of naltrexone 
hydrochloride forms: tetra-hydrate (bottom spectra), anhydrate (top), 
undetermined hydrate (middle) 
The 13C-NMR spectra for naloxone hydrochloride di-hydrate, anhydrate and 
amorphous forms are shown in Fig. 6.16. The spectra of the di-hydrate and the 
anhydrate forms indicate the existence of one molecule per asymmetric unit 
cell. Clear differences can be observed between the di-hydrate and anhydrate. 
The spectrum of the amorphous compound displays broad resonances, at the 
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position of the originating anhydrate, at the position of the di-hydrate, or in 
between. This clearly indicates the structural heterogeneity. Amorphous and 
materials of poor crystallinity have broader resonances because of the 
heterogeneity of structural forms found in the sample. This heterogeneity 
results in a distribution of isotropic shifts for a given carbon.   
 
 
Figure 6.16. Solid-state 13C CP/MAS NMR spectra of naloxone 
hydrochloride forms: di-hydrate (bottom spectra), anhydrate (top), amorphous 
(middle) 
6.3.7 Structural aspects of hydration and dehydration 
The characteristic structural features of the hydrated and anhydrate forms of 
naltrexone and naloxone hydrochloride are presented in Table 6.5. 
The naltrexone molecules in naltrexone hydrochloride tetra-hydrate are 
packed in a three-dimensional network with the aid of water molecules. H-
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bonds are formed between the –OH group attached to C(3), respectively C(14) 
and water molecules (for atom numbering see Fig. 6.3). The Cl- is involved in 
H-bonding with the water molecules and also with the –OH group attached to 
C(14) (Table 6.5). The carboxyl group forms H-bonds only with the N atom. H-
bonds between different water molecules are also observed. Obviously, the 
water molecules play a stabilizing role in the network formation of naltrexone 
hydrochloride tetra-hydrate. The naltrexone molecules in naltrexone 
hydrochloride anhydrate are assembled in a two-dimensional network, this time 
with the aid of the Cl- anion and N atom. The Cl- forms H-bonds with the (-OH) 
groups attached to C(3), and C(14). As for the case of the tetra-hydrate form, 
the carboxyl group forms only H-bonds with the N atom. The packing of the 
naltrexone molecules in naltrexone hydrochloride tetra-hydrate and 
hydrochloride anhydrate is presented in Fig.6.17 a and b. 
Comparing the SSNMR spectra of the anhydrate with the tetra-hydrate, 
significant differences can be found in the cyclopropane substituents (C18, 
C19, C20 between 0-11 ppm) which can be easily traced back to their 
significantly different surroundings in the crystal lattice (presence of chlorine in 
the anhydrate vs hydroxyl in the tetra-hydrate, see Fig. 6.17 a-b). It is 
interesting to note that the shift of the carboxyl hardly changes between the two 
forms (215.9 ppm in the tetra-hydrate vs 215.8 ppm in the anhydrate), in line 
with the fact that in both the tetra-hydrate and the anhydrate this carboxyl is 
only involved in the same type of hydrogen bond to N. By contrast, the 
unknown form shows 3 peaks with different shifts (215.0, 216.0, and 216.4), a 
strong indication that the hydrogen bonding in this form is significantly 
changed. 
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a)      b) 
 
c)      d) 
Figure 6.17. The crystal structures of the: a) naltrexone hydrochloride tetra-
hydrate, b) naltrexone hydrochloride anhydrate, c) naloxone hydrochloride di-
hydrate, d) naloxone hydrochloride anhydrate 
The naloxone molecules in naloxone hydrochloride di-hydrate are also 
packed in a three-dimensional network with the aid of water molecules. H-
bonds are formed between the –OH group attached to C(3), respectively C(14) 
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and water molecules. The carboxyl group and the Cl- are also involved in H-
bonding with the water molecules. The N atom forms H-bonds only with the  
Cl-. The naloxone molecules in naloxone hydrochloride anhydrate are also 
assembled in a three-dimensional network, this time with the aid of the Cl- 
anion. Cl- forms H-bonds with the N atom and with the (-OH) groups attached 
to C(3), and C(14) (Guguta et al., 2008). The packing of the naloxone 
molecules in naloxone hydrochloride di-hydrate and hydrochloride anhydrate is 
presented in Fig. 6.17 c and d.  
The SSNMR data showed that for those carbon atoms involved in the 
hydrogen bonding, going from the anhydrate to the di-hydrate, the chemical 
shift changes in the C3 hydroxyl at 141.1 ppm shifts -2.9 ppm (becomes more 
shielded) and the C6 carboxyl at 208.1 ppm shifts +3.6 ppm in the di-hydrate 
(more deshielding). Interestingly, also other carbon atoms are affected: C17 and 
C10 are not involved in hydrogen bonding but still their chemical shifts change 
going from anhydrate to di-hydrate from 50.3 ppm to 48.9 ppm for C17 and 
from 23.4 ppm to 25.1 ppm for C10. Because the conformation of the naloxone 
molecules is virtually the same for the anhydrate and the di-hydrate, these 
changes in chemical shift therefore reflect the effect of the differences in 
stacking of the molecules. One should note that all peaks that are present in the 
anhydrate still exist in the amorphous form, except the carboxyl. On the whole 
this indicates that locally, for at least a significant number of molecules, the 
environment still resembles the anhydrate structure. The positions of the 
carboxyl on the other hand seem to be the first to be entirely affected by 
hydration. From the crystal structure one can see that the carboxyls are located 
in the voids in the structure and are therefore most readily hydrated. 
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Table 6.4. Characteristic structural data of the investigated forms 
Antagonist 
Opioids 
H-bond 
network
H-bonds 
formed by 
N atom 
H-bonds 
formed by 
Cl- anion 
Other H-bond 
Naltrexone 
hydrochloride 
tetra-hydrate 
3D 
 carboxyl 
group 
 water 
 C(14)-OH 
C(3)-OH...O(water) 
C(14)-OH...O(water) 
OH(water)...Cl- 
OH(water)...O(water) 
Naltrexone 
hydrochloride 
anhydrate 
2D 
 carboxyl 
group 
 C(3)-OH 
 C(14)-OH - 
Naloxone 
hydrochloride 
di-hydrate 
3D  Cl- anion 
 C(3)-OH 
 water 
 N-H 
C(3)-OH...O(water) 
C(14)-OH...O(water) 
OH(water)...Cl- 
OH(water)... O-C(6) 
Naloxone 
hydrochloride 
anhydrate 
3D  Cl- anion 
 C(3)-OH 
 C(14)-OH 
 N-H 
- 
A comparison between the crystal structures of the hydrated and anhydrate 
forms of naltrexone and naloxone hydrochloride can now be made. By 
dehydrating the naltrexone hydrochloride tetra-hydrate, the water disappears 
from the net without breaking of the symmetry, but with lowering of the 
dimensionality of the H-bond network. The dehydration process of the tetra-
hydrate form induces shrinkage of the unit cell in two directions and small 
expansion in the third direction (Table 6.5).  
By dehydrating the naloxone hydrochloride di-hydrate, the water disappears 
from the net again without breaking of the symmetry but without lowering of 
the dimensionality of the H-bond network. In contrast to naltrexone 
hydrochloride tetra-hydrate the water molecules in the naloxone di-hydrate are 
isolated and therefore are not mutually attached by H-bonds. The DSC 
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measurements indicate that the dehydration of the naloxone hydrochloride di-
hydrate takes place in two steps, but at the same time hot-humidity stage XRPD 
could only record the powder patterns corresponding to the di-hydrate and 
anhydrate forms. The structural data together with the DSC and XRPD data 
suggest the formation of an intermediate hydrate form isostructural to the di-
hydrate. The two water molecules in naloxone hydrochloride di-hydrate form 
different H-bonds. One of the water molecules forms H-bonds with the -OH 
group attached to C(3) and C(14). The second water molecule forms H-bonds 
with the carboxyl group and with the Cl- anion. The H-bonds formed by the 
water molecule with the -OH groups are significantly shorter (L1=1.731 and 
L2=1.864) than those formed by the second water molecule (L3=2.882 and 
L4=2.184). Therefore the first dehydration event noticed in the DSC data 
probably corresponds to the loss of the water molecules that are involved in H-
bonding with the carboxyl group and Cl- anion. The same loosely bonded water 
molecules are probably also responsible for loss of water noticed in the 
microphotographs that were taken at room temperature. Figure 6.18 presents the 
two water molecules involved in H-bonds with different lengths, together with 
the symmetry related water molecules. 
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Figure 6.18. The H-bonds and their lengths formed by the two water 
molecules present in naloxone hydrochloride di-hydrate, together with the 
symmetry related water molecules 
 
Table 6.5. Unit cell parameters of the investigated forms showing the 
dehydration pathway 
Cell 
parameters 
Naltrexone 
hydrochloride
tetra-hydrate 
Naltrexone 
hydrochloride 
anhydrate 
Naloxone 
hydrochloride 
di-hydrate 
Naloxone 
hydrochloride 
anhydrate 
System Orthorhombic Orthorhombic Orthorhombic Orthorhombic 
Space 
group 
P212121 P212121 P212121 P212121 
a (Å) 18.099(5) 14.9942 (4) 18.569(5) 14.681 (4) 
b (Å) 15.926(6) 15.5338(4) 13.185(5) 17.452(4) 
c (Å) 7.768(1) 7.8420(2) 7.833(3) 7.978 (2) 
V(Å3) 2239.08 1826.53 1917.77 2044.11 
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The dehydration process of the di-hydrate form induces shrinkage of the unit 
cell in one direction and expansion in two directions (Table 6.5).  
The hot-humidity stage XRPD data showed that the anhydrate form of 
naloxone hydrochloride converts (at similar conditions) faster to the di-hydrate 
than the anhydrate form of naltrexone hydrochloride converts to the tetra-
hydrate form. In both cases, the conversions to the hydrated forms of naloxone 
and naltrexone hydrochloride are taking place via an intermediate form. 
Naloxone hydrochloride di-hydrate is obtained via an amorphous form and the 
naltrexone hydrochloride tetra-hydrate via an unknown crystalline hydrate. The 
principal packing of the molecules in the naloxone hydrochloride anhydrate is 
considerably changed in comparison with the di-hydrate, leaving voids in the 
crystal structure (Fig. 6.19) that are not present in the anhydrate of naltrexone 
hydrochloride. This could be a reason that the hydration process of naloxone is 
faster compared to naltrexone. 
 
Figure 6.19. Naloxone hydrochloride anhydrate and the voids created after 
dehydration, depicted in gray 
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Another significant structural difference is that the N atom prefers to form H-
bonds with the carboxylic group in the naltrexone hydrochloride forms, and 
with the Cl- anion in the naloxone hydrochloride forms.  
Moreover, dehydration of naltrexone hydrochloride tetra-hydrate takes place 
with shrinkage of the volume of the unit cell with 18.42%, while naloxone 
hydrochloride di-hydrate shows an expansion of the unit cell with 6.18% during 
dehydration. 
Despite naltrexone and naloxone hydrochloride are chemically and 
structurally related and show some similarities in their behavior, the overall 
hydration and dehydration process is fundamentally different. 
6.4  CONCLUSIONS 
The crystal structure of naltrexone hydrochloride anhydrate was determined 
successfully from X-ray powder diffraction data collected in transmission 
capillary geometry and using the DASH software for structure determination 
and Topas software for the final Rietveld refinement.  
The combination of the applied techniques (DSC, TGA, SSNMR, hot-
humidity XRPD) together with the structural data show consistent results and 
yields a detailed conversion scheme for naltrexone hydrochloride as well as for 
naloxone hydrochloride. Hot-humidity stage X-ray powder diffraction showed 
complete and reversible conversion between the tetra-hydrate and the anhydrate 
forms of naltrexone hydrochloride, respectively between the di-hydrate and the 
anhydrate forms of naloxone hydrochloride. The conversion of naltrexone 
hydrochloride anhydrate to the tetra-hydrate form takes place via an 
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intermediate hydrate form. The conversion of the naloxone hydrochloride 
anhydrate to the di-hydrate form takes place via an amorphous form. The 
existence of a intermediate hydrate isostructural to naloxone hydrochloride di-
hydrate is suggested from the combination of DSC, XRPD and SSNMR 
measurements. The conversions can be summarized in the following scheme for 
naltrexone hydrochloride:  
Tetra-hydrate
Hydrate Y
Anhydrate
RHC %07525  
RHC %8040 
RHC %8040 
 
and for naloxone hydrochloride: 
Di-hydrate
Amorphous
Anhydrate
Intermediate
hydrate
RHC %014525  
RHC %014525   RHC %8040 
RHC %8040 
 
SSNMR confirmed the existence of another hydrate form for naltrexone 
hydrochloride and discharged the existence of a mixture of the anhydrate and 
tetra-hydrate forms. In the case of naloxone hydrochloride, the existence of the 
amorphous form was also confirmed. The impact of dehydration and hydration 
on the H-bonding networks is clearly reflected in the solid state NMR C13 
spectra. 
Comparison of the crystal structures of the hydrated and the anhydrate forms 
of naltrexone and naloxone hydrochloride reveals some similarities but also 
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significant differences. The investigated forms of the two antagonists crystallize 
all in the orthorhombic space group P212121. The dehydration processes for 
naltrexone hydrochloride tetra-hydrate and naloxone hydrochloride di-hydrate 
induces different changes in the unit cells of the hydrated forms in order to form 
the anhydrated forms. The difference in the H-bonding pattern showed by the 
two opioids seems to be a footprint for the crystal structures and also for the 
hydration/dehydration behavior of the two antagonists. Remarkably, 
dehydration of naltrexone hydrochloride tetra-hydrate takes place with 
shrinkage of the volume of the unit cell with 18.42%, while naloxone 
hydrochloride di-hydrate shows an expansion of the unit cell with 6.18% during 
dehydration. Despite the fact that naltrexone and naloxone hydrochloride are 
chemically and structurally related and show some similarities in their behavior, 
the overall hydration and dehydration process is fundamentally different. 
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The usual process for crystal structure determination from powder 
diffraction data consists of (1) indexing of the powder pattern, (2) 
space group determination, (3) structure solution and (4) structure 
refinement. Despite the success of methods for powder indexing, 
there are many cases in which the very first step in a structure 
determination fails or is far from straightforward. Due to a number of 
fundamental and experimental problems, like peak broadening, the 
presence of impurity phases, dominant zones and geometrical 
ambiguities, powder indexing will remain difficult in many cases, 
thereby hampering the next steps in the structure determination.  
FIDDLE is a method for the determination of crystal structures from 
powder diffraction data that circumvents the difficulties associated 
with separate indexing. Structure determination from powder 
diffraction data can be seen as a process of global optimization of all 
model parameters, including the unit cell parameters. This strategy is 
applied in the FIDDLE program. For the simultaneous optimization of 
the parameters that describe a crystal structure a genetic algorithm is 
used together with a pattern matching technique based on auto and 
cross correlation functions. This "one-pot" strategy for indexing and 
structure determination was successfully used for determining the 
unknown crystal structures of ethinyl estradiol anhydrate, naloxone 
monohydrate and creatine anhydrate, cases for which indexing was 
problematic. 
 
7.1  INTRODUCTION  
Nowadays, single-crystal X-ray diffraction is a standard method for the 
determination of molecular structures and for the elucidation of intra and 
intermolecular interactions in various materials. Often, however, crystals 
suitable for single-crystal diffraction cannot be obtained (easily). Compounds 
that show polymorphism or solvate (hydrate) formation frequently cause 
difficulties in the crystallization of one of the modifications. In addition, most 
of the times recrystallization of unstable compounds that are initially obtained 
as microcrystalline powders is not feasible.  
A possible route for crystal structure analysis of "problematic" compounds is 
to make optimal use of powder diffraction data. These data contains less 
information than single crystal diffraction data but for a lot of compounds 
powder diffraction has allowed for a full crystal structure determination. 
The complexity of crystal structures determined from powder diffraction data 
has steadily increased through further development of "traditional" methods for 
structure determination in reciprocal space and application of global 
optimization algorithms in direct space (Harris et al., 2001; David et al. 2002; 
Favre-Nicolin et al., 2002; Altomare et al., 2004; Altomare et al., 2004; 
Tremayne, 2004; David and Shankland, 2008). The published number of crystal 
structures determined by powder diffraction is still rather limited, compared to 
the enormous amount of structures determined by single crystal diffraction. 
Clearly, structure determination from powder diffraction data is not a generally 
applicable method yet.  
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The lack of success in the indexing step has become one of the major 
bottlenecks in structure determination from powder diffraction data. There are a 
number of fundamental and experimental problems that can make powder 
indexing problematic or simply impossible: peak broadening (leading to a loss 
in resolution), increasing peak density at higher angles, peak shifts, systematic 
or accidental absences of reflections, the presence of impurity phases, 
inaccuracies in the experimental measurements, dominant zones and 
geometrical ambiguities. Problems that originate from the use of laboratory 
instruments, like peak broadening caused by the instrumental profile and 
experimental inaccuracies, can be reduced by measuring on synchrotron 
facilities. However, problems originating from specific powder imperfections 
(impurities, crystallite size, strain, lattice mistakes) cannot be solved by going 
to more sophisticated instruments. This means that for powder patterns 
measured on laboratory as well as synchrotron facilities the problem of limited 
quality can exist.  
It is clear that particularly for compounds for which no suitable single 
crystals can be grown the powder method is an attractive alternative. Often, 
however, the problematic crystallization behavior of these compounds is also 
reflected by the moderate quality of their microcrystalline powders and their 
corresponding powder diffraction data.  
Despite the success of standard methods for powder indexing, like ITO 
(Visser, 1969), TREOR (Werner, 1985) and DICVOL91 (Boultif, 1991), there 
are many cases in which the very first step in structure determination fails or is 
far from straightforward. New strategies and enhancements will certainly 
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extend the possibilities of powder indexing methods (Coelho, 2003; Neumann, 
2003; Altomare et al., 2000). However, the problems associated with the nature 
of powder diffraction data (absences, increasing peak density etc.) together with 
the usual strategy of applying a separate indexing step, which may lead to 
geometrical ambiguities, will be a fundamental limitation for improvement. 
Recently, a method called OCEANA was reported for structure determination 
from powder diffraction data without prior indexing (Padgett et al., 2007). 
OCEANA is a grid search based method which uses a genetic algorithm to 
adjust the cell parameters, potential packing energy and Rwp to locate the global 
minimum in a given space group. The method is limited to Z'≤1. 
In this paper a different methodology (FIDDLE) for the determination of 
crystal structures from powder diffraction data is presented that circumvents the 
difficulties associated with separate indexing. The method implemented in 
FIDDLE has the possibility of searching through the most common space 
groups, while varying Z' and without taking into account any energy or packing 
considerations. By using correlations functions for pattern matching the method 
is able to optimize cell and structural parameters simultaneously using a genetic 
algorithm, without any assumptions on cell parameters or density. Results from 
several tests of the method on various organic compounds are presented to 
demonstrate the effectiveness of the concept. Moreover, using FIDDLE, three 
previously unknown crystal structures, cases for which indexing was 
problematic, could be determined successfully. 
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7.2  COMPUTATIONAL METHODOLOGY 
7.2.1 Program description 
There is no fundamental reason to separate, as is usual today, the process of 
unit cell determination and the process of structure solution. If one is able to 
describe the main part of a crystal structure by a model consisting of a discrete 
set of parameters (cell parameters {a, b, c,  space group number S and - 
using information on molecular structures - a limited set of structural 
parameters describing the positional parameters {(x, y, z)j}), then a structure 
determination from powder diffraction data can be seen as a process of (global) 
optimization of all crystal structure parameters, including the unit cell 
parameters. This is the strategy implemented in the FIDDLE program. Structure 
solution then means that in the end the calculated powder diffraction pattern 
corresponding to the complete set of optimized parameters, including the cell 
parameters, must match the experimental pattern, assuming that there is one 
unique structure which has this property.  
The FIDDLE method is a direct space method. Prior knowledge of the 
structure of molecular fragments (and the internal degrees of freedom) is 
needed to define a model of the crystal structure in terms of structural 
parameters that can be optimized. Like in other direct space methods FIDDLE 
reduces the set of positional parameters to a set of rotation angles {}, 
which define the orientation of a molecular fragment in the unit cell, a 
translation vector {x, y, z}, which defines the position of the molecular 
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fragment in the cell and a set of n torsion angles n}, which describe 
the intramolecular geometry of the fragment.  
Part of the parameters, the cell parameters, define the positions of the peaks 
in the powder pattern. The other parameters, space group and positional 
parameters, define the intensities of the peaks. Together, they define the total 
pattern (not regarding zero-point shifts and peak shapes). A suitable measure 
for similarity between experimental and calculated pattern must be used to be 
able to optimize both sets of parameters simultaneously. FIDDLE uses 
weighted auto and cross correlation functions for pattern matching and the 
mathematics for this fitness function are described below.   
For space group determination FIDDLE uses a strategy that is also applied in 
crystal structure prediction: the frequency of the occurrence of space groups in 
the CSD (Cambridge Structural Database) is used and systematically the most 
common space groups are explored. About 79% of all organic and 
organometallic compounds crystallize in only 5 space groups: P21/c, P-1, 
P212121, C2/c and P21 (Allen, 2002). Chiral molecules (non-superimposable on 
their mirror image) crystallize in chiral space groups and this further reduces 
the number of possible space groups. FIDDLE now explores the space groups 
P21/c, P-1, P212121, P21, C2/c, Pbca, Pnma, Pbcn, and P1 and varies Z’. Prior 
knowledge about Z’ obtained from methods like solid-state NMR reduces of 
course the problem. Fig. 7.1 shows the main steps in the FIDDLE procedure. 
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 Define molecular 
structure and rotatable 
torsion angles 
Best models 
become parents 
Sort on fitness 
Compare experimental 
pattern with calculated 
patterns: WCC fitness 
Apply reproduction 
(crossover, mutations): 
new population 
Create random crystal 
structure models 
Accept
Calculate PXRD 
patterns 
The final crystal 
structure 
Reject
Figure 7.1. Overview of the main steps in the FIDDLE procedure 
7.2.2 The Genetic Algorithm 
A Genetic Algorithm (GA) is a global optimisation method based on 
evolution principles (Harris et al., 1998). Evolutionary operations such as 
mating, mutation and "natural selection" are applied, through which members 
with the highest fitness value within a population survive and procreate. 
Genetic algorithms can be applied to any problem in which the quantity to be 
optimized can be written as a function of a set of variables (Goldberg, 1989; 
Cartwright, 1993; Keane, 1996). 
The settings of the Genetic Algorithm implemented in the FIDDLE program 
were determined by trial and error and were initially based on experience with 
the determination of molecular constants from rovibronic spectra with genetic 
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algorithms (Hageman et al., 2000). Table 7.1 shows the genetic algorithm 
settings used in FIDDLE. 
 
Table 7.1. Genetic algorithm settings in FIDDLE 
Settings Value 
Maximum number of generations 300 
Population size 400 
Elitism 200 
Crossover type Two-point crossover 
Unit cell edges boundaries 3-40 Å 
Unit cell angles boundaries 60-120° 
Orientation angles boundaries 0-360° 
Torsion angles boundaries 0-360° 
New random value within 
boundaries 
Mutation type 
Mutation probability 0.02 
Selection type Probabilistic 
Fitness type Weighted cross correlation function 
 
The unit cell parameters (cell edges and angles) and the positional parameters 
such as orientation angles and the torsion angles are randomly set within a 
range of values during initialization (see Table 7.1). This also holds for the 
translation vector(s) but the boundaries for these parameters are dependent on 
the space group.  
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7.2.3 Comparison of powder diffraction patterns in FIDDLE: the fitness 
function 
The RMS (Root Mean Square) criterion is a well known criterion that is based 
on the sum of the squared differences between n observed and n calculated data 
values, respectively yi(obs) and yi(calc). A well-known criterion for powder 
pattern similarity is Rwp (R-weighted pattern). This criterion is used for the 
refinement of crystal structures on XRPD data and also for structure solution 
from XRPD data. Rwp is similar to an RMS criterion but the squared differences 
are weighted according to the standard deviations in the observed intensities.  
R  wp =( i=1, n wi (yi(obs)-yi(calc))2)1/2 / ( i=1, n wi yi(obs)2 )1/2
wi = 1/yi(obs) 
Rwp can only be used when the peak positions in the observed and calculated 
powder patterns are the same or at least very close. It is therefore useless for the 
comparison of powder patterns corresponding to structures with significantly 
different unit cells. 
The WCC (Weighted Cross Correlation) criterion was developed to deal with 
cases where two patterns are different with respect to peak positions. It is based 
on correlation functions (de Gelder et al., 2001):  
WCC =  wfg(r)cfg (r)dr / ( wff (r)cff (r)dr  wgg(r)cgg (r)dr) 1/2 
cfg (r) = f(x)g(x+r)dx 
The weighting function, which extracts information from the correlation 
functions, can be adapted to influence the sensitivity for shifts in peak 
positions, in XRPD as a result of lattice parameter variations. This is done by 
changing the value of width l: 
wfg(r) = 1 - | r | / l  if | r | < l 
wfg(r) = 0   if | r |  l 
wff (r) = wgg(r) = wfg(r) 
The WCC criterion is always normalized and scaling is unnecessary since this is 
done implicitly. Comparison of deformed patterns, caused by unit cell 
variations, is possible with the WCC criterion since it recognizes shifted peaks. 
When we divide the intensities of the powder patterns by the standard 
deviations in the observed intensities and calculate WCC at r = 0, we obtain the 
relation between WCC and Rwp, a relation between a sine and cosine function: 
WCCr=0 = (1 - Rwp2)1/2 
So, (only) for r = 0 there is a direct and clear relation between Rwp and WCC. 
 
7.3  EXPERIMENTAL 
16 compounds covering a range of structural complexity, number of torsion 
angles, different Z’ and different space groups were selected from the CSD in 
order to test the methodology implemented in the FIDDLE program (Table 
7.2). 
The known crystal structure of morphine anhydrate was re-determined from 
laboratory X-ray powder diffraction data with the FIDDLE program. This re-
determination was carried out to test the performance of the FIDDLE method 
for experimental data. 
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Table 7.2. Compound name and corresponding molecular formula 
Code Compound name Molecular formula 
CSD Refcode 
1 Dihydroqinghaosu C15H24O5 COTYAL 
2 
3-Methoxy-11-methyl-4a,5,9,10,11,12-
hexahydro-6H-benzofuro(3a,3,2-
ef)(2)benzazepin-6-ol 
C17H21NO3 SIBHAM 
3 17-Hydroxy-7-methyl-androst-5-en-3-one C20H30O2 HMANDR 
4 (-)-S-2-(2-Chlorophenyl)-2-methylaminocyclohexanone C13 H16ClNO XURCAO 
5 (+)-R-2-(2-Chlorophenyl)-2-methylaminocyclohexanone C13H16ClNO XURCES 
6 2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid C13H8F2O3 FAFWIS02 
7 (R)-(-)-3-Acetoxy-quinuclidine methiodide C10H18NO2
+I - ACQUIN 
8 2-Amino-6-ethyl-4,5,7,8-tetrahydro-6H-oxazolo(5,4-d)azepine C9H15N3O BERFUZ 
9 3-(2-Hydroxyphenyl)-4-methyl-1,2,4-2-triazoline-5-thione C9H9N3OS HPMTZT 
10 (R)-(+)-2-(2-Oxo-3-piperidinyl)-1,2-benzisothiazol-3(2H)-one-1,1-dioxide C12H12N2O4S SUCROS01 
11 Sucrose C12 H22 O11 CAVGOV 
12 2-(2,6-Dichloro-3-methylphenyl)-aminobenzoic acid C14H11Cl2NO2 MECLOF10 
13 
(3a)-4,4,6-Trichloro-7-methoxy-
3,4,5,6-tetrahydro-2H-3a,5-
methanoazulene 
C12H13Cl3O RUWLOK 
14 2-Phenyl-7-methyl-8-azahypoxanthine C11H9N5O AZHPXA 
15 10,11-Dihydro-10-hydroxy-5(H)-dibenz(b,f)azepine-5-carboxamide C15H14N2O2 KAMCEG 
16 
(3-(((2-((Aminoiminomethyl)amino)-4-
thiazolyl)methyl)thio)-N-
(aminosulfonyl)propanimidamide)-
nickel(ii) 
C8H13N7NiO2S
3 
BEVQAV 
 
The unknown crystal structures of three compounds (ethinyl estradiol 
anhydrate, naltrexone monohydrate and creatine anhydrate) were determined 
from laboratory X-ray powder diffraction data using the FIDDLE program. 
Indexing the three powder patterns with the most commonly used indexing 
programs, such as: DICVOL91, ITO and TREOR, was not successful and 
therefore the determination of these three crystal structures was of particular 
interest. 
The X-ray powder diffraction measurements for the structure solutions were 
performed using a Bruker D8 AXS Advance X-ray Diffractometer. The D8 was 
equipped with a Johansson type monochromator with a focusing curved Ge 111 
crystal. A VÅNTEC-1 detector was used with an effective angular region of 2. 
The data were collected in transmission capillary geometry using 
monochromatic Cu K1 radiation. The most important instrumental and data 
collection parameters are presented in Table 7.3. 
Table 7.3. Instrumental and data collection parameters 
Typical instrument settings 
System  Bruker D8 AXS Advance /2 
Generator  40 kV, 40 mA 
Measuring circle (mm)  435 
Radiation (Å)  Cu K1, =1.54056Å 
Monochromator  Primary, focusing curved Ge 111 
Geometry  Transmission capillary configuration 
Sample holder  0.5 mm glass capillary tube 
Detector  VÅNTEC-1 
Typical measuring conditions 
 2-50 Range ( 2) 
 0.0084696 Step size ( 2) 
Step time (s)  50 
Total data collection time (h)  ca 74 
Spinning (rpm)  15 
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7.4 TESTS APPLIED TO CALCULATED POWDER 
DIFFRACTION DATA (A) 
The crystal structures of 16 compounds selected from the CSD database were 
determined with FIDDLE to verify the effectiveness of the program and the 
methodology, for cases with various symmetries and structural complexities 
(Table 7.2 and 7.4). The input molecular models were also obtained from the 
CSD. The calculations were performed on 6 AMD Dual-Core Opteron 280 
machines (two dual core 2.4GHz processors each), all running under the 
LINUX operating system. The total number of seeds used for the various 
crystal structure determinations was between 2400 and 4800. The maximum 2θ 
range used was 40. For each compound the tests were done in the correct space 
group and for the true value for Z'. On the best FIDDLE solutions having the 
highest fitness values a full final Rietveld refinement was carried out using 
Topas 3. Fig. 7.2 shows a representative overlay between the solution with the 
highest fitness value obtained from FIDDLE and the known crystal structure in 
the CSD for one of the studied compounds (FAFWIS02). It is clear that the 
final result obtained with FIDDLE is close to the true crystal structure of this 
compound. The compound has one torsion angle and crystallizes in the 
orthorhombic space group P212121 with unit cell parameters: a=39.700(1) Å, 
b=14.129(2) Å, c=3.835(6) Å, V=2151.51 Å3, Z’=2. From the data presented in 
Table 7.4 it can clearly be seen that when the correct space group and Z' is 
used, the correct unit cell parameters are always found for the top twenty 
solutions. Always the first solution with the highest fitness value appeared to be 
the correct crystal structure. 
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 Figure 7.2. The overlay between the solution with the highest fitness value 
obtained from FIDDLE (red) and the known crystal structure in the CSD 
(green) for FAFWIS02 
Table 7.4. CSD compounds selected for testing of FIDDLE 
CSD refcode Space group Z’ 
No. 
torsion 
angles 
Width 
(Å)* 
No. 
seeds 
Best 
Fitness 
value 
No. 
correct 
unit 
cells in 
the first 
20 
No. 
correct 
solutions 
in the 
first 20 
COTYAL P212121 1 0 1.5 2400 0.8369 20 20 
SIBHAM P212121 1 1 1.5 2400 0.8236 20 20 
HMANDR P212121 1 0 1.5 2400 0.8058 20 20 
XURCAO P212121 1 2 1.5 2400 0.7946 20 20 
XURCES P212121 1 2 1.5 2400 0.7973 20 20 
FAFWIS02 P212121 2 4 0.5 4800 0.7477 20 2 
ACQUIN P1 1 2 1.5 2400 0.9796 19 19 
BERFUZ P21/c 1 1 1.5 4800 0.9491 20 19 
HPMTZT P21/c 1 1 1.5 4800 0.9631 20 20 
SUCROS01 P21 1 5 1.5 2400 0.9619 20 20 
CAVGOV P21 1 1 1.5 4800 0.9706 20 20 
MECLOF10 P-1 1 3 1.5 4800 0.9510 17 17 
RUWLOK Pna21 1 1 1.5 4800 0.9763 20 20 
AZHPXA C2/c 1 1 1.5 4800 0.9664 20 20 
KAMCEG Pbca 1 1 1.5 4800 0.9730 20 20 
BEVQAV Pbcn 1 2 1.5 4800 0.9797 20 20 
*See point 7.5 Tests applied to calculated powder diffraction data (B) 
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To illustrate that in general the correct crystal structure is the one having the 
highest fitness value and that the correct unit cell parameters are more often 
found than a complete solution, a simple test on sucrose data was performed. 
Sucrose is a compound crystallizing in the monoclinic space group P21, with 
unit cell parameters: a=7.7235(5) Å, b=8.6786(7) Å, c=10.824(1) Å, 
=102.982(3)°, V= 706.98 Å3, Z’=1 and having five torsion angles. For this 
compound 20 optimizations were performed. The graph showing the different 
fitness values vs. the number of generations for sucrose is presented in Fig.7.3. 
The simple test for sucrose showed that the correct unit cell parameters are 
found for all 20 optimizations and that the solution with the highest fitness 
value corresponds to the correct crystal structure. 
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Figure 7.3. The different fitness values vs. the number of generations for 
sucrose 
The overlay between the solution with the highest fitness value and the known 
crystal structure in the CSD (green) is presented in Fig. 7.43 as well as a 
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comparison between its corresponding pattern and the theoretical pattern for 
sucrose. 
 
  
Target pattern
Best pattern in population
 
 
 
Figure 7.4. The overlay between the solution with the highest fitness value 
obtained from FIDDLE and the known crystal structure in the CSD (green) for 
sucrose as well as a comparison between the best pattern in the population and 
the theoretical pattern for sucrose 
7.5 TESTS APPLIED TO CALCULATED POWDER 
DIFFRACTION DATA (B) 
Another experiment was carried out on the sucrose data in order to check the 
influence of the value of the width of the weighting function. For this test the 
space group and Z' were again fixed. 2400 Seeds and a maximum 2θ value of 
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40° were used. Fig. 7.5 shows the width vs. the number of correct solutions 
found in the top 80. There is a tendency to a smaller number of correct solutions 
for smaller values of the width, which indicated again that going to narrow 
weighting functions, with Rwp as an extreme case, reduces the performance of 
the genetic algorithm. On the other hand there is a wide range for the value of 
the width for which good results are obtained. Experience showed that a width 
of 0.7 Å is a good compromise between calculation speed and efficiency. 
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Figure 7.5. The number of correct solutions vs. the width 
Searching through all ten space groups implemented in FIDDLE while varying 
Z' from 1 to 3 and using 1.5 Å for the width, the correct crystal structure of 
sucrose was again found, the best solution having a fitness value of 0.9690 (see 
Fig. 7.6). This experiment mimicks the actual situation in a structure solution 
from powder diffraction data where in principle space group and Z' are 
unknown. 
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 Figure 7.6. The overlay between the solution with the highest fitness value 
obtained from FIDDLE (red), obtained after varying the space group and Z', 
and the known crystal structure in the CSD (green) for sucrose 
7.6 TEST APPLIED TO EXPERIMENTAL DATA 
When re-determining the crystal structure of morphine anhydrate, the 
effectiveness of the program was proved once again. For this test the space 
group and Z' were set to their correct value. The number of seeds used was 
9600. A width of 0.7 Å and a maximum 2θ of 50° was used. The first 8 
solutions having the highest fitness value returned the correct crystal structure, 
although the correct unit cell parameters were found within the first 37 
solutions. The quality of the best solution returned by FIDDLE could be used 
directly for Rietveld refinement. The full Rietveld refinement proceeded 
smoothly to reach a minimum characterized by a good fit to the diffraction 
profiles presented in Fig. 7.7 (Rwp=4.31). Morphine anhydrate crystallizes in 
the orthorhombic space group P212121 with unit cell parameters: a=13.8616(5) 
Å, b=12.7775(4) Å, c=7.6903(3) Å, V= 1362.07 Å3. A comparison between the 
best solution obtained from FIDDLE and the final structure obtained after 
Rietveld refinement is presented in Fig. 7.8. 
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 Figure 7.7. The fit after the final Rietveld refinement for morphine anhydrate 
  
Figure 7.8. Comparison between the best solution obtained from FIDDLE (red) 
and the final structure obtained after Rietveld refinement (green) for morphine 
anhydrate 
7.7 APPLICATION TO UNKNOWN CRYSTAL 
STRUCTURES 
Of particular interest were the crystal structures of ethinyl estradiol 
anhydrate, naloxone monohydrate and creatine anhydrate. After collecting the 
X-ray powder diffraction data for the three compounds, indexing using 
DICVOL91, ITO and TREOR failed. The unknown crystal structures of ethinyl 
estradiol, naloxone monohydrate and creatine anhydrate could successfully be 
determined using FIDDLE. Prior information regarding the number of 
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molecules per asymmetric unit was obtained from solid-state NMR and used as 
input in FIDDLE, in order to reduce the computing time. The input molecules 
were obtained from related structures in the CSD. Searching through all ten 
space groups implemented in FIDDLE, using the information about Z’ obtained 
from solid-state NMR, and using a maximum 2θ of 40° and 0.7 Å for the width, 
the final crystal structures of the three compounds were determined 
successfully. 4800 Seeds were used in total for all space groups. For ethinyl 
estradiol the first 40 solutions obtained from FIDDLE indicated the correct unit 
cell. In the case of naloxone monohydrate and creatine anhydrate the first 5, 
respectively 4 solutions indicated the correct unit cell. On the best FIDDLE 
solutions having the highest fitness value a full final Rietveld refinement was 
carried out using Topas 3. The full Rietveld refinements proceeded smoothly to 
reach a minimum characterized by a good fit to the diffraction profiles 
presented in Fig. 7.9 for all three cases. Comparisons between the best solution 
obtained from FIDDLE for ethinyl estradiol anhydrate, naloxone monohydrate 
and creatine anhydrate and the final structures obtained after Rietveld 
refinement are presented in Fig. 7.10. 
Initially, the crystal structure of ethinyl estradiol was determined with the use 
of four programs: IsoQuest, FIDDLE, DASH and TOPAS 3. The IsoQuest 
program was used in order to get information about the unit cell parameters 
from isostructural compounds in the CSD. IsoQuest is a program, which can 
use as input the X-ray powder diffraction pattern and can search for 
isostructural compounds in the CSD (de Gelder et al., 2006).  As a result an 
isostructural compound  (CSD refcode - EYHENO) was found. IsoQuest has an 
extremely low computing time and therefore is a good choice for obtaining 
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information about the space group and Z'. Therefore the computing time of 
FIDDLE can be reduced significantly.  The information about the space group 
obtained from IsoQuest together with the information obtained from solid-state 
NMR about Z' was used in the FIDDLE program in order to determine the 
crystal structure of ethinyl estradiol anhydrate. After running 2400 seeds and a 
width of 1.5 Å the unit cell of ethinyl estradiol anhydrate was obtained. Using 
the unit cell from FIDDLE, the DASH program was applied, followed by a full 
Rietveld refinement (using TOPAS 3). Afterwards, several tests were performed 
on ethinyl estradiol anhydrate data using the FIDDLE program only. It was 
shown that ethinyl estradiol anhydrate could also be determined with FIDDLE 
alone (Rwp=2.15). Therefore, when IsoQuest does not give any useful results, 
performing a full determination with FIDDLE always can lead to a correct 
result although computing time is higher. 
Ethinyl estradiol anhydrate crystallizes in the orthorhombic space group 
P2 2 21 1 1 with unit cell parameters: a=6.918(2) Å, b=21.109(5) Å, c=22.147(6) 
Å, V=3234.5 Å3. 
Naloxone monohydrate (Rwp=2.901) crystallizes in the orthorhombic space 
group P2 2 21 1 1 with unit cell parameters: a= 13.902(7) Å, b=7.257(3) Å, 
c=16.640(8) Å, V= 1678.98 Å3. 
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b) 
 
c) 
Figure 7.9. The fit after the final Rietveld for: a) ethinyl estradiol anhydrate; 
b) naloxone monhydrate; c) creatine anhydrate 
 2 Theta (degrees)
 2 Theta (degrees)
 2 Theta (degrees)
 a) 
 
b) 
 
c) 
Figure 7.10. Comparison between the best solution obtained from FIDDLE 
(red) and the final structure obtained after Rietveld refinement (green) for: 
a) ethinyl estradiol anhydrate; b) naloxone monhydrate; c) creatine anhydrate 
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Creatine anhydrate was successfully determined with FIDDLE and refined 
using Topas3 (Rwp=7.20). Creatine anhydrate crystallizes in the monoclinic 
space group P21/c with unit cell parameters: a=9.838(8) Å, b=5.831(5) Å, 
c=11.679(9) Å, =74.31(2)°, V= 645.062 Å3. Creatine monohydrate, which is 
obtained after hydration of creatine anhydrate, crystallizes in the monoclinic 
space group P21/a with unit cell parameters: a=12.159(1) Å, b=5.038(2) Å, c= 
12.491(2) Å, = 108.87(1)°, V=724.038 Å3.  From a comparison between the 
anhydrate form of creatine and the monohydrate it is clear that dehydration 
takes place with an anisotropic shrinkage of the unit cell of the monohydrate 
(Fig. 7.11). 
 
Figure 7.11. Comparison between the anhydrate (left) and the monohydrate 
(right) forms of creatine 
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Although the quality of the powder diffraction patterns recorded for ethinyl 
estradiol anhydrate and naloxone monohydrate was high enough for crystal 
structure determination, standard indexing proved not to be successful. After 
determining the crystal structure of the two forms, the FIDDLE results pointed 
at impurity peaks appearing at low 2θ angles, peaks that probably hampered the 
indexing process. The impurity in the case of ethinyl estradiol corresponds to 
the hemi-hydrate form and for naloxone monohydrate to the anhydrate form. 
Eventually we were able to obtain a pure form of ethinyl estradiol anhydrate 
and therefore the data presented here do not show any impurity corresponding 
to the hemi-hydrate form. This is not the case for naloxone monohydrate for 
which the most pure form of the monohydrate still had an impurity peak 
corresponding to the anhydrate form. In the case of creatine anhydrate, the 
quality of the X-ray powder diffraction pattern was low and therefore the 
indexing step was impeded by severe peak overlap. Even using the knowledge 
obtained from FIDDLE about the unit cell parameters, the quality of the 
recorded data restricted a Pawley refinement and subsequent structure solution 
with other programs.  
7.8  CONCLUSIONS 
Simultaneous indexing and structure solution is possible using a global 
optimization approach. FIDDLE was successfully used to determine known and 
unknown crystal structures and can be applied to compounds for which the 
indexing step is impeded, for several reasons. Indexing with FIDDLE is 
computationally cheaper than complete structure determination, meaning that 
when a structure is not fully solved the program can still deliver the correct unit 
cell. Any information related to the number of molecules per asymmetric unit 
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obtained from solid-state NMR or knowledge about the chirality of the 
compounds may be input into the program in order to reduce the computational 
time. Nevertheless, FIDDLE is capable of solving structures for which unit cell, 
space group and Z' are unknown. 
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Pharmaceutical compounds have the tendency to crystallize in various 
polymorphs, solvates or hydrates as a function of the crystallization medium, 
temperature and humidity. This can cause many practical problems, including 
changes in stability, dissolution rates, bioavailability, morphology, vapor 
pressure, and packaging: the key factors to the development of appropriate 
dosage forms. Therefore, understanding polymorphism and solvate or hydrate 
formation at the molecular level is of particular interest. It critically depends, 
however, on the availability of powerful structure elucidation methods and 
other methods for solid-state analysis. 
This thesis presents a new strategy for crystal structure determination 
from powder diffraction data that circumvents the difficulties associated with 
separate indexing, one of the major bottlenecks in the powder method. 
Moreover, this thesis deals also with application of different solid-state 
techniques in combination with crystal structure determination for the study of 
solvate and hydrate formation of pharmaceutical compounds and excipients. 
Chapter 2 and 3 deal with aspartame, a sweetener and excipient in drug 
formulation. The crystal structure of aspartame anhydrate was determined 
successfully by collecting X-ray powder diffraction data. Comparison of the 
structures of the hydrates and the anhydrate reveals a remarkable similarity 
between the structures of IA and IB on the one hand and between IIA and IIB 
on the other hand. Minimization experiments suggest that another hemi-hydrate 
polymorph exists and that the ordering of the water molecules inside the 
channels is an essential step in the dehydration mechanism of the hemi-hydrate. 
The hydration/dehydration behavior of aspartame was investigated using hot-
humidity stage X-ray powder diffraction (XRPD) and molecular mechanics 
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modeling in combination with differential scanning calorimetry (DSC) and 
thermogravimetric analysis (TGA). The results are compared to earlier studies 
on aspartame as described in literature. It is shown that earlier transition studies 
were hampered by incomplete conversions and wrong assignment of the forms. 
The combination of the techniques applied in this study now shows consistent 
results for aspartame and yields a clear conversion scheme for the 
hydration/dehydration behavior of the four forms. The systematic study on 
aspartame as presented in this thesis may be of importance for a further 
understanding of the formation of hydrates and shows that the availability of 
crystal structures together with analytical data provides a detailed insight into 
the hydration/dehydration behavior of compounds. 
Chapter 4 presents the crystal structures of four new ethinyl estradiol solvates 
together with a structural study of H-bond formation and isostructurality. The 
characteristic H-bonds formed by the ethinyl estradiol pseudo-polymorphs are 
between the –OH groups attached to C(3) and/or C(17) and the corresponding 
solvent molecules, as well as  hydrogen bonds between different ethinyl 
estradiol molecules, namely between the –OH groups attached to C(3) and 
those attached to C(17).  
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The molecular structure of ethinyl estradiol 
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Ethinyl estradiol forms pseudo-polymorphs mainly with solvents having H-
bond accepting or both accepting and donating propensity and shows a 
remarkable flexibility in forming distinctly different hydrogen-bonding 
patterns, resulting in a diverse set of solvate structures. A high degree of 
similarity can be observed between the crystal packing of the nitromethane and 
dioxane solvates, forming isostructural sheets of ethinyl estradiol molecules 
arranged parallel in a head-to-tail fashion. 
In Chapter 5 the crystal structures of naloxone monohydrate and four new 
anhydrate forms of morphine, naloxone, and their hydrochloride salts, all 
determined from X-ray powder diffraction data, are presented. These new 
structures, together with already known structures from the Cambridge 
Structural Database, enabled us to investigate the influence of the subtle 
molecular differences between these agonist and antagonist, the role of water 
and the effect of the chloride counter-ion on structural properties of morphine 
and naloxone in the solid state. The results suggest that the introduction of 
water or counter-ions like chlorine generate structures with higher dimensional 
hydrogen bonding networks than the corresponding anhydrate or free base 
structures. The counter ion Cl- takes over the role of the water molecules in the 
anhydrates forming H-bonds with the N atom as well. When water molecules 
are present, Cl- prefers the water molecules instead of the N atom. If water 
molecules and the counter ion are not present, intermolecular H-bonds are 
formed between different -OH groups. The allylic group of the naloxone 
molecule takes over the role of the counter ion Cl- only in its absence. Further 
more, the N atom can act as a H-bond donor as well as an acceptor. 
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Chapter 6 deals with two antagonists, naloxone and naltrexone, chemically 
and structurally related. All known hydrate and anhydrate forms of naltrexone 
and naloxone hydrochloride crystallize in the orthorhombic space group 
P212121, although the crystal packings show clear differences. Dehydration 
causes in both cases no breaking of the symmetry but the change in unit cell is 
for naltrexone profoundly different from naloxone. Dehydration of naltrexone 
hydrochloride tetra-hydrate takes place with shrinkage of the volume of the unit 
cell, while dehydration of naloxone hydrochloride di-hydrate results in an 
expansion of the unit cell. The H-bonding patterns corresponding to the two 
antagonists seem to be footprints for the crystal structures and also for their 
hydration/dehydration behavior. Despite naltrexone and naloxone 
hydrochloride are chemically and structurally related and show similarities in 
their biological behavior, the overall hydration and dehydration process is 
fundamentally different. 
In Chapter 7 a new methodology for structure determination is proposed for 
non-indexable powder patterns. FIDDLE is a method for determination of 
crystal structures from powder diffraction data that circumvents the difficulties 
associated with separate indexing. Structure determination from powder 
diffraction data can be seen as a process of global optimization of all model 
parameters, including the unit cell parameters. This strategy is applied in the 
FIDDLE program. For the simultaneous optimization of the parameters that 
describe a crystal structure a genetic algorithm together with a pattern matching 
technique based on auto and cross correlation functions is used. This "one-pot" 
strategy for indexing and structure determination, as applied in FIDDLE, was 
successfully used for determining the unknown crystal structures of ethinyl 
     | Summary  208 
estradiol anhydrate, naloxone monohydrate and creatine anhydrate, cases for 
which indexing was problematic. 
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Farmaceutische verbindingen hebben vaak de neiging om in verschillende 
polymorfen, solvaten of hydraten te kristalliseren, afhankelijk van het 
kristallisatiemedium, de temperatuur en/of luchtvochtigheid. Dit kan vele 
praktische problemen geven, zoals veranderingen in stabiliteit, oplossnelheid, 
biobeschikbaarheid, morfologie, dampspanning en verpakking: de belangrijkste 
factoren bij de ontwikkeling van de juiste dosis-formulering. Inzicht in 
polymorfie, solvaat- en/of hydraatvorming op moleculair niveau is hierbij van 
bijzonder belang. Bepalend hiervoor is echter wel de beschikbaarheid van 
krachtige methodes voor structuuropheldering en andere methodes voor de 
analyse van vaste stoffen.  
Dit proefschrift stelt een nieuwe strategie voor de bepaling van de 
kristalstructuur uit poederdiffractiegegevens voor die problemen bij indicering 
van poederpatronen, één van de belangrijkste stappen en knelpunten bij de 
poedermethode, kan omzeilen. Voorts behandelt dit proefschrift ook de 
toepassing van verschillende vaste stof technieken, in combinatie met 
kristalstructuurbepaling, op de bestudering van solvaat- en hydraatvorming van 
een aantal farmaceutische verbindingen en vulstoffen.  
Hoofdstuk 2 en 3 behandelen aspartaam, een zoetstof en een vulmiddel 
gebruikt in medicijnformuleringen. De kristalstructuur van aspartaam anhydraat 
kon met succes bepaald worden uit gegevens verkregen met 
Röntgenpoederdiffractie. Vergelijking van de structuren van de hydraten en het 
anhydraat levert een opmerkelijke gelijkenis op tussen de structuren van vorm  
IA en IB enerzijds en die van IIA en IIB anderzijds. Uit minimalisatie-
experimenten komt naar voren dat er misschien nog een ander hemi-hydraat 
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bestaat en dat het ordenen van de watermoleculen binnen de kanalen een 
essentiële stap is in het dehydratatiemechanisme van het hemi-hydraat van 
aspartaam.  
Het hydratatie/dehydratatiegedrag van aspartaam wordt ook onderzocht 
gebruik makend van "hot-humidity stage"  Röntgenpoederdiffractie (XRPD) en 
moleculaire mechanica in combinatie met differential scanning calorimetry 
(DSC) en thermogravimetrische analyse (TGA). De resultaten worden 
vergeleken met vroegere studies van aspartaam zoals beschreven in de 
literatuur. Er wordt hierbij aangetoond dat de vroegere overgangsstudies door 
onvolledige omzettingen en verkeerde toekenningen van de verschillende 
vormen werden belemmerd.  
De combinatie van technieken, zoals in deze studie worden toegepast, laten 
nu consistente resultaten zien voor aspartaam en leveren een duidelijk 
omzettingsschema op voor het hydratatie/dehydratatiegedrag van de vier 
vormen. De systematische studie van aspartaam zoals in dit proefschrift wordt 
toegepast kan van belang zijn voor een verder inzicht in de vorming van 
hydraten en toont aan dat de beschikbaarheid van kristalstructuren tezamen met 
analytische gegevens een gedetailleerd inzicht geeft in het 
hydratatie/dehydratatiegedrag van verbindingen. 
Hoofdstuk 4 beschrijft de kristalstructuren van vier nieuwe ethinylestradiol 
solvaten tezamen met een studie van waterstofbrugvorming en isostructuraliteit. 
De kenmerkende waterstofbruggen die door de pseudo-polymorfen van 
ethinylestradiol worden gevormd bevinden zich tussen de -OH groepen die aan 
C(3) en/of C(17) zijn gebonden en de betreffende oplosmiddelmoleculen, 
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evenals tussen verschillende moleculen van ethinylestradiol, te weten tussen de 
-OH groepen die aan C(3) zijn gebonden en die aan C(17). 
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De moleculaire structuur van ethinylestradiol 
Ethinylestradiol vormt hoofdzakelijk pseudo-polymorfen met oplosmiddelen 
die waterstofbruggen kunnen accepteren of zowel waterstofbruggen kunnen 
accepteren als doneren en vertoont een opmerkelijke flexibiliteit in het vormen 
van duidelijk verschillende waterstofbrugpatronen, resulterend in een 
uiteenlopende reeks solvaatstructuren. Een hoge graad van gelijkenis kan tussen 
de kristalpakking van het nitromethaan- en dioxaansolvaat worden 
waargenomen. In beide gevallen worden isostructurele lagen van 
ethinylestradiol moleculen in een kop-staart configuratie waargenomen.  
In Hoofdstuk 5 worden de kristalstructuren van naloxon monohydraat en vier 
nieuwe anhydraatvormen van morfine, naloxon, en hun 
waterstofchloridezouten, allen bepaald uit poederdiffractiegegevens, 
gepresenteerd. Deze nieuwe structuren, tezamen met reeds bekende structuren 
uit de Cambridge Structural Database, stelden ons in staat om de invloed van de 
subtiele moleculaire verschillen tussen deze agonist en antagonist, de rol van 
water en het effect van het chloride tegenion op structurele eigenschappen van 
morfine en naloxon in de vaste toestand te onderzoeken. De resultaten 
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suggereren dat het introduceren van water of tegenionen zoals chloor structuren 
met hogerdimensionale waterstofnetwerken dan het overeenkomstige anhydraat 
of de vrije base opleveren. Het Cl- tegenion neemt de rol van de 
watermoleculen over in de anhydraten waarbij waterstofbruggen met het 
stikstofatoom worden gevormd. Wanneer watermoleculen aanwezig zijn, 
verkiest Cl- de watermoleculen in plaats van het stikstofatoom. Als zowel de 
watermoleculen als het tegenion niet aanwezig zijn, worden de intermoleculaire 
waterstofbruggen gevormd tussen verschillende -OH groepen. De allylgroep 
van het naloxonmolecuul neemt de rol van het Cl- tegenion over zodra Cl- 
afwezig is. Verder treedt het stikstofatoom zowel als waterstofbrugdonor als     
-acceptor op.  
Hoofdstuk 6 behandelt twee antagonisten, naloxon en naltrexon, die 
chemisch en structureel verwant zijn. Alle bekende hydraat- en 
anhydraatvormen van naltrexon- en naloxonwaterstofchloride kristalliseren in 
de orthorhombische ruimtegroep P212121, hoewel de kristalpakkingen 
duidelijke verschillen vertonen. Dehydratatie veroorzaakt in beide gevallen 
geen verbreking van de symmetrie maar de verandering in de eenheidscel is 
voor naltrexon aanmerkelijk anders dan voor naloxon. Dehydratatie van het 
tetrahydraat van naltrexonwaterstofchloride vindt plaats met verkleining van 
het volume van de eenheidscel, terwijl dehydratatie van het dihydraat van 
naloxonwaterstofchloride in uitzetting van de eenheidscel resulteert. De 
waterstofbrugpatronen behorende bij de twee antagonisten lijken vingerdrukken 
te zijn voor de kristalstructuren en ook voor hun hydratatie/dehydratatiegedrag. 
Ondanks dat naltrexon- en naloxonwaterstofchloride chemisch en structureel 
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verwant zijn en gelijkenissen vertonen in hun biologisch gedrag, is het algehele 
hydratatie en dehydratatieproces fundamenteel verschillend.  
In Hoofdstuk 7 wordt een nieuwe methodologie voor structuurbepaling 
voorgesteld voor niet-indiceerbare poederpatronen. FIDDLE is een methode 
voor bepaling van kristalstructuren uit poederdiffractiegegevens die problemen 
die samenhangen met de afzonderlijke indiceringsstap kan omzeilen. 
Structuurbepaling uit poederdiffractiegegevens kan gezien worden als een 
proces van globale optimalisering van alle modelparameters, met inbegrip van 
de parameters van de eenheidscel. Deze strategie wordt toegepast in het 
FIDDLE programma. Voor de gelijktijdige optimalisering van de parameters 
die een kristalstructuur beschrijven wordt een genetisch algoritme samen met 
een patroonherkenningsstechniek, gebaseerd op auto- en kruiscorrelatiefuncties, 
gebruikt. Deze strategie voor simultane indicering en structuurbepaling, zoals in 
FIDDLE wordt toegepast, werd met succes gebruikt voor het bepalen van de 
onbekende kristalstructuren van ethinylestradiol anhydraat, het monohydraat 
van naloxon en het anhydraat van creatine, allen gevallen waarbij indicering 
van de poederpatronen problematisch was. 
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